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The regulatory capacity of long non-coding RNA in 
Plasmodium falciparum malaria 
 
 
Abstract 
The mechanisms underpinning gene regulation in P. falciparum malaria remain largely 
elusive, though mounting evidence suggests a major role for epigenetic feedback. Interestingly, 
long non-(protein)-coding RNAs (lncRNAs) have been found to play a dominant role in 
initiating and guiding the transcriptional, epigenetic, and post-transcriptional status of specific 
loci across a broad range of organisms. LncRNAs are uniquely poised to act co-transcriptionally 
on neighboring loci, and/or to remain physically tethered at their site of origin, and through 
sequence-specific binding activities can impart temporal and spatial specificity to ubiquitously 
expressed nuclear protein complexes. Proteins, on the other hand, must be translated in the 
cytoplasm, and hence lose memory of their transcriptional origins. Encouraged by these features 
of lncRNAs, we set out to investigate the regulatory capacity of P. falciparum lncRNAs on a 
genome-wide scale.  
First, we surveyed transcriptional activity across approximately one quarter of the P. 
falciparum genome using a custom high-density DNA tiling array. We predicted a set of 60 
developmentally regulated intergenic lncRNAs, and found that many of these novel loci 	 ﾠ
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neighbored genes involved in parasite survival or virulence pathways. Remarkably, upon further 
analysis of intergenic lncRNA properties, we discovered a family of twenty-two telomere-
associated lncRNAs encoded in the telomere-associated repetitive element (TARE) region of P. 
falciparum chromosome ends. We found that each lncRNA-TARE was encoded adjacent and 
divergent to a subtelomeric var virulence gene. Moreover, we found that lncRNA-TARE 
expression was sharply induced between the parasite DNA replication and cell division cycles, 
that lncRNA-TARE loci contained numerous transcription factor binding sites only otherwise 
found in subtelomeric var promoter regions, and that the GC content and evolutionary sequence 
conservation of lncRNA-TAREs was similar to that of P. falciparum ribosomal RNA.  
Next, we set out to assemble P. falciparum intergenic lncRNA and antisense RNA 
transcript structures using state-of-the-art deep sequencing and computational tools. Towards this 
end, we harvested an unprecedented sample set that finely maps temporal changes across 56 
hours of P. falciparum blood stage development, and developed and validated strand-specific, 
non-polyA-selected RNA sequencing methods. This enabled the annotation of over one thousand 
high-confidence, bona fide lncRNA transcript models, and their comprehensive global analysis. 
We discovered an enrichment of negatively correlated, tail-to-tail overlapping sense-antisense 
transcript pairs, suggesting a conserved role for antisense-mediated transcriptional interference in 
P. falciparum gene regulation. We also discovered a highly correlated spliced antisense 
counterpart to a gene required for sexual commitment, that the expression of an intriguing subset 
of antisense transcripts significantly dropped during parasite invasion, and that lncRNA-TARE 
and ‘sterile’ var virulence gene transcription was markedly up-regulated during parasite 
invasion. Lastly, we predicted over one thousand circular RNAs (circRNAs), and validated six 
circRNA transcript structures.  	 ﾠ
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Importantly, this thesis work represents the first focused investigation of lncRNAs in P. 
falciparum malaria, with the characterization of a compelling family of telomere-associated 
lncRNAs and numerous antisense RNAs. The data, methods, and results herein offer exceptional 
technological advancements coupled with compelling insights into the biology of the devastating 
human pathogen P. falciparum malaria. It is my hope that this work will facilitate future P. 
falciparum lncRNA functional studies and the strand-specific profiling of additional P. 
falciparum samples. 
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Chapter 1 | Introduction 
1. 1  Malaria 
There are at least one hundred species of the genus Plasmodium, and each parasite 
species is highly specialized to cause malaria in a specific host: humans, primates, birds, reptiles, 
or rodents. Transmission of each species depends on a specific vector as well, such as flies or 
mosquitoes. Of the four Plasmodium species that commonly infect humans, P. falciparum is by 
far the most lethal, and is alone responsible for over 90% of malaria-associated deaths. While 
many drugs can cure P. falciparum malaria, and less than 1% of natural infections lead to severe 
malaria, P. falciparum malaria remains one of the most deadly, burdensome, and unchecked 
infectious diseases of 2014 [1-4]. Annual malaria-associated deaths continue to approach one 
million [2]. This is largely due to the lack of an effective vaccine, limited access to drugs, the 
rapid emergence of drug-resistant strains, and, perhaps most significantly, one hundred countries 
where malaria infection and transmission constantly occur [1,5].  
In contrast to cancer, dementia, or other diseases that are often contracted in old age, 
malaria is disproportionately taxing to the young and the innocent. Children living in sub-
Saharan Africa, or other malaria-endemic regions, are particularly vulnerable to severe malaria 
and malaria-associated death [1,3]. Additionally, pregnancy-associated malaria can be highly 
deadly to both the mother and developing child [6]. While repeated exposure to P. falciparum 
does not render the parasite incapable of establishing an infection, clinical immunity, or 
protection from the life-threatening consequences of malaria infection, does typically accumulate 
with age and exposure to different P. falciparum strains [7]. In sum, malaria symptoms may 	 ﾠ
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range in severity from entirely asymptomatic, to headaches, low blood sugar, anemia, and fevers, 
to kidney failure, severe anemia, respiratory distress, cerebral malaria, and death [3,4].  
A single-dose, long-lasting malaria vaccine conferring sterilizing immunity is the 
ultimate hope for the future [8,9]. However, as neither naturally occurring sterilizing immunity 
nor elite controllers of P. falciparum infection have been documented, this is a daunting 
challenge. On the other hand, acquired immunity is virtually 100% protective against severe 
malaria [7], children refractory to severe malaria have recently been reported [10], and 
pregnancy-associated infections are known to involve a moderately conserved parasite ligand 
[11]. Thus, development of a vaccine conferring protective, clinical immunity to malaria-naïve 
individuals or during pregnancy may be more immediately feasible [12]. Transmission-blocking 
vaccine (TBV) development is another intriguing consideration, as are novel approaches that 
target the vector stages and/or vectors specifically [13,14]. To develop and deploy anti-malarial 
strategies faster than the parasite and vector thwart them, and potentially faster than nature has 
provided them, will require a sustained commitment to basic, field, and translational malaria 
research, cross-disciplinary approaches, improvements in local health care systems and 
surveillance, and cross-talk between the various groups [5,15].  
1.2  The P. falciparum life cycle 
  The P. falciparum life cycle is complex, and involves multiple stage transformations in 
both a human host and an anopheline mosquito vector [Figure 1.1] [16-18]. During a blood 
meal, only a few infectious parasite forms may be transferred from mosquito to human and/or 
vice-versa [19]. However, the parasite utilizes a unique form of schizogony involving multiple 
rounds of asexual replication to rapidly expand population numbers after both bottlenecks [20]. 	 ﾠ
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In the human, an asexual liver schizogony stage precedes the asexual blood schizogony stage. 
The latter blood stage occurs in host red blood cells (RBCs), repeats every 48 hours, and causes 
all clinical malaria symptoms [3,4]. In the mosquito, when both a male and a female gametoycte 
are ingested, rapid sexual replication events are followed by asexual schizogony [20]. The P. 
falciparum parasite thus also uses sexual replication in the mosquito vector to recombine genetic 
information and to accumulate adaptations. Importantly, while sexual replication occurs in the 
mosquito, the prerequisite switch from asexual to sexual stage gametocyte development, or 
gamete precursor development, takes place within the human host [21].  
Figure 1.1 | Overview of the P. falciparum malaria life cycle and host transfer. Reprinted by 
permission from Macmillan Publishers Ltd: Nature Reviews Genetics [16], copyright 2007.  
 
Traversing the parasite cycle in more detail reveals the remarkable fine-tuning of 
developmental programs and parasite processes necessary for parasite survival. From the 
perspective of an infectious mosquito bite, the first stage in the parasite life cycle is the rapid 
traversal of approximately 15-40 haploid sporozoites from below the skin layer into the human 	 ﾠ
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blood stream [22]. Within thirty minutes, a handful of these sporozoites successfully invade liver 
cells [23]. Over the course of two weeks, each sporozoite then duplicates its genome and 
completes approximately 13 to 14 rounds of alternating DNA synthesis and mitosis (S/M) [20]. 
Subsequently, thousands of haploid daughter merozoites are released into the blood stream, 
streamlined to find, invade, and feed on RBCs [24]. Within minutes, these liver-stage merozoites 
accomplish their mission, marking the end of the clinically asymptomatic pre-erythrocytic phase.  
  During the next phase of parasite development, known as the clinically symptomatic 
intraerythrocytic developmental cycle (IDC), the parasite repeatedly progresses through a ring 
(0-24 hours post-invasion [hpi]), a trophozoite (24-36 hpi), and a schizont (36-48 hpi) stage in 
host RBCs [25]. During the ring stage, the parasite flattens into a thin ring-like form, and begins 
digesting RBC cytosol and catabolizing hemoglobin [26]. Notably, the parasite also exports 
hundreds of proteins to repurpose and remodel the normal RBC machinery and RBC surface, 
such that the later trophozoite and schizont stages are able to adhere to microvasculature, 
sequester in various host tissues, and avoid splenic clearance [25,27]. During the trophozoite 
stage, the parasite becomes notably rounder and larger; DNA replication begins, and metabolic 
activity and protein synthesis dramatically increase [26]. During the schizont stage, 
approximately 3 to 4 rounds of S/M occur, followed by nuclear division, packaging, and the 
release of up to 32 haploid daughter merozoites into the blood stream [20]. The vast majority of 
these blood-stage merozoites are committed to initiate a new IDC [28,29].   
  Interestingly, however, a poorly defined switch in developmental program occurs in a 
small subset of asexually cycling blood stage parasites, such that all of the daughter merozoites 
from a given schizont become sexual gametocytes. Moreover, all of the daughter merozoites 
become either male or female gametocytes [21,28,30]. Sex ratios can vary considerably, though 	 ﾠ
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a three-fold higher female to male gametocyte ratio is typically observed in vivo [31]. Mature 
gametocyte development takes approximately 8-12 days in P. falciparum, which is significantly 
longer than gametocytogenesis in any other Plasmodium species (except P. reichenowi), and 
progresses through five distinct morpholigical stages [32].  
Stage I gametocytes (up to 40 hpi) are hard to discern from asexual parasite stages by 
eye, though an antibody to the membrane protein Pfs16 or the cytoplasmic RNA-binding protein 
Pfg27/25 can be used to identify early gametocytes [33,34]. During this stage, the parasite 
exports hundreds of proteins, again repurposing and remodeling the normal RBC machinery and 
surface [35,36]. These changes confer novel adhesive properties to the host RBC, and allow 
gametocytes to strategically sequester and avoid splenic clearance until they reach maturity 
[37,38]. Stage II-V gametocytes can be distinguished by eye. The growing gametocyte lengthens 
to occupy the majority of the RBC, and from stage IV onwards, male and female gametocytes 
are visibly distinct [21]. Mature stage V gametocytes are often crescent shaped, and circulate in 
the peripheral blood stream, waiting to be ingested by a mosquito [39].  
  When a male gametocyte is ingested, within fifteen minutes it completes three rounds of 
S/M, nuclear division, and cytokinesis to create eight male gametes [20,37]. When a female 
gametocyte is ingested, it also rapidly develops into a female gamete. The fusion between a male 
and a female gamete then yields a diploid zygote. The zygote soon develops into a motile 
ookinete, which must traverse the mosquito midgut epithelial wall, and embed itself into the 
basal lamina as an oocyst [18]. Over the next few days, the oocyst undergoes 10 to 11 rounds of 
S/M, which is followed by a mass nuclear division and the release of thousands of haploid 
daughter sporozoites [20]. These sporozoites then migrate to the mosquito salivary gland, ready 	 ﾠ
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to be transmitted to a new host. All together, the mosquito phase of the P. falciparum life cycle 
takes approximately 10-14 days [19].  
1. 3  Pathogenesis of P. falciparum infection 
  There are three major severe malaria syndromes: severe anemia, cerebral malaria, and 
respiratory distress [3,4,40]. Respiratory distress presents in 40-60% of severe malaria cases, and 
is caused by reduced oxygen delivery to tissues and metabolic acidosis [4]. As only about 1% of 
malaria infections progress to severe malaria, severity of disease and clinical outcome is likely 
caused by a complex combination of parasite, host, geographic, and social factors [3]. In terms of 
P. falciparum factors, different parasite strains have different multiplication rates, drug 
sensitivities, and repertoires of antigen and invasion ligands [41-44]. Protective host factors 
include previous exposure, lack of pregnancy, otherwise good health, and certain genetic 
backgrounds [3]. For example, sickle cell trait or α-thalassaemia alleles greatly reduce the 
incidence of severe malaria [45-47]. Access to treatment, political stability, transmission 
intensity, and other geographic, cultural, and socioeconomic factors are also important variables 
in severe malaria progression [3].  
Interestingly, P. falciparum is responsible for the vast majority of severe malaria cases 
and deaths. This heightened pathogenicity is largely due to the redundancy and diversity of 
invasion and adhesion ligands that have expanded in the P. falciparum genome, as well as their 
precise regulation [3,4,48-50]. For example, in contrast to the human malaria parasite P. vivax, 
which historically can only invade reticulocytes with the Duffy blood group (Fy) antigen [51], P. 
falciparum can invade most types of RBCs [24,52]. It can also use sialic acid dependent or 
independent invasion pathways [52]. The multi-gene P. falciparum Erythrocyte Binding Antigen 	 ﾠ
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(PfEBA) and P. falciparum Reticulocyte Binding Antigen Protein homolog (PfRh) families 
encode sialic acid dependent and independent invasion ligands, respectively, with many 
redundant family members [53-55].  
The host splenic clearance system removes RBCs with altered deformability, which in 
itself is an effective way to clear parasite-infected RBCs from the blood stream [56]. However, 
P. falciparum encodes a hyper-variable family of sixty P. falciparum Erythrocyte Membrane 
Protein 1 (PfEMP1)-encoding var genes [57]. This family contributes a key RBC surface adhesin 
during the asexual blood stage, and gives P. falciparum unique cytoadherence properties as 
compared to other human Plasmodium species. PfEMP1 adhesins can bind to protein and 
carbohydrate receptors on the surface of endothelial cells, such as CD36, ICAM1, PECAM, 
CR1, heparin sulfate (HS), and placental chondroitin sulfate A (CSA) [4,49]. The ability of P. 
falciparum to hide out and sequester in various host organs, such as the heart, lungs, kidneys, 
liver, brain, and/or placenta, is critical for P. falciparum pathogenesis and persistence [3,4,48-
50]. Developing sexual stages are also known to cytoadhere until reaching maturity, although the 
adhesion molecules involved are less clear [37,38].  
1.4  Gene regulation in P. falciparum 
  Approximately 5,300 protein-coding genes are encoded in the 24 megabase P. falciparum 
genome, in addition to clusters of non-(protein)-coding ribosomal RNA (rRNA), transfer RNA 
(tRNA), and small nucleolar RNA (snoRNA) genes [58]. P. falciparum genes are distributed 
onto fourteen linear chromosomes, and two small circular apicoplast and mitochondrial 
chromosomes [58]. Remarkably, approximately 80% of the P. falciparum genome is periodically 
regulated during the asexual blood stage [59,60]. By comparison, only 15% of yeast and human 	 ﾠ
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genes are periodically regulated during the cell cycle [61,62]. Moreover, gene ontology analysis 
of co-expressed P. falciparum genes has suggested that the periodic blood stage cascade dictates 
a ‘just in time’ manufacturing process, or in other words that the steady-state mRNA levels of 
most genes strongly correlates with the timing of their function [59,60].  
Notably lacking from the P. falciparum genome are the RNA interference machinery 
components and microRNAs, as well as many classes of sequence-specific transcription factors 
[63,64]. However, the parasite does have 27 plant-like ApiAP2 DNA-binding factors with 
putative sequence-specific transcription factor activities, an intriguing abundance of CCCH-type 
zinc finger proteins, and several classes of RNA-binding proteins [64-67]. CCCH-type zinc 
finger proteins are known to regulate mRNA stability and translation in other eukaryotes, though 
their roles in P. falciparum have not yet been functionally investigated [68]. To date, numerous 
ApiAP2 DNA-binding factors have been experimentally knocked out or knocked down, and 
have been shown to play an important role in P. berghei ookinete formation, oocyst to sporozoite 
maturation, liver stage development, and gametocyte development [69-72]. ApiAP2 factors have 
been implicated in P. falciparum gametocyte development and virulence gene regulation as well 
[73-75].   
The P. falciparum genome encodes a wide array of conserved chromatin reader, writer, 
and eraser enzymes, and both conserved and unusual histone variants [76]. Additionally, at least 
44 different histone tail post-translational modifications (PTMs) have been observed using mass 
spectrometry [77]. Genome-wide chromatin immunoprecipitation ChIP-chip and ChIP-seq 
studies have shown that the distribution of many PTMs is dynamic [78-80]. Specifically, the 
parasite has at least four histone acetyltransferases (HATs), at least ten histone lysine 
methyltransferases (HKMTs), and at least five histone deacetylases (HDACs) [76]. Common 	 ﾠ
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histone tail PTMs include acetylation, methylation, phosphorylation, ubiquitination, poly-ADP-
ribosylation, and sumoylation [77]. Complex combinatorial effects of histone variants and PTMs 
are hypothesized [76]. Notably, more activating PTMs have been observed in P. falciparum than 
silencing PTMs, which is consistent with reports showing that approximately 90% of the P. 
falciparum genome is in a transcriptionally permissive, euchromatic state [77,80]. The other 10% 
of the genome is marked by H3K9me3 and P. falciparum Heterochromatin Protein 1 (PfHP1) 
[80-82], and is thought to represent heterochromatic islands that help to maintain multi-gene 
family members in a silenced state [83]. Indeed, the vast majority of PfHP1 occupancy overlaps 
with multi-gene families [81].   
Taken together, it is likely that both transcription factors and chromatin state are largely 
important in the precise control of P. falciparum network-wide and local gene expression 
programs [76,84-86]. It is also becoming increasingly clear that post-transcriptional 
modifications, such as mRNA stability and translational repression, are global themes in P. 
falciparum gene regulation [17,87-90]. Early case studies pointed to a role for post-
transcriptional regulation in sexual differentiation events [91,92] and mitochondrial RNA 
processing [93]. Shock et al. then investigated mRNA decay rates during the asexual blood stage, 
and found a profound global extension in the rate of mRNA decay during the blood stage [88]. 
Other groups have compared steady-state mRNA levels to protein levels or ribosome-associated 
RNA levels during the blood stage, and have reported that approximately 30% of P. falciparum 
genes are subject to significant translational repression [60,87].  
Focusing in on sexual stage gametocyte development, translational repression is likely to 
be key to the rapid developmental events triggered in the mosquito midgut [94]. Experiments in 
P. falciparum suggest that there is no DNA replication during gametocyte development [95], and 	 ﾠ
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that RNA synthesis significantly declines after day six [96,97]. However, from studies involving 
the rodent malaria parasite P. berghei, it appears that the female gametocyte stockpiles mRNAs 
during the later gametocyte stages in a ribonucleoprotein complex containing the DDX6-class 
RNA helicase DOZI (development of zygote inhibited) and several additional factors [94,98]. 
Potentially hundreds of mRNAs, including Pfg25 and Pfg28, are then rapidly translated in the 
mosquito in response to environmental stimuli [60,94,99]. Knocking out the Puf-family RNA-
binding protein (PfPuf2) has also been shown to disproportionately repress male gametocyte 
development [100]. Puf-family proteins are known to regulate translation and RNA stability in 
other eukaryotes [101].   
Additionally, case studies point to the important roles of PTMs in regulating P. 
falciparum protein activity. For example, proteolytic cleavage of two P. falciparum phosphatases 
(PP7 and PP2b) confers unique functional properties to the processed enzymes, as does cleavage 
of an ApiAP2 DNA-binding factor during the schizont stage [75]. As another example, at least 
five enolase post-translationally modified isoforms have been described, which seem to 
preferentially localize to different subcellular compartments [102]. Out of 54 schizont stage 
proteins studied by mass spectrometry, at least half were observed to have multiple isoforms 
[90]. This set included enolase again, as well as actin I, eukaryotic initiation factors eIF4A and 
eIF5A, and numerous heat shock proteins. Importantly, Zhang et al. have recently shown that 
eIF2α phosphorylation by the PfPK4 kinase is essential for blood stage development in P. 
berghei, and have hypothesized that this interaction is likely to be broadly conserved amongst 
Plasmodium species [103].  
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1.5  Signatures of multi-gene family regulation 
  The expression pattern of multi-gene families such as the PfEMP1-encoding vars, 
PfEBAs, and PfRhs has been well studied during P. falciparum blood stage development [104]. 
In the case of PfEMP1, expression is mutually exclusive, meaning that only a single PfEMP1 
variant is displayed on the RBC surface at a given time [105,106]. PfEMP1 expression choice is 
also largely clonally inherited during the blood stage by daughter parasites [104-106]. However, 
in vivo experiments have shown that up to 18% of daughter parasites may switch to express a 
different PfEMP1 variant during the initial stage of infection [107]. A similar program of 
mutually exclusive, heritable gene expression has been documented for the two neighboring 
Cytoadherence Linked Asexual Gene 3 (CLAG3) loci [108,109]. The CLAG3 loci encode nutrient 
uptake channel proteins [110,111]. Expression of PfEBA and PfRh genes is clonally variant and 
heritable as well, though a few genes from each family are typically co-expressed at any given 
time [104]. Whether the basis for locus-specific expression and expression switching of multi-
gene families is purely stochastic, or if it involves host-parasite interactions is debated [105]. 
Regardless, it is clear that this strategy is key to P. falciparum pathogenicity and immune 
evasion [3,24,49,50].   
  The PfEMP1-encoding var genes have been studied in the most detail out of P. 
falciparum multi-gene families, and their regulation involves many layers: epigenetic memory 
passed from generation to generation, conserved sequence elements encoded in var gene 
promoters and introns, and subnuclear localization events, amongst others (reviewed in [105]). 
Specific histone modifications are known to mark active, poised, and silenced var loci [82,112]. 
Additionally, Volz et al. have implicated PfSET10, one of many P. falciparum HKMTs, in 	 ﾠ
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maintaining the H3K4me3 histone modification over the poised var gene [113]. Deitsch et al. 
and others have shown that strict promoter-intron pairing is required for mutually exclusive var 
gene regulation, and that distinct nuclear protein complexes bind pairing elements (PE) located 
in these regulatory regions [114-117]. Regarding subnuclear localization, Ralph et al. and others 
have used fluorescence in situ hybridization (FISH) to show that both subtelomeric and internal 
var genes cluster at the nuclear periphery in 4-7 distinct foci, and that var gene activation 
involves subnuclear repositioning events [118,119].  
  Providing a molecular basis that connects many of these results, Zhang et al. have 
recently characterized a nuclear actin-protein complex that recognizes a short repeat region 
present in internal var gene introns [74]. This 18 base pair element is termed iNPE (intron 
nuclear protein-binding element), and is directly bound by the ApiAP2 DNA-binding factor 
Pf3D7_1107800. Specifically, this group showed that iNPE is sufficient to recruit episomes to 
the nuclear periphery, and that actin polymerization is essential for spatial repositioning and var 
gene regulation [74]. Another recent study by Coleman et al. has shed new light on variant gene 
expression in P. falciparum as well [53]. This group specifically investigated the timing of PfRh4 
nuclear repositioning and chromatin accessibility, and found that two distinct regulatory steps are 
involved in activation of this locus. Notably, Coleman et al. found that nuclear repositioning of 
PfRh4 to a transcription-permissible site is necessary but not sufficient for transcriptional 
activation of this locus. In other words, nuclear repositioning does not in itself cause 
transcriptional activation or promoter accessibility, but it does markedly increase the frequency 
of transcriptional activation events. This two-step activation model may also hold for var gene 
regulation [53].  
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1.6  Outstanding gene regulatory questions 
One important question is the extent to which the P. falciparum blood stage 
transcriptome is hard-wired versus reactive to environmental factors, and how putative response 
signals may be integrated. In support of the notion that the P. falciparum transcriptome is rigid, 
the blood stage expression cascade of geographically diverse P. falciparum isolates is 
remarkably similar [120,121]. This is true for different Plasmodium species as well [121]. 
Moreover, lethal dosage with chloroquine or the antifolate drug WR99210 yielded a minimal 
transcriptome-wide effect [122,123]. Arguing for transcriptome plasticity, Chaal et al. showed 
that treatment with the HDAC inhibitor apicidin affected the stage-specific expression of 
approximately half of the P. falciparum transcriptome [124]. Other groups have shown that 
treatment with artesunate, an artemesinin derivative, or the bisthiazolium compound T4 elicited 
major transcriptional effects as well [125,126]. Notably, P. falciparum responded in an expected 
manner to febrile temperatures or hyperoxia exposure, up-regulating protective antioxidant 
systems and down-regulating glycolysis in the latter case [127,128]. As speculated by Kato et al., 
it is likely that P. falciparum has lost some of the response mechanisms of free-living 
eukaryotes, but retained the ability to respond to key growth and environmental perturbations. 
Understanding the parasite elements that guide such responses may lead to novel blood stage 
therapeutic targets [129]. 
  How gametocyte commitment is regulated remains an open question, and again the 
degree to which environmental triggers are involved is debated [37]. A growing list of studies, 
primarily performed in vitro, have shown that environmental factors such as RBC age, hypoxia, 
drug exposure, and overcrowding can impact commitment rates [13,37,130]. Most recently, roles 	 ﾠ
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for host microRNAs and/or microvesicles, which bleb from infected RBCs prior to parasite 
egress, have been connected to in vitro gametocyte commitment rates as well [131-133]. In terms 
of molecular insights into gametocyte commitment, two nuclear proteins have been strongly 
implicated: P. falciparum Gametocyte Developmental Protein 1 (PfGDV1) and an ApiAP2 
DNA-binding factor [73,134]. The PfGDV1 locus was discovered due to reports showing that 
parasites cultured in vitro often spontaneously deleted this genomic region, overtook cultures, 
and could no longer produce visible gametocytes [135-137]. As each committed gametocyte 
represents a dead end in vitro, this growth advantage suggested that gametocyte commitment was 
likely blocked in these deletion strains. Recent random mutagenesis and complementation 
experiments performed by Ikadai et al. have also linked at least four additional genes to 
gametocyte commitment and/or early developmental events [138]. Notably, while Kafsack et al. 
have proposed that stochastic activation of the ApiAP2 factor Pf3D7_1222600 controls baseline 
gametocyte commitment [73], this model is likely incomplete. Knockdown of Pf3D7_1222600 
was not found to alter the expression of PfGDV1 or the other gametocyte-implicated genes 
reported by Ikadai et al. [73,134,138], suggesting additional complexity.  
Albeit a rapidly advancing field, mutually exclusive var gene regulation is far from 
understood. For example, while maintenance of heterochromatin marks and clustering at the 
nuclear periphery appear necessary for var gene silencing, how var genes reposition to a 
transmission-permissible site remains unclear[105]. Moreover, observations implicating non-
coding RNA and RNA-binding proteins in var gene regulation have not been experimentally 
investigated [139]. In 2003, Kyes et al. described ‘sterile’ non-coding RNAs transcribed from 
bidirectional var intron promoters [140]. Epp et al. then showed that these non-coding transcripts 
associated with chromatin [141]. Recently, RNA-binding proteins have been identified 	 ﾠ
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associated with both PfSET10 and the iNPE using pull-down experiments [74,113]. In fact, ten 
out of the thirteen top candidate proteins in complex with the iNPE have predicted RNA-binding 
domains [74].  
1.7  The regulatory capacity of lncRNA 
Long non-(protein)-coding RNAs (lncRNAs) represent a diverse class of regulatory 
molecules that have been found to modulate gene expression from every conceivable angle, often 
in a uniquely site-specific manner [142]. To date, detailed experimental dissection of lncRNAs 
and their target genes has been performed for numerous lncRNAs [Table 1.1] (Reviewed in[143-
145]). However, the mammalian X-inactive-specific transcript (Xist), which represents one of 
the first bona fide lncRNAs to be discovered, continues to be one of the most experimentally 
investigated lncRNAs [146-150]. Numerous studies have demonstrated the essential role for 
Xist, a 17-20 kb lncRNA expressed from the inactive X chromosome, in X chromosome 
inactivation (XCI) [149,151]. Moreover, many additional lncRNAs in the X-inactivation center 
(Xic) regulate XIC through a series of RNA-based switches, and together contribute to the 
pairing of Xic on different chromosomes, the recruitment of numerous chromatin modifying 
enzymes, and the spread and maintenance of heterochromatic silencing marks along the entire 
inactive X chromosome [Figure 1.2] [152-156]. In brief, Xist is positively regulated by the 
upstream Jpx lncRNA and negatively regulated by its antisense transcript Tsix [157-159]. X-
inactivation intergenic transcription elements (Xite) positively regulate Tsix [160].   
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Table 1.1 | Examples of lncRNA-mediated gene expression control. Adapted by permission 
from Macmillan Publishers Ltd: Nature Reviews Molecular Cell Biology [143], copyright 2013. 
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Table 1.1 (Continued) | Examples of lncRNA-mediated gene expression control. 
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Figure 1. 2 | Non-coding genes at the Xic. Reprinted from Science, Volume 338, Page 1436 
[142], with permission from the American Association for the Advancement of Science. 
Epigenetic Regulation by Long Noncoding RNA. Jeannie T. Lee. Copyright 2012. 	 ﾠ
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To put the XCI cascade into the larger picture of mammalian development, Oct4 binding 
activates Tsix and Xite expression [161,162]. The pluripotency-associated transcription factor 
Oct4 is thus able to initiate local effects at the Xic through Oct4-responsive lncRNAs. 
Additionally, Oct 4 is able to initiate genome-wide transcriptional programs in response to bone 
morphogenetic protein signaling or leukemia inhibitory factor [142,161,162]. Intriguingly, it has 
also recently been suggested that Oct4 is itself transcriptionally regulated by the lncRNA asOct4-
ps5, an antisense transcript to Oct4-pseudogene 5 [163]. Taken together, XCI demonstrates the 
complex collaboration between site-specific lncRNAs, transcription factors, and chromatin 
modifiers, which together provide spatial and temporal specificity during mammalian 
development. The lncRNAs in the Xic are amongst the most well studied lncRNAs, and continue 
to provide insight into the mechanisms by which lncRNAs may exert regulatory control 
[150,152,153].  
Additional well-characterized mammalian lncRNAs include lncRNAs involved in the 
epigenetic phenomenon known as imprinting. The silenced alleles in imprinted gene clusters are 
marked by DNA methylation and repressive histone modifications, reminiscent of the inactive X 
chromosome [164,165]. However, in this case, monoallelic gene silencing is dependent on 
parental origin. For example, the insulin-like growth factor type-2 receptor (Igf2r) lies within an 
imprinted gene cluster. Only the maternal Igf2r allele is expressed [166]. Transcription of 
Antisense to Igf2r RNA non-coding (Airn) from the second intron of paternal Igf2r alleles 
induces the silencing of paternal Igf2r and two neighboring alleles [167]. As another example, 
Kcnq1 lies within a one megabase imprinted gene cluster [168]. The antisense Kcnq1ot1 RNA 
from intron 10 of paternal Kcnq1 alleles induces the silencing of paternal Kcnq1 and neighboring 
alleles through interactions with a histone methyltransferase (HMT) and the polycomb repressive 	 ﾠ
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complex 2 (PRC2) [169]. LncRNAs have also been implicated in Alzheimer’s disease [170], 
Parkinson’s disease [171], Fragile X syndrome [172], and various forms of cancer [173,174].   
1.8  LncRNA case studies in model organisms 
  The model budding yeast Saccharomyces cerevisiae is a unicellular eukaryote of 
comparable genome size and gene density to P. falciparum [58]. Interestingly, S. cerevisiae also 
lacks the RNA interference pathway [175,176]. It is thus possible that the functional roles of 
lncRNAs in S. cerevisiae may be particularly predictive of lncRNA functions in P. falciparum 
[177]. The list of functionally validated lncRNAs in S. cerevisiae continues to grow, with 
regulatory roles ranging from mating-type control of meiosis entry to blocking serine 
biosynthesis [177-180].  
  In S. cerevisiae, entry into meiosis requires the function of many genes and the 
convergence of many external signals [181]. Nutritional and respiratory signals include 
starvation, the lack of fermentable sugar and nitrogen sources, and the presence of non-
fermentable carbon sources. Furthermore, only diploid mating type locus MATa/α cells can 
undergo meiosis and sporulation. The a1/α2 heterodimer, unique to diploid cells with both a 
MATa and MATα allele, represses haploid functions. The meiotic cascade is set into motion by a 
family of IME (inducer of meiosis) genes. The promoter of IME1 is highly regulated, and 
integrates both environmental and mating-type control signals. Another gene required for meiotic 
entry is IME4, a putative RNA methyltransferase [181].  
  Interestingly, lncRNAs regulate both IME1 and IME4 in S. cerevisiae [Figure 1.3] [179-
181]. In haploid MATa and MATα cells, IME4 antisense RNA is constitutively transcribed and 
IME4 sense RNA is silenced [179]. In diploid MATa/α cells, the inverse relationship is true. 	 ﾠ
	 ﾠ
	 ﾠ
21	 ﾠ
Through a series of genetic perturbation assays, Hongay et al. discovered that IME4 sense and 
antisense transcription inhibit each other in cis, and that the relative strength of their promoters is 
cell-type specific. Namely, while the IME4 antisense promoter is stronger in haploid cells, 
binding of the 1a/2α heterodimer (present only in MATa/α diploid cells) at a conserved site 
downstream of IME4 favors the IME4 sense promoter. Taken together, this system ensures that 
only diploid cells are competent for meiosis entry [179]. At the IME1 locus, the repressor of 
meiosis 1 protein (Rme1p) binds to the IME1 promoter in haploid cells [181]. Rme1p binding 
activates transcription of IME1 regulatory transcript 1 (IRT1), which spans the IME1 promoter 
[180]. IRT1 transcription recruits HMT (Set2) and HDAC (Set3C) complexes to the IME1 
promoter, which in turn establishes a repressive chromatin state that prevents further binding by 
other transcription factors [180].   
 
Figure 1. 3 | Mating-type control of meiosis entry is regulated by two lncRNAs. Reprinted 
from Cell, Volume 150, Issue 6, with permission from Elsevier. Transcription of Two Long 
Noncoding RNAs Mediates Mating-Type Control of Gametogenesis in Budding Yeast. Folkert J. 
van Werven, Gregor Neuert, Natalie Hendrick, Aurélie Lardenois, Stephen Buratowski, 
Alexander van Oudenaarden, Michael Primig, Angelika Amon. Copyright 2012.   	 ﾠ
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At the S. cerevisiae SER3 locus, which encodes an enzyme involved in serine 
biosynthesis, transcription of SER3 regulatory gene 1 (SRG1) represses SER3 transcription 
[178]. The SRG1 locus overlaps with the SER3 upstream regulatory sequence, and functions by 
interfering with activator binding at the SER3 promoter. SRG1 is only transcribed when cells are 
grown in the presence of serine, however, such that SER3 expression may be induced when 
serine biosynthesis is necessary [178]. LncRNAs also regulate the expression of enzymes 
involved in galactose biosynthesis (GAL10 and GAL4) [182], the adhesion-conferring FLO11 
cell wall glycoprotein [183,184], and the inorganic phosphate transporter PHO84 [185].  
  Fundamental roles for lncRNAs have been documented in numerous other model 
organisms as well [186,187]. In the plant Arabidopsis thaliana, for example, exposure to winter 
cold triggers the epigenetic silencing of the flowering locus c (FLC) gene, and gives A. thaliana 
the ability to flower in the spring [188]. This process is called vernalization. The COLD 
ASSISTED INTRONIC NON-CODING RNA (COLDAIR) is transcribed from the first FLC 
intron after prolonged cold exposure, and is required for long-term maintenance of FLC 
repression and vernilization [189]. COLDAIR associates with the HMT component of PRC2, 
and likely targets PRC2 to the FLC locus [189]. In the fruit fly Drosophila melanogaster, sex 
chromosome dosage compensation is achieved by up-regulating the single male X chromosome 
two-fold, rather than by silencing one of the female X chromosomes [190]. However, the 
coordination between lncRNAs and chromatin remodelers is again central in the process. RNA 
on the X (roX) lncRNAs are an integral component of the dosage compensation complex (DCC), 
and help to guide this complex to specific sites on the male X chromosome, which leads to the 
formation of euchromatin [191-194].  
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1.9  Summary of thesis aims and chapters 
Without RNA interference, microRNAs, or many sequence-specific transcription factors, 
P. falciparum may rely heavily on transcriptional interference, epigenetic feedback, post-
transcriptional modification, and nuclear positioning to regulate gene expression. In humans and 
model organisms, lncRNAs play dominant roles in all of the above mentioned gene regulatory 
mechanisms [Table 1.1] [143-145]. Moreover, the potential for lncRNAs to remain physically 
tethered at their site of origin, while interacting with other cellular factors such as chromatin 
remodeling complexes, provides these molecules with unique site-specific regulatory advantages 
[150]. Supporting this notion, lncRNAs have been found to play pivotal roles in allele-specific 
chromatin repression during XCI and imprinting [195], and site-specific chromatin repression 
during mating-type control of meiosis [181], and vernilization [186].  
We hypothesized that lncRNAs may be important master regulators of P. falciparum 
gene expression and chromatin state as well. As of 2009, when I initiated this thesis work, there 
were preliminary reports describing the presence of developmentally regulated antisense RNA 
[196], var gene intron-derived RNA [140], and centromeric RNA in P. falciparum [197]. It was 
also clear that multi-gene families, such as the PfEMP1-encoding var genes, were epigenetically 
regulated in a monoallelic fashion, with intriguing parallels to lncRNA-mediated epigenetic 
regulation mechanisms emerging in humans and model organisms [106]. However, the 
functional significance of P. falciparum lncRNAs had not been investigated. A genome-wide 
map of P. falciparum lncRNAs was also fundamentally lacking, and lncRNA transcript 
properties, such as expression, conservation, and structure, had not been investigated on a broad-
scale.  	 ﾠ
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In Chapter 2, using a custom high-resolution DNA tiling array, we probe expression 
across approximately one quarter of the P. falciparum genome [198]. We identify blood stage-
specific expression patterns for 60 putative P. falciparum lncRNAs and characterize a novel 
family of telomere-associated lncRNAs. Importantly, this represents the first experimental 
evidence showing that multiple P. falciparum chromosome ends coordinate transcription via a 
large non-coding RNA gene family, termed lncRNA-TARE (telomere-associated repetitive 
element). Our results indicate that lncRNA-TARE plays a central role in the transcriptional and 
epigenetic status of P. falciparum chromosome ends. Specifically, we find that all twenty-two 
lncRNA-TARE genes are located next to clinically important var genes; var genes are expressed 
through epigenetically mediated allelic exclusion [105]. We also find that lncRNA-TARE loci 
comprise the majority of subtelomeric var promoter element (SPE2) binding sites for the P. 
falciparum SPE2-interacting protein (PfSip2). PfSip2 is an ApiAP2 DNA-binding factor 
implicated in subtelomeric heterochromatin formation and var gene regulation [75].  
  In Chapter 3, we develop and validate strand-specific, non-polyA-selected RNA 
sequencing methods sensitive to the extreme AT content of P. falciparum. We use this approach 
to sequence the P. falciparum blood stage transcriptome across 56 hours of development at 
unprecedented resolution, including during red blood cell rupture and parasite invasion. We then 
pursue the first assembly of P. falciparum transcript structures from RNA sequencing data, and 
assemble over one thousand high-confidence, bona fide lncRNA transcripts. We perform 
extensive global analysis of 660 intergenic lncRNA and 474 antisense RNA transcript properties: 
coding prediction, periodicity, stage-specificity, correlation, GC content, length, splicing, and 
location relative to annotated transcripts. Our results indicate a functional role for many P. 
falciparum lncRNAs. For example, we find evidence of transcriptional interference between 	 ﾠ
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sense-antisense partners, a subset of antisense RNAs whose transcript levels drop significantly 
during invasion, a global and a highly coordinated invasion-specific transcript profile for 
lncRNA-TAREs and ‘sterile’ var transcripts, and a multi-exonic and highly correlated antisense 
RNA counterpart to a gene required for sexual commitment. Lastly, we validate six P. 
falciparum circular RNA (circRNA) transcript structures in an organism lacking RNA 
interference, and predict the non-canonical splice junctions of over one thousand additional P. 
falciparum circRNAs.  
In Chapter 4, I summarize the contributions of my thesis work, and suggest future 
directions for genome-wide and case-by-case P. falciparum lncRNA studies. Taken together, this 
thesis represents a node connecting recent advancements in the lncRNA and genomics fields to 
the biology of the devastating human pathogen P. falciparum malaria. At the unique intersection 
between these worlds, I develop novel high-throughput methods and discover compelling P. 
falciparum lncRNAs with predicted roles in development, virulence, and transmission. 
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Abstract 
 
Mounting evidence suggests a major role for epigenetic feedback in Plasmodium 
falciparum transcriptional regulation. Long non-coding RNAs (lncRNAs) have recently emerged 
as a new paradigm in epigenetic remodeling. We therefore set out to investigate putative roles for 
lncRNAs in P. falciparum transcriptional regulation. We used a high-resolution DNA tiling 
microarray to survey transcriptional activity across 22.6% of the P. falciparum strain 3D7 
genome. We identified 872 protein-coding genes and 60 putative P. falciparum lncRNAs under 
developmental regulation during the parasite's pathogenic human blood stage. Further 
characterization of lncRNA candidates led to the discovery of an intriguing family of long non-
coding RNA telomere-associated repetitive element transcripts, termed lncRNA-TARE. We have 
quantified lncRNA-TARE expression at fifteen distinct chromosome ends and mapped putative 
transcriptional start and termination sites of lncRNA-TARE loci. Remarkably, we observed 
coordinated and stage-specific expression of lncRNA-TARE on all chromosome ends tested, and 	 ﾠ
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two dominant transcripts of approximately 1.5 kb and 3.1 kb transcribed towards the telomere. In 
conclusion, we have characterized a family of twenty-two telomere-associated lncRNAs in P. 
falciparum. Homologous lncRNA-TARE loci are coordinately expressed after parasite DNA 
replication, and are poised to play an important role in P. falciparum telomere maintenance, 
virulence gene regulation, and potentially other processes of parasite chromosome end biology. 
Further study of lncRNA-TARE and other promising lncRNA candidates may provide 
mechanistic insight into P. falciparum transcriptional regulation.  
 
 
Authors’ contributions 
JLR and PCS conceived of the study and participated in its design, coordination, and 
interpretation. DP carried out the computational design of arrays. JS harvested and extracted 
samples for arrays, and KMB harvested and extracted samples for qRT-PCR and RLM-RACE. 
ARW performed sample labeling and array hybridizations. KMB analyzed raw and normalized 
data and wrote/implemented the sliding-window TAR detection algorithm. KMB and DP 
analyzed predicted TARs to assess biological validity and filter for lncRNA candidates. KMB 
and DP characterized putative lncRNAs, and KMB designed/performed qRT-PCR and RLM-
RACE analysis. DW, MD, SV, DVT, and UR contributed to the acquisition and interpretation of 
data. KMB wrote the manuscript, JLR and PCS critically revised the manuscript, and all authors 
have read and given approval of the version to be published.  
 
Acknowledgements 
We would like to thank M. Koziol and D. Shechner of the Broad Institute and Harvard 
University for experimental assistance and for Figure 3b illustration support, respectively. We 
would also like to thank members of the Broad Institute-Harvard Malaria Initiative for helpful 
feedback throughout. This work was supported by grants from the Gates Foundation and the 
National Institutes of Health Director’s New Innovator Awards (1DP2OD00667-01). P.C.S. is a 
Packard and Burroughs Wellcome fellow. J.L.R is a Damon Runyon-Rachleff, Searle, Smith 
Family and Merkin Fellow. K.B and D.P are National Science Foundation Graduate Research 
Fellows. 	 ﾠ
	 ﾠ
	 ﾠ
37	 ﾠ
2.1  Introduction 
The causative agent of the most severe form of human malaria, P. falciparum, is a 
unicellular eukaryotic parasite transmitted through the bites of infected mosquitoes. The most 
vulnerable population to malarial disease is African children, but a staggering 3.3 billion people - 
half the world’s population – are at risk for malarial infection. Despite recent research advances 
[2-7], the mechanisms P. falciparum utilizes to regulate mutually exclusive expression of multi-
gene virulence families and stage-specific expression of approximately 80% of its genome 
during pathogenic blood stage development remain elusive.  
Most confounding is the scarcity of sequence-specific transcription factors and cis-acting 
regulatory elements, coupled with the apparent lack of both RNA interference machinery and 
DNA methylation in the parasite [8,9]. However, the recent discovery of an expanded lineage of 
27 ApiAP2 transcription factors may partially explain how the parasite regulates its unusual 
genome [10,11]. Additionally, it is becoming increasingly clear that chromatin remodeling and 
epigenetic memory play an important role in blood stage-specific expression and antigenic 
variation of virulence genes [7,12,13].  Notably, while the parasite lacks many of the 
conventional regulatory mechanisms of other organisms, it has a full arsenal of conserved 
histone modifying enzymes, and a higher than average number of RNA-binding proteins [9,14].  
In eukaryotes spanning from yeast to humans, epigenetic regulation incorporates 
feedback from non-coding RNAs. Specifically, long non-coding RNAs (lncRNAs) and small 
non-coding RNAs often interface with RNA binding proteins and chromatin remodeling 
complexes to modulate their targeted genomic loci [15-19]. For example, in X chromosome 
inactivation at least seven distinct lncRNAs coordinate the selection and silencing of an entire 	 ﾠ
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chromosome [20]. As another example, long telomeric repeat-containing RNA (TERRA) 
transcripts have been recently discovered as a major constituent of telomeric heterochromatin. 
TERRA interacts with telomere-associated proteins such as telomerase, is developmentally 
regulated, and is implicated in telomere replication and structural maintenance processes [21-26]. 
To investigate putative regulatory roles for lncRNAs in P. falciparum, we designed a 
high-resolution DNA tiling array to survey transcriptional activity during the parasite’s 
pathogenic human blood stage. We identified 60 lncRNA candidates and characterized their GC 
content, evolutionary conservation, expression profile, and correlation with neighboring genes. 
Notably, our transcriptional profiling and subsequent analysis revealed an outlier on all fronts: a 
long telomere-associated non-coding RNA gene, termed lncRNA-TARE-4L, encoded in the 
telomere-associated repetitive element (TARE) tract of chromosome four.    
Upon further investigation of the lncRNA-TARE-4L locus, we discovered a multi-gene 
family of lncRNA-TAREs. We have mapped homologous lncRNA-TARE loci on twenty-two of 
twenty-eight P. falciparum chromosome ends, and quantified the coordinated, stage-specific 
transcription of fifteen distinct lncRNA-TARE sequences using quantitative Real-Time PCR 
(qRT-PCR). We additionally employed RNA Ligase Mediated Rapid Amplification of cDNA 
Ends (RLM-RACE) to map putative transcriptional start and termination sites of lncRNA-TARE 
genes, including three sequences not investigated by qRT-PCR. Our RLM-RACE results 
suggested two dominant transcripts of approximately 1.5 kb and 3.1 kb are transcribed from the 
TARE 3 boundary towards the telomere. Interestingly, we also found that an upsB-type var 
virulence gene is adjacent to each predicted lncRNA-TARE gene and that lncRNA-TARE 
sequence is enriched with transcription factor binding sites only otherwise found in upsB-type 
var gene promoters. 	 ﾠ
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Our results complement the recent P. falciparum transcriptome studies of Otto et al., 
Raabe et al., and others by providing stage-specific profiling and characterization of several 
previously unidentified P. falciparum lncRNA candidates, including a long telomere-associated 
non-coding RNA family [6,27]. Specifically, we have demonstrated that long telomere-
associated lncRNAs are coordinately expressed after parasite DNA replication from at least 
eighteen chromosome ends. Taken together, this work provides new insights into P. falciparum 
non-coding RNA transcription and contributes a previously uncharacterized parallel between P. 
falciparum and model eukaryote chromosome end biology.  
2.2  Results 
Tiling Microarray Experimental Design 
In order to comprehensively identify and characterize long non-coding transcripts in P. 
falciparum, we selected overlapping probes tiling approximately 22.6% of the P. falciparum 
genome at 12 bp median resolution. Notably, our DNA tiling array design provides over one 
order of magnitude denser probe coverage than previous P. falciparum transcriptional profiling 
arrays, and is unique in that it deeply samples both genic and intergenic sequence [5]. Probes 
cover 561 Watson (+) strand protein-coding genes, 699 Crick (-) strand protein-coding genes, 
two ribosomal RNA genes, and 1.73 Mb of intergenic sequence on P. falciparum chromosomes 
2, 3*, 4, 5*, 7, 9, 12* (* indicates partial coverage) [see 2.4 Methods and Supplementary 
Figure 1.1 for further genome coverage details].  
We harvested RNA from highly synchronous 3D7 parasites to capture global 
transcriptional changes during the parasite’s two major intraerythrocytic developmental cycle 
(IDC) transitions: ring to trophozoite and trophozoite to schizont stage. During the P. falciparum 	 ﾠ
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IDC, the parasite first exports cytoadherence surface proteins to sequester itself in host tissue 
(ring stage = 0-24 hours). This is followed by hemoglobin digestion and DNA replication 
(trophozoite stage = 24-36 hours), and, finally, nuclei segmentation and formation of 16-32 
daughter merozoites (schizont stage = 36-48) [28,29]. Specifically, we profiled the 
polyadenylated RNA population transcribed from both genomic strands at 18 (ring), 24 
(ring/trophozoite), 30 (trophozoite), and 36 (trophozoite/schizont) +/- 3 hours post-erythrocyte 
invasion (hpi) using our custom DNA tiling microarray. 
Identification of lncRNA candidates 
To identify transcriptionally active regions (TARs) along the P. falciparum genome, we 
analyzed normalized probe hybridization intensities using a window-based scan statistic 
algorithm. As proposed by Guttman et al, a TAR can be reasonably defined as a contiguous 
stretch of tiling probes with signal intensity significantly above the background distribution of 
permuted hybridization intensities [30,31]. Briefly, we calculated a scan statistic score for 
iterative window intervals, controlling the probability of one or more intervals being erroneously 
called significant at 5% [32]. As the final step, we merged overlapping intervals to define TAR 
boundaries. Taken together, this highly conservative approach corrects for multiple testing and 
provides strong family-wise type I error rate (FWER) control in our set of significant TARs.  
Our transcriptional profiling approach identified 1360 significantly expressed TARs. 
Specifically, 1229 TARs exhibited overlap with 872 probed PlasmoDB v6.5 protein-coding 
genes, 8 TARs overlapped the two probed ribosomal RNA genes, and 123 TARs represented un-
annotated, putative non-coding transcripts from P. falciparum intergenic regions [Figure 2.1a]. 
In summary, both ribosomal RNA genes and 64.1% of protein-coding genes on the array were 	 ﾠ
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identified as expressed in at least one of the four time-points tested. This is consistent with 
previous studies showing that 70-90% of protein-coding genes are expressed during P. 
falciparum intraerythrocytic development [4-6].  
 
 
Figure 2.1 | Global transcriptional profiling of the P. falciparum IDC reveals 60 putative 
lncRNAs under developmental regulation. (a) We identified 1360 transcriptionally active 
regions (TARs) along the P. falciparum genome, of which 1229, 8, and 123 predicted transcripts 
exhibit overlap with known protein-coding genes, ribosomal RNA genes, and un-annotated 
intergenic regions, respectively. Further filtering of un-annotated transcripts for putative long 
non-coding RNAs (lncRNAs) eliminated 46 putative small RNAs and 17 putative novel protein-
coding genes or pseudogenes, leaving a set of 60 putative lncRNAs for additional 
characterization. (b/d) Protein-coding and putative lncRNA transcripts follow the global 
expression cascade expected during the P. falciparum IDC. The mean log2 probe hybridization 
for each transcript is plotted from time-points T18, T24, T30, and T36 +/- 3 hpi corresponding to 
the ring, ring/trophozoite, trophozoite, and trophozoite/schizont intraerythrocytic stages of 
parasite growth (pictured below each column). Rows are mean centered. (c/e) Housekeeping 
gene seryl-tRNA synthetase (PF07_0073), early stage marker (PFD0020c), and late stage marker 
(PFB0275w) exhibit expected differential expression patterns. Examples of putative lncRNAs 
are also shown, including lncRNA-TARE-4L (***). Positive probe hybridization intensities are 
plotted from each sample after quantile normalization, log2 transformation, and median 
centering.  	 ﾠ
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We next investigated our expression data for known patterns of gene regulation. We 
performed clustering analysis to confirm the stage-specific transcription cascade expected for P. 
falciparum’s protein-coding genome [Figure 2.1b and Supplementary Figure 2.2], and 
ontology analysis of stage-specific genes to confirm the parasite processes known to occur 
during our time-points [Supplementary Table 2.1]. As a further control, we confirmed that 
known housekeeping genes such as seryl-tRNA synthetase (PF07_0073) were not differentially 
expressed, while early and late stage markers such as PFD0020c and PFB0275w were maximally 
expressed in T18 and T36, respectively [Figure 2.1c] [4-6]. Collectively, these analyses 
confirmed the biological representation of our samples and provided meaningful context to 
investigate lncRNA expression during the parasite’s pathogenic human blood stage.  
We applied conservative criteria to identify bonafide P. falciparum lncRNAs from the set 
of 123 expressed intergenic transcripts. Namely, we required transcripts to be larger than 200 
nucleotides, eliminating 46 putative small RNAs from further analysis [Supplementary Table 
2.2]. We also eliminated transcripts having even marginal protein-coding potential. Briefly, we 
used BLASTX to translate the remaining 77 transcripts and search for significant protein 
matches across all 439,884 and 12,597,337 sequences represented in the Swissprot and non-
redundant protein sequence (nr) databases, respectively. We also searched subsets of both 
databases with the following organism queries: Plasmodium, Plasmodium falciparum, and 
Plasmodium falciparum strain 3D7. While the large majority of analyzed transcripts lacked any 
coding potential, BLASTX analysis predicted that seventeen transcripts might, in fact, be novel 
P. falciparum genes or pseudogenes [Supplementary Table 2.3]. Thus our conservatively 
filtered set of putative lncRNAs for additional characterization consisted of 60 candidate 
sequences [Figure 2.1a and Supplementary Table 2.4].  	 ﾠ
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Additional Characterization of lncRNA Candidates Highlights a Novel Telomere-
Associated lncRNA 
To systematically prioritize the 60 putative lncRNAs for functional follow-up, we looked 
for lncRNAs with similar properties to known functional transcripts in P. falciparum and/or 
bonafide lncRNAs in other organisms. We also investigated the possibility that lncRNA 
candidates may be spliced to nearby genes or represent un-annotated untranslated regions 
(UTRs). To this end, we assessed each lncRNA candidate’s GC content and evolutionary 
conservation, as well as the correlation between lncRNA and neighboring gene expression 
profiles, and the distance between lncRNA and neighboring genes to infer transcript 
independence.   
Known classes of functional non-coding RNA in P. falciparum, such as ribosomal RNA 
and transfer RNA, have high GC content [33,34]. While high GC content is certainly not 
sufficient or necessary for function, we were nonetheless interested in the GC content of our 
putative lncRNAs. We found the average GC content of lncRNA candidates (15.4%) to be 
typical of P. falciparum intergenic regions [35] and well below the coding transcript average 
(23.7%). This is not an unexpected result and, importantly, indicates no systematic hybridization 
bias towards detection of expressed non-coding regions with higher than expected GC content. 
Interestingly, however, this analysis highlighted one lncRNA with similar GC content (32.1%) to 
ribosomal RNA transcripts [Figure 2.2a]. We termed this candidate lncRNA-TARE-4L, as it is 
encoded in the telomere-associated repetitive element (TARE) tract on the left end of 
chromosome four. 
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Figure 2.2 | Additional characterization of putative lncRNAs highlights the striking 
properties of a telomere-associated long non-coding RNA (a) GC content comparison 
between predicted non-coding and protein-coding transcripts shows that non-coding GC content 
is typically lower than coding transcript GC content. LncRNA-TARE-4L (red/arrow) and 
ribosomal RNAs (stars) have high GC content. (b) The sequence of eight functional ribosomal 
RNAs is broadly conserved across Plasmodium species. The sequence of nineteen putative 
lncRNAs is also significantly conserved in at least one other species (BLASTN p-value < 0.01), 
suggesting a preserved functional role. LncRNA-TARE-4L is strongly conserved across all eight 
species analyzed.  Such a broad level of conservation is rarely seen in randomly sampled 
intergenic regions from P. falciparum (p-value = 0.045). Rows are ordered by number of species 
with BLASTN hits (p-value < 0.01), and then by strength of hits (defined by the product of p-
values). Species are clustered based on the phylogeny proposed by Escalante and Alaya [86].  
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We next explored the evolutionary conservation of putative lncRNA sequences as an 
indicator of preserved functionality [36]. We performed BLASTN sequence alignment within the 
partially assembled, closely related P. reichenowi chimpanzee parasite genome and across six 
other partially sequenced, more distant Plasmodium species [Figure 2.2b]. We found that 
nineteen lncRNAs exhibited some level of conservation in the Plasmodium species investigated, 
but that only lncRNA-TARE-4L was strongly conserved across all species tested. To assess the 
significance of this result, we repeated this analysis for 600 size-matched random intergenic 
sequences, as well as for ribosomal RNAs and size-matched coding exons. We found that, 
respectively, 4.5%, 87.5%, and 33.3% had BLASTN hits to all Plasmodium species analyzed. 
Thus, the broad sequence conservation of lncRNA-TARE-4L is significant (p-value = 0.045) and 
more similar to the level of conservation expected for ribosomal RNAs and coding regions. 
Interestingly, we also found that 23 of the 27 broadly conserved null intergenic sequences map to 
either the telomeric or subtelomeric repeats.   
The vast majority of P. falciparum genes are highly expressed only once per 48-hour 
IDC, and genes in related cellular processes are induced together [4]. Given this model for 
functional protein-coding transcripts, we reasoned that lncRNA candidates are more likely 
biologically significant if expressed in a stage-specific manner. Moreover, regulatory lncRNAs 
have been reported to act in cis to their targeted loci [36-38]. Consistent with this notion, 
lncRNAs that are both differentially expressed and encoded nearby essential or pathogenic genes 
may be involved in regulating these important loci. Figures 1d and 1e show that putative 
lncRNAs are developmentally regulated similar to protein-coding transcripts [See 2.4 Methods 
and Supplementary Figure 2.2 for detailed comparisons]. Additionally, we found that many 
lncRNA candidates neighbor essential genes and factors involved in parasite pathogenesis. 	 ﾠ
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Given clear patterns of transcriptional regulation, we next tested if the 60 candidate 
lncRNAs were likely to be independent transcripts as opposed to un-annotated UTRs or small 
spliced exons to neighboring coding genes. To this end, we measured the Pearson correlation 
between putative lncRNA and neighboring gene expression profiles, conservatively selecting the 
most correlated, adjacent, expressed gene as the neighboring gene [Supplementary Table 2.4 
and Methods 2.5]. We found that 40 lncRNA candidates were highly correlated, raising the 
possibility that they may be spliced to or represent UTRs of adjacent coding genes. Of the 
remaining 20 lncRNA candidates exhibiting patterns of correlation consistent with independent 
transcription, 16 displayed biologically meaningful variation across our time-points. Thus, 
correlation analysis highlighted 16 candidates with clear evidence of independent transcriptional 
regulation.  
While the null distribution of correlations from adjacent pairs of coding genes 
demonstrated that approximately 30 of 40 highly correlated lncRNA candidates may be UTRs or 
otherwise spliced to nearby genes, it also suggested that ten independent transcripts should 
exhibit this level of correlation by chance [Supplemental Figure 2.3]. To further distinguish 
such potential transcripts, we considered the distance of each putative lncRNA to the nearest 
neighboring coding gene. We found that 11 lncRNA candidates were over 1 kb from a coding 
gene. As the mean intron length in P. falciparum is 168 bp [35], we considered this as evidence 
of independence regardless of correlation value. Taken together, these results point to a highly 
conservative set of 23 lncRNA candidates based on correlation and distance analyses.  
Strikingly, we found that lncRNA-TARE-4L exhibited the strongest evidence of 
independent transcriptional regulation. LncRNA-TARE-4L is flanked by the telomere and an 
upsB-type var gene [Figure 2.3a]. However, the var gene is over 20kb away and the exon 	 ﾠ
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structure of var transcripts has been previously mapped [39,40]. Given a mean intron length of 
168 bp and maximum intron length of 4.9 kb in P. falciparum [35], the splicing of lncRNA-
TARE-4L to the nearest neighboring var gene would be biologically unprecedented. Moreover, 
correlation analysis revealed that lncRNA-TARE-4L is anti-correlated with the nearest expressed 
gene (r = -0.296). The nearest expressed gene (PFD0020c) is an additional 20 kb beyond the 
silenced upsB-type var gene and is profiled in Figure 1c for visual comparison to lncRNA-
TARE-4L [Figure 1e, stars].  
Collectively, lncRNA-TARE-4L emerged as the lncRNA candidate with the most 
promising properties for functional follow-up. LncRNA-TARE-4L is encoded in the TARE 2-3 
subtelomeric repeat region between the telomere and a silenced upsB-type var gene [Figure 
2.3a], has GC content and sequence conservation similar to that of functional ribosomal RNA, is 
sharply induced after parasite DNA replication, and is clearly an independent transcript.  
As we further investigated the sequence properties of lncRNA-TARE-4L, we found that 
homologous lncRNA-TARE sequences are encoded adjacent to upsB-type var genes on twenty-
two of twenty-eight P. falciparum chromosome ends [Figure 2.3b] [41-43]. In five cases where 
there is no lncRNA-TARE gene, there is similarly not an upsB-type var gene. This perhaps 
suggests concurrent evolutionary pressure acting on lncRNA-TARE and upsB-type var genes. 
Consistent with this notion, the LncRNA-TARE loci are highly similar; the average pairwise 
identity between sequences is 88.1% [Supplementary Figure 2.4]. 	 ﾠ
	 ﾠ
	 ﾠ
48	 ﾠ
 
 
 
Figure 2.3 | The telomere-associated lncRNA-TARE family neighbors upsB-type var loci 
and is coordinately expressed during parasite schizogony. (a) DNA dot plot analysis of the 
first 50,000 bp on chromosome four pinpoints lncRNA-TARE-4L in the (telomere-associated 
repetitive element) TARE 2-3 region between the telomere (Tel) and a silenced upsB-type var 
virulence gene. (b) Subtelomeric features are diagrammed on the eleven chromosomes from 
which we were able to specifically amplify lncRNA-TARE sequence. Features are not to scale, 
and grayed out chromosome ends were not probed. Notably, an upsB-type var gene (orange) is 
located adjacent to each predicted lncRNA-TARE gene (red). Furthermore, qRT-PCR 
amplification of fifteen distinct lncRNA-TARE genes shows a coordinated pattern of late stage 
expression. LncRNA-TARE relative expression is plotted in time-points T20, T30, and T40 +/ 3 
hpi with respect to T30. Error bars represent the propagated standard error of the mean (pSEM) 
from two biological replicate experiments. Housekeeping gene PF08_0085 was used as the 
reference gene.  
 
 
LncRNA-TARE Loci are Coordinately Expressed from at least Fifteen Chromosome Ends 
Given our evidence for expression of the TARE 2-3 region on chromosome four and 
conservation of this region on twenty-two P. falciparum chromosome ends, we hypothesized that 
the twenty-two TARE 2-3 regions may be coordinately expressed.  We thus set out to further 
investigate the expression properties of lncRNA-TARE loci in independent blood stage time 
courses. In line with our array results, we expected lncRNA-TARE-4L, and potentially other 
lncRNA-TARE genes, to be differentially expressed after parasite DNA replication.  	 ﾠ
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We conducted two additional highly synchronous P. falciparum time courses focused on 
stage-specific time-points T20 (ring), T30 (trophozoite), and T36/T38/T40 (schizont) +/-3 hpi, 
and subsequently isolated RNA from each stage. We were able to design specific primer pairs 
targeting fifteen chromosome ends and used qRT-PCR to probe expression at the TARE 2-3 
region. Primer pairs were excluded if they did not have at least 90% amplification efficiency or 
amplified non-specific products [Methods 2.5 and Supplementary Table 2.5].  
We found that the TARE 2-3 region is expressed on all fifteen distinct chromosome ends 
tested. Remarkably, all fifteen lncRNA-TARE genes are coordinately and strongly induced after 
parasite DNA replication, with maximal lncRNA-TARE transcript abundance observed in the 
T40 +/- 3 hpi time-point [Figure 2.3b]. This result is the first quantitative experimental evidence 
showing that fifteen, if not more, P. falciparum chromosome ends are transcriptionally active 
between the parasite’s DNA replication and cell division cycles. Taken together, we have 
validated and expanded the microarray discovery of lncRNA-TARE-4L to define a novel 
telomere-associated lncRNA family, termed lncRNA-TARE. We have also shown that lncRNA-
TARE is maximally expressed during an important stage of parasite blood stage development. 
RLM-RACE Defines Two Dominant Long Telomere-Associated Transcripts   
We next pursued RLM-RACE to map putative transcriptional start and termination sites 
of lncRNA-TARE. We used a priming strategy in which both the 5’ and 3’ RACE reactions were 
primed using the same primer sequence, albeit reverse complemented, to ensure amplification of 
a contiguous long transcript. Additionally, as we aimed to investigate the transcript boundaries of 
multiple lncRNA-TARE loci in parallel, we designed RACE primers to simultaneously target 
twenty lncRNA-TARE sequences [Figure 2.4, black triangles, and Supplementary Table 2.5].  	 ﾠ
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Figure 2.4. RLM-RACE mapping suggests two long telomere-associated transcripts are 
transcribed in the TARE 2-3 region. 3’ RACE products of seven distinct lncRNA-TARE 
sequences terminated at a precise syntenic site on either side of TARE 2 (stars). Taken together 
with the 5’ RACE product suggests two species approximately 1.5 kb and 3.1 kb in length are 
transcribed towards the telomeres from the TARE 3 boundary.  Genome-wide, the palindromic 
SPE2 DNA motif (green triangles) is enriched only in the TARE 2-3 region from which 
lncRNA-TARE is transcribed and in the upstream promoter element of upsB-type var genes. 
Primers are depicted as black triangles.  
3’ RACE analysis suggested two dominant lncRNA-TARE species are transcribed from 
the centromere towards the telomere on at least twelve different chromosome ends [Figure 2.4, 
Supplementary Table 2.6, and Supplementary Figure 2.5]. Interestingly, we found that the 
longer transcript corresponded to termination immediately after the TARE 2 element, while the 
shorter transcript corresponded to termination immediately prior to TARE 2. Additionally, the 
syntenic termination site for seven distinct lncRNA-TARE family members encompassing 
TARE 2 was identical and corresponded to the transcript model predicted by our sliding-window 
algorithm [Methods 2.5]. In terms of the shorter transcript, we again found that seven distinct 
lncRNA-TARE species shared a precise syntenic termination site just upstream of TARE 2 
[Figure 2.4, stars].  	 ﾠ
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We discovered a single putative 5’ transcriptional start site for the lncRNA-TARE locus 
on the left end of chromosome three. Notably, this start site corresponded to the boundary of the 
TARE 3 element [Figure 2.4, Supplementary Table 2.6, and Supplementary Figure 2.5]. The 
intrinsic tendency of PCR amplification of multi-gene families to result in strongly biased 
representation of certain family members [44] likely explains the homogeneity of our cloned 5’ 
RACE products.  
Collectively, our RLM-RACE results provide strong evidence that long non-coding RNA 
genes are present in the P. falciparum TARE 2-3 subtelomeric repeats. Furthermore, our results 
support a model of unidirectional transcription towards the telomeres, as we were unable to 
amplify transcripts of the opposite polarity. We note, however, that our results do not explicitly 
rule out bidirectional transcription or the presence of alternative transcript models beyond the 
approximately 1.5 kb and 3.1 kb species defined here. For example, the high AT content of the 
P. falciparum genome poses a technical barrier for 3’ RACE analysis, as internal A-rich regions 
may hybridize with the 3’ RACE primer targeted to poly-A transcript tails.  
LncRNA-TARE Loci are Enriched with Transcription Factor Binding Sites 
An additional salient feature of lncRNA-TARE is that the TARE 2-3 subtelomeric region 
contains approximately fifteen occurrences of the bipartite palindromic SPE2 motif on average 
[45]. This pattern seems to be non-random as there are only two SPE2-enriched loci along the P. 
falciparum genome: the TARE 2-3 region and the upstream promoter element of upsB-type var 
genes. Notably, these two loci account for 94% of 777 predicted SPE2 consensus sites, and both 
the presence and position of SPE2 sites is conserved on intact chromosome ends [Figure 2.4 and 
Supplementary Figure 2.4] [11,43,45,46].  	 ﾠ
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Interestingly, Flueck et al. and others have recently demonstrated that a member of P. 
falciparum’s ApiAP2 transcription factor family specifically binds subtelomeric SPE2 sites in 
late stage parasites [11,45,47,48]. We thus further investigated, using qRT-PCR, the expression 
of lncRNA-TARE-4L and the P. falciparum SPE2-Interacting Protein PfSip2 (PFF0200c). We 
compared expression at T30 +/- 3 hpi during peak DNA replication to expression at T36, T38, 
and T40 +/- 3 hpi during parasite schizogony. We found lncRNA-TARE-4L and PfSip2 to have 
highly correlated late stage temporal profiles. Our results also suggested that PfSip2 is expressed 
prior to maximal lncRNA-TARE-4L expression, which may indicate PfSip2 induction of the 
lncRNA-TARE locus and/or co-activation of lncRNA-TARE [Supplementary Figure 2.6].  
2.3  Discussion 
In the present work we have identified and characterized several previously undetected 
lncRNAs in P. falciparum, such as a novel family of twenty-two homologous lncRNA-TARE 
genes that exhibit coordinated expression at a key stage in the P. falciparum life cycle. This 
family of lncRNA-TAREs encompasses the majority of known binding sites (SPE2) for the 
ApiAP2 transcription factor PfSip2 [Figure 2.4 and Supplementary Figure 2.4]. As PfSip2 is 
expressed and specifically binds subtelomeric SPE2 sites at the stage of maximal lncRNA-TARE 
transcription, these results suggest that PfSip2 binding may positively regulate the lncRNA-
TARE locus [45]. Alternatively, lncRNA-TARE transcription may allow PfSip2 binding, or in 
the case that both models are valid, a regulatory feedback loop between PfSip2 binding and 
lncRNA-TARE transcription may exist [Figure 2.5 model one] [49].  
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Figure 2.5 | Potential models for lncRNA-TARE at P. falciparum chromosome ends. (1) 
PfSip2 binding at SPE2 sites induces lncRNA-TARE transcription and/or vice-versa. (2) 
LncRNA-TARE guides multiple copies of PfSip2 to chromosome ends. (3) LncRNA-TARE 
recruits chromatin-remodeling factors to initiate post-S-phase memory marks at upsB-type var 
loci. (4) LncRNA-TARE facilitates telomeric heterochromatin assembly and/or interacts with 
telomere-associated proteins.  
The only other conserved cluster of SPE2 sites is in the upstream promoter element of 
upsB-type var genes. This suggests that lncRNA-TARE may play a role in subtelomeric upsB-
type var gene regulation. Consistent with this notion, all twenty-two lncRNA-TARE genes are 
encoded adjacent to an upsB-type var gene. Moreover, PfSip2 is implicated in silenced 
subtelomeric var gene regulation [45]. Thus, lncRNA-TARE may help regulate upsB-type var 
genes by directly or indirectly interacting with and/or recruiting multiple copies of PfSip2 to 
chromosome ends [Figure 2.5 model 2] [50].  
Mutually exclusive var gene regulation is known to involve nuclear repositioning and 
heritable chromatin memory marks [7,51-56]. An emerging theme in mammalian epigenetic 
regulation is the association of lncRNAs with chromatin modifying complexes, which in turn 
recruits these factors to their sites of action [37,57-59]. Notably, the induction of lncRNA-TARE 
transcription between P. falciparum DNA replication and cell division is ideally timed to help 	 ﾠ
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initiate post-S-phase epigenetic memory marks at nearby upsB-type var genes. Thus, it is 
possible that lncRNA-TARE may interface with chromatin reading and/or writing factors to 
modulate the precise epigenetic regulation of nearby subtelomeric var loci [Figure 2.5 model 3].  
Non-coding transcripts expressed from a conserved bidirectional promoter in var gene 
introns provide some precedent for the proposed link between lncRNA-TARE and var gene 
regulation. Perhaps non-coincidentally, both lncRNA-TARE and var gene ‘sterile’ transcripts 
have a similar post-S-phase transcriptional profile [60]. However, while the twenty-two lncRNA-
TARE loci exclusively pair with upsB-type var genes, the previously described var gene ‘sterile’ 
transcripts are expressed from both silenced and activated var genes of all types [39,61]. Thus, 
lncRNA-TARE may provide a different and/or additional level of regulation unique to 
subtelomeric upsB-type var loci. We also note that in a complementary study by Raabe et al., 
small subtelomeric ncRNAs ranging in size from 31-103 nucleotides were identified in this 
region [27]. Taken together, our results perhaps support a model of long precursor transcripts 
being processed into small ncRNAs. 
Interestingly, the origin and transcriptional profile of lncRNA-TARE is strongly 
reminiscent of the eukaryotic non-coding RNA family TERRA. Across numerous eukaryotic 
model systems, TERRA is transcribed from subtelomeric loci, associates with telomeric repeats, 
and is implicated in telomere structural integrity and heterochromatin assembly [21-26,62-67]. 
Consistent with a possible TERRA-like role for lncRNA-TARE, large chromatin state changes 
occur at P. falciparum chromosome ends in concordance with maximal lncRNA-TARE 
transcription [Figure 2.5 model 4] [68,69]. Moreover, TERRA transcript levels are regulated by 
the cell cycle, with lowest TERRA abundance observed during DNA replication [23,70]. We 	 ﾠ
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similarly observe the lowest lncRNA-TARE transcript levels at T30 +/- 3 hpi, which corresponds 
to peak parasite DNA replication.  
In summary, several pieces of evidence point to a key role for lncRNA-TARE in 
transcriptional and/or epigenetic regulation of P. falciparum telomeric and subtelomeric regions. 
This work motivates further experimentation to resolve the mechanistic details of lncRNA-
TARE and other promising P. falciparum lncRNA candidates.   
2. 4  Conclusion 
Our global transcriptional profiling study provides a catalyst for in-depth functional 
analyses of high-confidence P. falciparum lncRNA candidates and for a full-genome 
investigation of parasite strains beyond 3D7. We have identified and characterized 60 putative 
lncRNAs using conservative thresholds for statistical and biological significance, providing 23 
strong candidates for further functional experimentation such as RNA binding assays and 
expression knockdown experiments. Such next studies will be key in establishing a direct 
molecular link between specific lncRNA transcripts and parasite proteins and in determining 
genes modulated by lncRNAs during P. falciparum blood stage development. Recent studies in 
model eukaryotes suggest that lncRNAs represent a new paradigm in genome regulation and 
chromatin remodeling. Hence, profiling the non-coding transcriptome of drug-resistant parasites, 
parasites with mis-regulated virulence gene phenotypes, and hyper-virulent clinical isolates is an 
exciting new research direction in the quest to eradicate malarial disease.  
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2.5  Methods 
Microarray Design 
The DNA tiling array was designed in conjunction with Roche NimbleGen to tile a 
portion of the P. falciparum genome with a targeted median probe spacing of 12 bp. The 3D7 
assembly (PlasmoDB v5.5) was used as the reference sequence. The design targeted all of 
chromosomes 2, 4, 7 and 9 and partial chromosomes 3:106138-147339, 5:947885-end, and 
12:start-66805 [Supplementary Figure 2.1]. The three chromosomes tiled in their entirety were 
selected at random. However, the four partially tiled chromosomes represent regions of particular 
interest given our hypothesis that lncRNAs may be involved in chromatin remodeling and 
clinically important parasite processes. Probes were variable length Tm-matched long 
oligonucleotides, averaging 55 bp each. Probe sequences were screened for excessive cross 
hybridization to 3D7 sequence: any probes with more than five close SSAHA (Sequence Search 
and Alignment by Hashing Algorithm) matches were eliminated [71,72].  The final design filled 
366479 probes on the array, 96.81% of which are unique. The raw and normalized data discussed 
in this publication have been deposited in NCBI's Gene Expression Omnibus and are accessible 
through GEO Series accession number GSE27937 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27937).  
Parasite Culture, RNA Preparation, and cDNA Labeling for Microarray Hybridizations 
A clone of P. falciparum strain 3D7 was cultured using standard methods [73,74] and 
total RNA isolated from each sample as described [75]. Total RNA was cleaned up with an 
RNeasy column (Qiagen) and concentrated in a Microcon YM-30 centrifugal filter (Millipore). 1 
µg of total RNA was then subjected to poly-A selective amplification using Message Amp II 	 ﾠ
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(Ambion), substituting biased dNTP/NTP mixes (2A/T/U:1C/G) for the solutions provided.  The 
resulting aRNA was labeled with Superscript II reverse transcriptase (Invitrogen), using random 
hexamers, and either Cy3- or Cy5-dUTPs (Amersham) for 2 hours at 42°C following a 10 
minute primer annealing step at 65°C. The reaction was concentrated on a Microcon YM-30 
column and subjected to array hybridization per standard NimbleGen protocol. 
Data Normalization and Quality Control 
Raw data from each sample was quantile normalized [76] and log2 transformed prior to 
prediction of transcriptionally active regions (TARs) along the P. falciparum genome. We based 
our pre-processing pipeline on established quality control metrics: removal of non-biological 
variation and a strong correlation between raw and normalized data [77]. Supplementary 
Figure 2.7 shows log2(intensity) distributions of each sample before and after quantile 
normalization, log2(intensity) boxplots of each sample after quantile normalization, and all pair-
wise correlation scatterplots of data before and after normalization. Pearson correlation is equal 
to 1.0 between raw and normalized data in all matched samples. Supplementary Figure 2.8 
shows that for each sample we observed only a minimal increase in median intergenic probe 
hybridization intensity with number of GC bases. Given that we make no absolute or quantitative 
expression comparisons of transcripts (only relative expression comparisons of the same 
transcript across time-points) and we confirm no GC content bias in predicted lncRNAs, we 
deemed this inconsequential. Normalized data was median centered (at zero) prior to expression 
profiling and data browsing in Integrated Genomics Viewer (IGV) [78]. 
Detection of Transcriptionally Active Regions (TARs) from Tiling Arrays 
We wrote and implemented an iterative sliding window algorithm to scan each sample’s 
normalized probe hybridization intensity values for statistically significant TARs. Specifically, 	 ﾠ
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we used a single-step maxT permutation procedure (1000 permutations) to transform the mean 
probe intensity score ‘T’ calculated in each of the approximately 366k possible window slides 
along normalized data into a multiple-hypothesis adjusted p-value [30-32]. We then discarded 
windows with adjusted p-values greater than .05 to control the family-wise error-rate (FWER) of 
windows predicted to be significant at 5%. We repeated this procedure a total of twenty-eight 
times using window sizes of 5, 10, 15, 20, 25, 30, and 40 probes. Next, we intersected all 
significant windows with PlasmoDB v6.5 gene annotations, and merged overlapping annotated 
windows to define the boundaries of 1229 protein-coding TARs and 8 ribosomal RNA TARs. 
Similarly, we merged overlapping windows that did not overlap any known or predicted gene to 
define the boundaries of 123 un-annotated TARs. BEDTools v4 was used for all data 
intersections and unions [79].  
Filtering Un-Annotated TARs  
We filtered un-annotated TARs by setting a minimum length criterion of 200 base pairs 
and ensuring no BLASTX predicted coding potential. Out of 123 predicted un-annotated TARs, 
46 were under 200 base pairs in length [Supplementary Table 2.2]. We retrieved FASTA 
sequence for the remaining 77 from plasmodb.org (v6.5), and used the NCBI BLASTX web 
server to search for any significant protein matches [80]. Default BLASTX settings 
(BLOSUM62, word size 3, low complexity filtering, etc.) were used except the Expect threshold 
for reporting match significance (i.e. coding potential) was set at .01. Seventeen sequences with 
an Expect score < .01 were categorized as putative novel P. falciparum genes or pseudogenes 
and were excluded from further lncRNA characterization [Supplementary Table 2.3]. We 
searched both the Swissprot and Non-redundant protein sequence (nr) databases with the 	 ﾠ
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following organism queries: all organisms, Plasmodium, Plasmodium falciparum, and 
Plasmodium falciparum strain 3D7.  
Gene Ontology (GO) Term Analysis of Stage-Specific Genes 
GO term analysis of stage-specific genes was performed using GOstat with default 
settings [81] and Sanger GeneDB P. falciparum gene annotations. Stage-specific genes were 
determined by intersection of PlasmoDB v6.5 gene annotations with protein-coding transcripts 
maximally expressed in each time-point. We looked for overrepresented GO terms in stage-
specific genes versus the 1360 protein-coding genes covered by the array. Supplementary 
Table 2.1 lists the top four most overrepresented GO terms in each time-point and respective p-
values. 
Evolutionary Sequence Conservation  
FASTA sequence for the 60 putative lncRNAs and 8 ribosomal RNA transcripts was 
retrieved from the 3D7 reference sequence (PlasmoDB v7.1). We also downloaded genomic 
FASTA sequence from PlasmoDB v7.1 representing all eight sequenced or partially sequenced 
Plasmodium species (P. falciparum, P. reichenowi, P. gallinaceum, P. knowlesi, P. vivax, P. 
berghei, P. yoelli, and P. chaubadi). We searched for sequence conservation using BLASTN 
(WU-BLAST 2.0MP-WashU [04-May-2006]) using the same low-complexity filtering and 
context parameters as the BLAST server on plasmodb.org (-filter seg -ctxfactor 2.00) and setting 
the Expect threshold for significance to 0.01. We recorded the lowest BLASTN p-value within 
each species [Supplementary Table 2.4]. 
The broad conservation of lncRNA-TARE-4L across all eight Plasmodium species was 
determined to be significant by null permutations. 600 random intergenic regions were chosen 	 ﾠ
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from the 3D7 reference genome (based on v7.1 annotation). These intergenic regions were sized 
to match the length distribution of the 60 putative lncRNAs, and were included in the WU-
BLAST search. Out of 600 random intergenic regions, we found only 27 to be conserved across 
all eight species, yielding an empirical p-value of 0.045. 
Expression Profiling 
To profile each predicted TAR, we calculated its expression in each time-point as the 
mean hybridization intensity of probes tiling within or up to 25 base pairs on either side of the 
predicted TAR start and stop coordinates. The expression profile of each TAR was then mean 
centered across time-points and visualized using a non-hierarchical clustering dimension 
reduction algorithm. Specifically, we used non-Metric Multi-Dimensional Scaling (nMDS) as 
implemented in the R-project ‘NeatMap’ package to order rows and preserve data topology. In 
development and validation of the ‘NeatMap’ package, Rajaram et al. have similarly applied 
nMDS to visualize yeast cell cycle expression data [82]. We point the reader to Figure 1d of 
Rajaram et al. [82] and Figure 4 of Taguchi et al. [83] for examples and thorough discussion of 
the utility of nMDS in determining relational patterns of gene expression. Notably, because 
nMDS is a non-linear numerical optimization technique, multiple ordinations were run to select 
the optimal solution.  
We conducted a detailed comparison of lncRNA and protein-coding expression, finding 
lncRNA candidates to be expressed on par with protein-coding transcripts. Included in 
Supplementary Figure 2.2 are additional visualizations of protein-coding transcript versus 
putative lncRNA expression, including standard heatmaps and nMDS ordinated heatmaps 
without mean centering across time-points. Supplementary Figure 2.2 also provides a 
histogram of the maximum expression values for lncRNA candidates and protein-coding 	 ﾠ
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transcripts. Notably, we found 30 lncRNA candidates (50%) to be induced by greater than 2-fold 
across our time course samples [Supplementary Table 2.4]. By comparison, 309 of 1229 
protein-coding transcripts (25%) match this criterion.  
Nearest-Neighboring Genes 
Nearest neighboring genes to the set of 60 putative lncRNAs were extracted using the 
Cistrome Analysis Pipeline (AP) Module and PlasmoDB v6.5 gene coordinates.  
Correlation Analysis 
To infer putative lncRNA splicing or UTR relationships with neighboring coding genes, 
we measured the Pearson correlation between putative lncRNA and neighboring coding gene 
expression profiles [Supplementary Table 2.4]. We conservatively defined the neighboring 
coding gene to be the highest correlated, expressed gene to either side of each putative lncRNA 
locus. We also examined a null distribution of correlations from adjacent pairs of coding genes. 
We found the 60 candidate lncRNAs to be enriched for high correlation to neighboring genes. 40 
of these candidates were highly correlated (r > 0.9), whereas only ten should be highly correlated 
as demonstrated by our null distribution [Supplementary Figure 2.3]. We then further 
investigated the expression profiles of lncRNA candidates with r < 0.9 to ensure correlation 
values reflected biologically meaningful variation. We defined biologically meaningful variation 
as a greater than 0.5-fold change across time-points.  
Mapping of Homologous lncRNA-TARE Sequences 
We used the PlasmoDB v6.5 BLASTN web server to record coordinates for homologous 
lncRNA-TARE sequences based on the predicted lncRNA-TARE-4L sequence. We then 
retrieved FASTA sequence of the most telomere-proximal 50000 bp on each chromosome end 	 ﾠ
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from plasmodb.org (v6.5), and used JDotter [84] software to create DNA dotplots mapping the 
telomeric repeats, TAREs 1-5, Rep20, and first predicted gene on each end. We placed each 
predicted lncRNA-TARE gene onto the dotplot maps to confirm that lncRNA-TARE maps to 
TARE 2 and the sequence between TARE 2 and TARE 3 on twenty-two chromosome ends. We 
then used Geneious to cluster (ClustalW) and investigate the conservation of lncRNA-TARE 
sequences.  
Parasite Culture for qRT-PCR Analysis 
Two independent biological replicate time courses were performed to validate and 
investigate lncRNA-TARE expression in more detail. For each time course, a freshly thawed P. 
falciparum strain 3D7 clone was cultured using standard methods [73] in human red blood cells 
(RBCs) at 4% hematocrit. RPMI-HEPES medium was supplemented with 5% human serum 
(O+) and 5% Albumax II (Gibco). Cultures were initially synchronized using two 5% sorbitol 
solution treatments [74] spaced by sixteen hours. To then obtain highly synchronized cultures, 
newly formed ring-stage parasites were selected for using 5% sorbitol solution treatments during 
the subsequent two re-invasion generations. Highly synchronized cultures were expanded and 
harvested at stage-specific time-points. Each harvested culture was centrifuged at 2400 rpm in a 
Sorvall RT6000B, and packed RBCs (2 ml) lysed using a 0.05% saponin solution. Liberated 
parasites were washed using phosphate-buffered saline (pH 7.4), pelleted at 13.2 RPM in a 
microcentrifuge, resuspended in 1 ml TRIZOL reagent, and stored at -80°C prior to RNA 
extraction.  
RNA Preparation for qRT-PCR and RLM-RACE Analysis 
TRIZOL-chloroform extraction was performed and the aqueous layer applied to an 
RNeasy column (Qiagen). On-column DNAse digestion was carried out for thirty minutes to 	 ﾠ
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remove genomic DNA. Eluted RNA was also treated with TURBO DNase (Ambion) and 
cleaned up on a second RNeasy column (Qiagen) to yield high-purity RNA samples. 
Quantitative Real-Time PCR (qRT-PCR) Analysis 
1 µg of RNA from each time course sample was reverse transcribed using a random 
priming strategy (Applied Biosystems cDNA High Capacity Reverse Transcription kit) along 
with a minus RT control reaction for each sample to confirm genomic DNA removal. qPCR 
reactions were carried out using 800 nM of primers and Roche FastStart SYBR Green Master 
(Rox) mix. Primer annealing and extension (55°C/60 seconds) was carried out for 40 cycles on 
an Applied Biosystems 7900 instrument.  
We used PCR Miner software [85] to calculate both the cycle threshold (Ct) of each 
qPCR reaction and the amplification efficiency of each primer pair. We then calculated the 
relative expression of each lncRNA-TARE gene in each time course sample by averaging 
technical replicates and using the reference gene PF08_0085 and reference time-point T30 
(trophozoite) for normalization. The error of normalized expression ratios was calculated using 
the delta method, based on a truncated Taylor series expansion, to account for technical 
variability in both the target and reference gene measurements. Biological replicate experiments 
were analyzed in isolation and then normalized expression measurements were averaged. We 
used a Taylor limited expansion method to determine how error propagated in the average 
expression value. 
qRT-PCR Primer Design 
Primer pairs to amplify predicted lncRNA-TARE genes and the SPE2-binding protein 
PfSip2 (PFF0200c) were designed using Premier Biosoft International AlleleID 7.6 software. 	 ﾠ
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AlleleID primer design software carries out highly specific primer design by BLAST searching 
sequences and masking redundant regions prior to primer design. We also independently verified 
primer specificity using BLASTN on the plasmodb.org (v6.5) website, and ensured single 
amplicon melting curves and no primer dimer formation. We required primer pair amplification 
efficiency, as calculated by PCR Miner software [85], to be at least 90% to ensure reproducible 
results. We used the previously described housekeeping gene P08_0085 (ubiquitin conjugating 
enzyme 1) [75] to calculate all normalized relative gene expression ratios. LncRNA-TARE and 
PfSip2 primer sequences are listed in Supplementary Table 2.5.  
RLM-RACE 
We employed RNA Ligase Mediated Rapid Amplification of cDNA Ends (RLM-RACE) 
following manufacturer specifications (Ambion) and using 10 µg of T40 +/- 3 hpi RNA mixed 
1:1 from two independent time course extractions. We used Premier Biosoft International 
AlleleID 7.6 software to design primers targeting twenty lncRNA-TARE loci [Supplementary 
Table 2.5]. To map the putative 5’ cap, we used a nested priming strategy with primers spaced 
roughly 350 bp antisense to the target sequence. To map 3’ termini, we used a semi-nested 
priming strategy using a single antisense primer to the target sequence and nested primers 
corresponding to the 3’ adapter sequence. Notably, the 5’ RACE outer primer is the reverse 
complement of the 3’ RACE primer, ensuring capture of contiguous transcripts. Minus RT 
control reactions were included for 3’ RACE.  
Outer and inner 5’ RACE PCR cycling was performed using SuperTaq Plus polymerase 
(Ambion) and the following cycling conditions: 94°C for 3 min, 5 cycles of 94°C for 30 seconds, 
60°C for 30 seconds, 68°C for 3 minutes, 35 cycles of 94°C for 30 seconds, 55°C for 30 seconds, 
68°C for 3 minutes, and a final extension for 10 minutes at 68°C. 3’ RACE PCR cycling was 	 ﾠ
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analagous except denaturation was performed at 94°C for 15 seconds and extension was 
performed at 68°C for 8 minutes. PCR products were gel excised, purified using QIAGEN 
MinElute Gel Extraction Cleanup columns, and cloned into the pCR-2.1TOPO vector 
(Invitrogen).  
27 and 10 colonies corresponding to 3’ and 5’ RACE products, respectively, were 
sequenced using Genewiz services and analyzed using Geneious software [86]. A total of 12 
different lncRNA-TARE loci were unambiguously represented in sequenced 3’ RACE products. 
The original chromosome and syntenic terminus coordinates on the left end of chromosome four 
for each sequenced RACE product is included in Supplementary Table 2.6 along with a 
graphical alignment of each sequenced RACE product to the left end of chromosome four in 
Supplementary Figure 2.5. RACE products were trimmed to exclude any low-quality base calls 
and vector sequence beyond the first four bases prior to alignment.  
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Abstract 
 
The human malaria parasite Plasmodium falciparum has a complex and multi-stage life 
cycle that requires extensive and precise gene regulation to allow invasion and hijacking of 
human host cells, transmission through the female Anopheles mosquito vector, and escape from 
the immune systems of both vector and host. To date, the regulatory elements orchestrating these 
critical parasite processes remain largely unknown. However, there is mounting evidence across 
a broad range of species that intergenic long non-coding RNA (lncRNA) and antisense RNA can 
regulate chromatin state and gene expression. To pursue such functional roles for lncRNAs in P. 
falciparum, we performed deep, strand-specific RNA sequencing of fifteen non-polyA-selected 
blood stage samples, and assembled and characterized the properties of 660 intergenic lncRNAs, 
474 antisense RNAs, and 1381 circular RNAs (circRNAs). We further validated the non-
canonical splice junctions of six P. falciparum circRNAs, an emerging class of non-coding RNA 
with regulatory potential and unexplored functional significance in P. falciparum. Our 
comprehensive analysis of P. falciparum lncRNAs indicates a functional role for these 
transcripts; P. falciparum intergenic lncRNAs and antisense RNAs are developmentally 	 ﾠ
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regulated in a similar periodic fashion to annotated transcripts, and sense-antisense pair 
expression is significantly anti-correlated. Notable outliers include intergenic lncRNAs that 
strongly peak in expression during parasite invasion, such as the telomere-associated lncRNA-
TARE family, antisense RNAs that drop in expression during parasite invasion, and a highly 
correlated, multi-exonic, antisense counterpart to P. falciparum Gametocyte Developmental 
Protein 1 (PfGDV1). Taken together, our results characterize over two thousand P. falciparum 
intergenic lncRNA, antisense, and circRNA candidates and highlight promising P. falciparum 
lncRNAs for future investigation.  
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3. 1  Introduction 
Plasmodium falciparum is the most deadly human malaria parasite, notorious for its 
immense disease burden, ability to persist in individuals for months if not longer, and rapid 
development of resistance to all currently available treatments [1-5]. The symptomatic 
characteristics of acute P. falciparum malaria infection correspond to cycles of red blood cell 
(RBC) rupture, as merozoite parasites invade RBCs, asexually replicate into 8-36 new daughter 
merozoites, egress from the RBCs, and repeat the process every 48 hours [6-9]. This process can 
be readily modeled in the lab, in contrast to the sexual stage required for transmission, which 
takes 8-12 days in human RBCs and then an additional 8-15 days in mosquitoes [10,11]. Due to 
the clinical symptoms associated with the asexual blood stage and the relative ease of obtaining 
samples, the vast majority of current anti-malarial compounds and research programs target this 
stage of the parasite life cycle [12]. However, the idea of targeting both the symptomatic and 
transmissible parasite form is garnering increased public attention, making research on sexual 
stage commitment and sexual development a priority as well [12-14].   
The first P. falciparum genome sequence was published in 2002 [15]. Our understanding 
of malaria biology has advanced considerably since this milestone, largely due to genome-wide 
studies [16,17]. Early transcriptome studies found that key P. falciparum proteins are typically 
transcribed only once per blood stage, ‘just-in-time’ for translation and function [18,19]. 
Subsequently, global ribosome profiling and proteome studies revealed significant post-
transcriptional regulation and a unique histone code involving at least 44 histone post-
translational modifications and four novel histone variants [20-23]. Additionally, paired 
transcriptome-epigenome studies found dynamic chromatin remodeling and clonally variant gene 	 ﾠ
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expression (CVGE) patterns during blood stage development [24-27], with independent studies 
confirming a heritable epigenetic layer to monoallelic expression of the 60-member P. 
falciparum Erythrocyte Membrane Protein 1 (PfEMP1)-encoding var gene family, and 
Cytoadherence Linked Asexual Gene 3 (CLAG3) loci [28-32].  
Remarkably, while it has become increasingly clear over the past decade that the P. 
falciparum genome is tightly regulated, the regulatory elements themselves are still largely 
unknown [33-36]. For example, it is not mechanistically clear how the parasite transcriptionally 
silences, activates, or switches Pfemp1-encoding var genes to evade the human immune system, 
or how the parasite switches from asexual to sexual development [37,38]. Few sequence-specific 
transcription factors have been identified, and P. falciparum does not encode microRNAs, 
microRNA processing machinery, or RNA-induced silencing complex (RISC) components [39-
41]. With the absence of many known transcription factors and the canonical RNA interference 
pathway, master regulatory elements orchestrating immune escape, invasion, transmission, and 
other critical parasite processes remain to be discovered.     
We hypothesized that long non-coding RNAs (lncRNAs) may provide a crucial 
regulatory layer in P. falciparum transcriptional, post-transcriptional, and chromatin state 
control. Recent survey studies have shown prevalent lncRNA transcription in P. falciparum [42-
47], and a growing body of evidence supports the dominant regulatory roles of lncRNAs in 
humans and model organisms [48,49]. For example, it has been shown that lncRNAs coordinate 
X chromosome inactivation in female mammalian cells, flowering time in plants, and 
gametogenesis in budding yeast [50-55]. However, while prior work has suggested the 
transcription of intergenic, antisense, and even circular RNA (circRNA) in P. falciparum, 
lncRNA transcript models have not been defined, non-coding properties have not been 	 ﾠ
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generalized on a broad scale, and only two examples of P. falciparum circRNAs have been 
described previously [42-46].   
In this study, we aimed to apply recent advancements in next generation sequencing 
technology to the transcriptome-wide assembly and characterization of P. falciparum intergenic 
lncRNA and antisense RNA, searching for evidence of circRNA transcription as well. The raw 
and analyzed data, along with the methodology of this study, are broadly useful to the malaria 
community and should facilitate both P. falciparum lncRNA functional investigation and strand-
specific sequencing of additional P. falciparum samples.   
3.2  Results 
Strand-Specific RNA Sequencing of Biological Replicate Blood Stage Time Courses 
To investigate P. falciparum lncRNA transcription, we harvested fifteen blood stage 
samples from two biological replicate time courses [Figure 3.1A]. The first time course 
comprised eleven samples that finely map temporal changes during P. falciparum blood stage 
development. We harvested samples over 56 hours, at roughly 4-hour time intervals, from a 
tightly synchronized P. falciparum 3D7 parasite population. As the asexual blood stage is an 
approximately 48-hour cycle, this time course allowed us to profile gene expression during RBC 
rupture and parasite invasion. The second time course comprised four samples harvested in 
synchronous P. falciparum 3D7 parasites approximately four hours before and after the ring to 
trophozoite and trophozoite to schizont morphological stage transitions, which occur during the 
blood stage at 24 hours post-infection (hpi) and 36 hpi, respectively [6-8].  
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Figure	 ﾠ3.1	 ﾠ|	 ﾠOverview	 ﾠof	 ﾠP.	 ﾠfalciparum	 ﾠRNA	 ﾠsequencing	 ﾠsample	 ﾠset,	 ﾠcomputational	 ﾠ
pipeline,	 ﾠand	 ﾠread	 ﾠalignment	 ﾠmetrics.	 ﾠ(A)	 ﾠWe	 ﾠharvested	 ﾠtotal	 ﾠRNA	 ﾠfrom	 ﾠtwo	 ﾠ
independent	 ﾠP.	 ﾠfalciparum	 ﾠblood	 ﾠstage	 ﾠtime	 ﾠcourses,	 ﾠincluding	 ﾠa	 ﾠ56-ﾭ‐hour	 ﾠtime	 ﾠcourse	 ﾠ
consisting	 ﾠof	 ﾠeleven	 ﾠsamples.	 ﾠWe	 ﾠcombined	 ﾠsamples	 ﾠharvested	 ﾠ4	 ﾠand	 ﾠ8	 ﾠhpi	 ﾠat	 ﾠequal	 ﾠratios	 ﾠ
(further	 ﾠreferred	 ﾠto	 ﾠas	 ﾠT6).	 ﾠSimilarly,	 ﾠwe	 ﾠcombined	 ﾠsamples	 ﾠharvested	 ﾠ12	 ﾠand	 ﾠ16	 ﾠhpi	 ﾠat	 ﾠ
equal	 ﾠratios	 ﾠ(further	 ﾠreferred	 ﾠto	 ﾠas	 ﾠT14).	 ﾠWe	 ﾠharvested	 ﾠfour	 ﾠsamples	 ﾠfrom	 ﾠa	 ﾠsecond	 ﾠtime	 ﾠ
course	 ﾠapproximately	 ﾠ4	 ﾠhours	 ﾠbefore	 ﾠand	 ﾠafter	 ﾠgross	 ﾠstage	 ﾠtransitions.	 ﾠThus	 ﾠthese	 ﾠsamples	 ﾠ
correspond	 ﾠto	 ﾠthe	 ﾠlate	 ﾠring,	 ﾠearly	 ﾠtrophozoite,	 ﾠlate	 ﾠtrophozoite,	 ﾠand	 ﾠearly	 ﾠschizont	 ﾠstages,	 ﾠ
respectively.	 ﾠIn	 ﾠtotal,	 ﾠwe	 ﾠsequenced	 ﾠ15	 ﾠstrand-ﾭ‐specific	 ﾠRNA	 ﾠsequencing	 ﾠlibraries	 ﾠon	 ﾠan	 ﾠ
Illumina	 ﾠHiseq	 ﾠ2000	 ﾠmachine.	 ﾠIllumina	 ﾠsequencing	 ﾠyielded	 ﾠapproximately	 ﾠ614	 ﾠmillion	 ﾠ101-ﾭ‐
bp	 ﾠpaired-ﾭ‐end	 ﾠreads.	 ﾠWe	 ﾠanalyzed	 ﾠreads	 ﾠusing	 ﾠthe	 ﾠTuxedo	 ﾠsuite	 ﾠ(Bowtie,	 ﾠTopHat,	 ﾠCufflinks,	 ﾠ
Cuffmerge,	 ﾠand	 ﾠCuffdiff)	 ﾠand	 ﾠaccording	 ﾠto	 ﾠthe	 ﾠcircBase	 ﾠcircRNA	 ﾠdiscovery	 ﾠpipeline.	 ﾠUsing	 ﾠ
this	 ﾠapproach,	 ﾠwe	 ﾠidentified	 ﾠ660	 ﾠintergenic	 ﾠlncRNA	 ﾠ(647	 ﾠunique	 ﾠloci),	 ﾠ474	 ﾠantisense	 ﾠRNA	 ﾠ
(467	 ﾠunique	 ﾠloci),	 ﾠand	 ﾠ1381	 ﾠcircRNA	 ﾠcandidates.	 ﾠAdditionally,	 ﾠ3815	 ﾠgenes,	 ﾠ127	 ﾠtranscripts,	 ﾠ
and	 ﾠ81	 ﾠpromoters	 ﾠreached	 ﾠstatistical	 ﾠsignificance	 ﾠin	 ﾠterms	 ﾠof	 ﾠdifferential	 ﾠexpression,	 ﾠ
alternative	 ﾠsplicing,	 ﾠand	 ﾠalternative	 ﾠpromoter	 ﾠusage,	 ﾠrespectively.	 ﾠ(B)/(C)	 ﾠNormalized	 ﾠread	 ﾠ
alignment	 ﾠtracks	 ﾠacross	 ﾠa	 ﾠPfEMP1-ﾭ‐encoding	 ﾠvar	 ﾠgene	 ﾠ(Pf3D7_0212700)	 ﾠand	 ﾠthe	 ﾠCLAG3.1	 ﾠ
gene	 ﾠ(Pf3D7_0302500)	 ﾠindicated	 ﾠthat	 ﾠthese	 ﾠchallenging	 ﾠloci	 ﾠcould	 ﾠgenerally	 ﾠbe	 ﾠ(perfectly	 ﾠ
and	 ﾠuniquely)	 ﾠmapped.	 ﾠAnnotated	 ﾠgene	 ﾠmodels	 ﾠare	 ﾠshown	 ﾠin	 ﾠdark	 ﾠgreen	 ﾠand	 ﾠdark	 ﾠblue.	 ﾠ
Reads	 ﾠfrom	 ﾠeach	 ﾠ56-ﾭ‐hour	 ﾠtime	 ﾠcourse	 ﾠsample	 ﾠmapping	 ﾠto	 ﾠthe	 ﾠ(-ﾭ‐)	 ﾠstrand	 ﾠare	 ﾠshown	 ﾠbelow	 ﾠ
each	 ﾠhorizontal	 ﾠaxis	 ﾠin	 ﾠlight	 ﾠgreen,	 ﾠwhile	 ﾠreads	 ﾠmapping	 ﾠto	 ﾠthe	 ﾠ(+)	 ﾠstrand	 ﾠare	 ﾠshown	 ﾠabove	 ﾠ
each	 ﾠhorizontal	 ﾠaxis	 ﾠin	 ﾠlight	 ﾠblue.	 ﾠUniqueness	 ﾠof	 ﾠ100mers	 ﾠis	 ﾠplotted	 ﾠin	 ﾠred	 ﾠas	 ﾠa	 ﾠmappability	 ﾠ
track,	 ﾠwhere	 ﾠthe	 ﾠbaseline	 ﾠrepresents	 ﾠa	 ﾠscore	 ﾠof	 ﾠone,	 ﾠor	 ﾠuniquely	 ﾠmapping.	 ﾠ	 ﾠ	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Figure	 ﾠ3.1	 ﾠ(Continued)	 ﾠ|	 ﾠOverview	 ﾠof	 ﾠP.	 ﾠfalciparum	 ﾠRNA	 ﾠsequencing	 ﾠsample	 ﾠset,	 ﾠ
computational	 ﾠpipeline,	 ﾠand	 ﾠread	 ﾠalignment	 ﾠmetrics.	 ﾠ(D)/(E)	 ﾠPlotting	 ﾠthe	 ﾠexpression	 ﾠ
during	 ﾠthe	 ﾠ56-ﾭ‐hour	 ﾠtime	 ﾠcourse	 ﾠof	 ﾠthe	 ﾠdominant	 ﾠPfemp1-ﾭ‐encoding	 ﾠvar	 ﾠgene	 ﾠ
(Pf3D7_0212700)	 ﾠand	 ﾠboth	 ﾠthe	 ﾠCLAG3.1	 ﾠ(Pf3D7_0302500)	 ﾠand	 ﾠCLAG3.2	 ﾠ(Pf3D7_0502200)	 ﾠ
genes	 ﾠshowed,	 ﾠrespectively,	 ﾠthat	 ﾠvar	 ﾠgene	 ﾠexpression	 ﾠpeaked	 ﾠduring	 ﾠthe	 ﾠring	 ﾠstage,	 ﾠwhereas	 ﾠ
CLAG3.1	 ﾠand	 ﾠCLAG3.2	 ﾠexpression	 ﾠpeaked	 ﾠduring	 ﾠthe	 ﾠschizont	 ﾠstage.	 ﾠMoreover,	 ﾠas	 ﾠCLAG3	 ﾠ
genes	 ﾠare	 ﾠmutually	 ﾠexclusively	 ﾠexpressed	 ﾠ[28,29],	 ﾠwe	 ﾠfound	 ﾠthat	 ﾠthat	 ﾠthe	 ﾠbulk	 ﾠof	 ﾠour	 ﾠ
parasites	 ﾠtranscribed	 ﾠonly	 ﾠthe	 ﾠCLAG3.1	 ﾠgene.	 ﾠExpression	 ﾠis	 ﾠplotted	 ﾠin	 ﾠunits	 ﾠof	 ﾠ
log2(FPKM+1).	 ﾠ(F)	 ﾠThe	 ﾠpercent	 ﾠof	 ﾠreads	 ﾠin	 ﾠeach	 ﾠlibrary	 ﾠmapping	 ﾠto	 ﾠannotated	 ﾠtranscripts	 ﾠ
in	 ﾠthe	 ﾠproper	 ﾠorientation	 ﾠ(per	 ﾠreads	 ﾠmapping	 ﾠto	 ﾠannotated	 ﾠtranscripts)	 ﾠranged	 ﾠfrom	 ﾠ
98.92%	 ﾠto	 ﾠ99.81%.	 ﾠThe	 ﾠaverage	 ﾠcalculated	 ﾠfrom	 ﾠboth	 ﾠreads	 ﾠis	 ﾠreported.	 ﾠ(G)	 ﾠThe	 ﾠaverage	 ﾠ
coefficient	 ﾠof	 ﾠvariation	 ﾠacross	 ﾠthe	 ﾠtop	 ﾠ2000	 ﾠexpressed	 ﾠgenes	 ﾠin	 ﾠeach	 ﾠlibrary	 ﾠ(or	 ﾠroughly	 ﾠtop	 ﾠ
50%	 ﾠof	 ﾠexpressed	 ﾠgenes)	 ﾠranged	 ﾠfrom	 ﾠ0.23	 ﾠto	 ﾠ0.33.	 ﾠ	 ﾠ
 
Given the high AT content and dense genic structure of the P. falciparum genome, we 
then extensively optimized RNA sequencing procedures, both experimental and computational, 
in order to derive a high-quality P. falciparum transcriptome. In terms of experimental 
optimization, we tested numerous variables and pursued technical developments shown to reduce 
sequence-based bias in DNA sequencing libraries and to improve strand-specificity in RNA 
sequencing libraries [56-62]. Subsequently, we established a library preparation protocol that 
uses multiple DNase treatments to remove genomic DNA, Ribo-Zero beads to remove ribosomal 
RNA, the dUTP method with Actinomycin D to preserve strand specificity, and the KAPA HiFi 
polymerase to amplify libraries in real-time for the minimum number of cycles necessary [see 
Methods 3.4, Supplementary Figure 3.1, and Supplementary Protocol 3.1 for further details].  
After harvesting samples from the two time courses and developing and validating our 
strand-specific library preparation protocol, we prepared libraries from the fifteen blood stage 
samples in parallel, and sequenced libraries on two lanes of an Illumina Hiseq 2000 machine. 
Illumina sequencing yielded 614 million 101 base-pair (bp) paired-end reads in total, with 
sequencing depth ranging from 20 to 30 million (perfectly and uniquely) alignable reads per 	 ﾠ
	 ﾠ
	 ﾠ
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sample. We noted high base quality scores and no significant adapter contamination 
[Supplementary Table 3.1, Supplementary Table 3.2, and Supplementary Figure 3.2].  
Aligning and Benchmarking Sequences 
We took a conservative approach to read alignment, requiring read pairs to map perfectly 
and uniquely to the P. falciparum 3D7 reference genome. In support of this, we determined that 
96.53% of all possible 100mers in the P. falciparum genome are unique. In addition, we tested 
our ability to map read pairs across repeated gene families, such as the Pfemp1-encoding var 
gene family and the two CLAG3 loci, which we calculated share 96.4% sequence similarity. 
Specifically, we visualized a lower bound to mappability across these repeated loci by plotting 
the uniqueness of 100mers as a mappability track. Figure 3.1B and Figure 3.1C show the 
mappability track (in red) compared to strand-specific read coverage across a Pfemp1-encoding 
var gene (Pf3D7_0412700) and the CLAG3.1 gene (Pf3D7_0302500), respectively. Figure 3.1C 
and Figure 3.1D plot the expression profiles of these genes, as well as the CLAG3.2 gene 
(Pf3D7_0302200). Using this stringent approach and paired-end information, we were able to 
uniquely map read pairs to these repeated loci, including through short stretches of non-unique 
sequence. 
After conservatively aligning reads using TopHat [63], we assessed data quality 
following the RNA sequencing benchmarking metrics put forth by DeLuca et al. and Wang et al. 
[64,65]. We calculated the strand-specificity, coefficient of variation, duplication rate, gap rate, 
ribosomal RNA rate, exonic rate, insert size, and GC content of each aligned set of reads 
[Supplementary Table 3.2]. Importantly, we found that greater than 98.92% of reads mapped to 
the reference strand in the expected orientation in each sample [Figure 3.1F]. This result was on 	 ﾠ
	 ﾠ
	 ﾠ
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par with yeast strand-specific sequencing libraries, and confirmed that our data was highly 
strand-specific [57]. We also found an average coefficient of variation (CV) of between 0.23 and 
0.33 across the top 2000 expressed genes (or roughly top 50% of expressed genes) in each 
sample [Figure 3.1G]. These CV values were lower than the lowest CV value reported in the 
benchmarking study referenced above (0.54), indicating more even read coverage in our samples 
[57]. Taken together, the rigorous examination of our data quality demonstrated that it was 
comparable to the state-of-the-art in model organisms.  
Benchmarking Time Courses 
Comparing samples between two independent time courses is a known challenge in the 
field, and can be confounded by experimental factors such as culture conditions [27,66,67]. We 
thus developed a computational solution that leverages multidimenstional scaling (MDS) to 
assess stage similarities on a transcriptome-wide scale. While MDS has not previously been used 
for P. falciparum sample comparisons, its utility has been demonstrated in humans and in model 
organisms such as yeast, especially when periodicity is expected [68,69]. MDS analysis using 
sample profiles from both time courses revealed the cyclical nature of the P. falciparum blood 
stage, with samples progressing in time around an approximately 48-hour clock [Figure 3.2A]. 
This analysis also confirmed that the four morphology-based samples corresponded to the 56-
hour, high-resolution time course samples at expected intervals.  
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Figure	 ﾠ3.2	 ﾠ|	 ﾠMultidimensional	 ﾠscaling	 ﾠand	 ﾠGene	 ﾠOntology	 ﾠconfirm	 ﾠexpected	 ﾠP.	 ﾠ
falciparum	 ﾠblood	 ﾠstage	 ﾠexpression	 ﾠpatterns.	 ﾠ(A)	 ﾠThe	 ﾠMDS	 ﾠplot	 ﾠof	 ﾠsample	 ﾠprofiles	 ﾠ
embedded	 ﾠsamples	 ﾠaround	 ﾠa	 ﾠcircle.	 ﾠTraversing	 ﾠthe	 ﾠcircle,	 ﾠwe	 ﾠfound	 ﾠthat	 ﾠsamples	 ﾠ
progressed	 ﾠthrough	 ﾠthe	 ﾠapproximately	 ﾠ48-ﾭ‐hour	 ﾠP.	 ﾠfalciparum	 ﾠblood	 ﾠstage	 ﾠaccording	 ﾠto	 ﾠtheir	 ﾠ
time	 ﾠand	 ﾠmorphology	 ﾠlabels	 ﾠas	 ﾠexpected.	 ﾠThe	 ﾠ56-ﾭ‐hour	 ﾠtime	 ﾠcourse	 ﾠsamples	 ﾠare	 ﾠlabeled	 ﾠin	 ﾠ
red,	 ﾠgreen,	 ﾠand	 ﾠblue,	 ﾠwith	 ﾠred	 ﾠcorresponding	 ﾠto	 ﾠsamples	 ﾠharvested	 ﾠwithin	 ﾠthe	 ﾠpredicted	 ﾠ
ring	 ﾠstage,	 ﾠgreen	 ﾠcorresponding	 ﾠto	 ﾠsamples	 ﾠharvested	 ﾠwithin	 ﾠthe	 ﾠpredicted	 ﾠtrophozoite	 ﾠ
stage,	 ﾠand	 ﾠblue	 ﾠcorresponding	 ﾠto	 ﾠsamples	 ﾠharvested	 ﾠwithin	 ﾠthe	 ﾠpredicted	 ﾠschizont	 ﾠstage.	 ﾠ
The	 ﾠmorphology-ﾭ‐based	 ﾠlabels	 ﾠcorrespond	 ﾠto	 ﾠthe	 ﾠlate	 ﾠring,	 ﾠearly	 ﾠtrophozoite,	 ﾠlate	 ﾠ
trophozoite,	 ﾠand	 ﾠearly	 ﾠschizont	 ﾠstages,	 ﾠrespectively.	 ﾠ(B)	 ﾠSimilarly,	 ﾠthe	 ﾠMDS	 ﾠplot	 ﾠof	 ﾠ
differentially	 ﾠexpressed,	 ﾠannotated	 ﾠmRNA	 ﾠgene	 ﾠexpression	 ﾠprofiles	 ﾠembedded	 ﾠgenes	 ﾠ
around	 ﾠa	 ﾠcircle,	 ﾠwith	 ﾠtheir	 ﾠangular	 ﾠposition	 ﾠcorresponding	 ﾠto	 ﾠtheir	 ﾠstage	 ﾠof	 ﾠmaximum	 ﾠ
expression.	 ﾠRed	 ﾠindicates	 ﾠ1632	 ﾠring-ﾭ‐specific	 ﾠgenes,	 ﾠgreen	 ﾠindicates	 ﾠ1378	 ﾠtrophozoite-ﾭ‐
specific	 ﾠgenes,	 ﾠand	 ﾠblue	 ﾠindicates	 ﾠ1274	 ﾠschizont-ﾭ‐specific	 ﾠgenes.	 ﾠGO	 ﾠterm	 ﾠenrichment	 ﾠ
analysis	 ﾠon	 ﾠeach	 ﾠset	 ﾠof	 ﾠstage-ﾭ‐specific	 ﾠgenes	 ﾠindicated	 ﾠthat	 ﾠgenes	 ﾠinvolved	 ﾠin	 ﾠhost	 ﾠcell	 ﾠ
adhesion	 ﾠprocesses	 ﾠwere	 ﾠexpressed	 ﾠduring	 ﾠthe	 ﾠring	 ﾠstage,	 ﾠfollowed	 ﾠby	 ﾠgenes	 ﾠinvolved	 ﾠin	 ﾠ
DNA	 ﾠreplication	 ﾠand	 ﾠmetabolic	 ﾠprocesses	 ﾠduring	 ﾠthe	 ﾠtrophozoite	 ﾠstage,	 ﾠfollowed	 ﾠby	 ﾠgenes	 ﾠ
involved	 ﾠin	 ﾠDNA	 ﾠreplication	 ﾠand	 ﾠprotein	 ﾠcatabolic	 ﾠprocesses	 ﾠduring	 ﾠthe	 ﾠschizont	 ﾠstage.	 ﾠAll	 ﾠ
GO	 ﾠterm	 ﾠp-ﾭ‐values	 ﾠ<	 ﾠ.002	 ﾠ(C)	 ﾠWe	 ﾠvisualized	 ﾠthe	 ﾠmean-ﾭ‐centered	 ﾠexpression	 ﾠprofiles	 ﾠof	 ﾠ
annotated	 ﾠmRNA	 ﾠgenes	 ﾠduring	 ﾠthe	 ﾠ56-ﾭ‐hour	 ﾠtime	 ﾠcourse	 ﾠin	 ﾠa	 ﾠcircular,	 ﾠnon-ﾭ‐clustering	 ﾠ
heatmap	 ﾠ[68].	 ﾠGenes	 ﾠare	 ﾠordered	 ﾠby	 ﾠtheir	 ﾠangular	 ﾠposition	 ﾠin	 ﾠthe	 ﾠMDS	 ﾠplot	 ﾠof	 ﾠgene	 ﾠ
expression	 ﾠprofiles	 ﾠand	 ﾠsamples	 ﾠare	 ﾠordered	 ﾠby	 ﾠtime.	 ﾠExpression	 ﾠis	 ﾠin	 ﾠunits	 ﾠof	 ﾠ
log2(FPKM+1).	 ﾠ	 ﾠ
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Figure	 ﾠ3.2	 ﾠ(Continued)	 ﾠ|	 ﾠMultidimensional	 ﾠscaling	 ﾠand	 ﾠGene	 ﾠOntology	 ﾠconfirm	 ﾠ
expected	 ﾠP.	 ﾠfalciparum	 ﾠblood	 ﾠstage	 ﾠexpression	 ﾠpatterns.	 ﾠ	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As a complementary analysis, we performed MDS using differentially expressed 
annotated messenger RNA (mRNA) gene expression profiles. We classified 1632 ring-specific, 
1378 trophozoite-specific, and 1274 schizont-specific genes according to their maximal 
expression time-point, and color-coded these genes as red, green, and blue, respectively, in the 
two-dimensional plot produced by MDS [Figure 3.2B]. The clear separation of ring-, 
trophozoite-, and schizont-specific genes indicated that genes were embedded in the MDS plot 
according to their functional stage of expression. To investigate this further, we ordered genes by 
their angular position in the MDS plot and samples by time, and visualized gene expression 
profiles in a circular non-clustering heatmap [Figure 3.2C] [68]. This revealed the expected 
periodic expression cascade of the P. falciparum blood stage, with most genes peaking in 
expression only once. 
We next sought to connect the cyclical, periodic expression patterns evident in our MDS 
results to P. falciparum biology. First, we considered the expression profiles of well-established 
stage-specific marker genes. For example, based on previous studies, the dominant Pfemp1-
encoding var gene should be maximally expressed during the ring stage, and one of the CLAG3 
genes should be maximally expressed during the schizont stage [29,32]. Our expression profiles 
matched these expectations [Figure 3.1F/G, and Supplementary Figure 3.3]. We similarly 
assessed many additional marker genes, confirming their expected stage-specific expression 
profiles in each time course [Supplementary Figure 3.4]. To gain a more global view of sample 
biology, we then computed GO term enrichment on the ring-, trophozoite-, and schizont-specific 
gene sets that we previously defined [70]. Ring-, trophozoite-, and schizont-specific GO terms 
were specific to host cell adhesion processes, metabolic processes, and protein catabolic 
processes, respectively, with DNA replication spanning both trophozoite- and schizont-specific 	 ﾠ
	 ﾠ
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GO terms [Figure 3.2B, and Supplementary Table 3.3]. These GO terms were highly 
consistent with our current understanding of P. falciparum biology [6-8]. Taken together, MDS 
paired with gene-by-gene and global GO term enrichment analysis validated the biological 
integrity of our time course samples.  
Transcript Assembly   
We next set out to assemble P. falciparum transcript structures, with or without the 
assistance of annotated transcript models, and to assess assembly performance using either 
Cufflinks or genome-guided Trinity [71-73] [Figure 3.1A]. Specifically, we were looking for 
high contiguity (a high rate of annotated transcripts being spanned by one assembled transcript 
over at least 90% of the annotated transcript exonic length), low chimerism (a low rate of 
assembled transcripts spanning more than one annotated transcript), and for the final assembly to 
be manageable and high-confidence [74,75].  
Using Cufflinks without the assistance of annotation, we found that 81.5% of annotated 
transcripts had assembled transcripts contiguously spanning them, while only 7.9% of assembled 
transcripts were chimeric [Table 3.1]. With the assistance of annotation, the chimerism rate 
dropped to 6.7% and the contiguity rate naturally rose to 100% [Table 3.1]. The number of 
predicted unannotated transcripts, however, did not appreciably change when we used Cufflinks 
in reference-annotation based transcript assembly (RABT) mode or without the assistance of 
annotated transcript models. Based on its performance features, we chose to further explore the 
high-confidence Cufflinks transcripts (at least 50 supporting reads in at least one sample). 
However, it may be possible to filter the genome-guided Trinity results based on read support or 
expression level to yield a more manageable P. falciparum transcriptome assembly [Table 3.1].  	 ﾠ
	 ﾠ
	 ﾠ
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Table	 ﾠ3.1	 ﾠ|	 ﾠComparative	 ﾠassessment	 ﾠof	 ﾠP.	 ﾠfalciparum	 ﾠtranscriptome	 ﾠassembly	 ﾠ
highlights	 ﾠthe	 ﾠperformance	 ﾠof	 ﾠCufflinks	 ﾠRABT.	 ﾠWe	 ﾠcompared	 ﾠthe	 ﾠcontiguity,	 ﾠchimerism,	 ﾠ
and	 ﾠfeature	 ﾠcounts	 ﾠof	 ﾠCufflinks	 ﾠversus	 ﾠGenome-ﾭ‐guided	 ﾠTrinity	 ﾠtranscriptome	 ﾠassembly,	 ﾠ
with	 ﾠor	 ﾠwithout	 ﾠthe	 ﾠassistance	 ﾠof	 ﾠannotation.	 ﾠCufflinks	 ﾠincorporating	 ﾠreference	 ﾠannotation	 ﾠ
based	 ﾠtranscriptome	 ﾠassembly	 ﾠ(RABT)	 ﾠprovided	 ﾠthe	 ﾠoptimal	 ﾠP.	 ﾠfalciparum	 ﾠtranscriptome.	 ﾠ	 ﾠ	 ﾠ
Contiguity	 ﾠis	 ﾠthe	 ﾠrate	 ﾠof	 ﾠannotated	 ﾠtranscripts	 ﾠcovered	 ﾠby	 ﾠone	 ﾠassembled	 ﾠtranscript	 ﾠover	 ﾠat	 ﾠ
least	 ﾠ90%	 ﾠof	 ﾠthe	 ﾠannotated	 ﾠtranscript	 ﾠexonic	 ﾠlength	 ﾠin	 ﾠthe	 ﾠcorrect	 ﾠorientation.	 ﾠChimerism	 ﾠis	 ﾠ
the	 ﾠrate	 ﾠof	 ﾠassembled	 ﾠtranscripts	 ﾠthat	 ﾠspan	 ﾠmore	 ﾠthan	 ﾠone	 ﾠannotated	 ﾠtranscript	 ﾠin	 ﾠthe	 ﾠ
correct	 ﾠorientation.	 ﾠTotal	 ﾠnumber	 ﾠof	 ﾠtranscripts,	 ﾠnumber	 ﾠof	 ﾠintergenic	 ﾠtranscripts,	 ﾠand	 ﾠ
number	 ﾠof	 ﾠantisense	 ﾠtranscripts	 ﾠcorrespond	 ﾠto	 ﾠthe	 ﾠtotal	 ﾠnumber	 ﾠof	 ﾠassembled	 ﾠtranscripts,	 ﾠ
the	 ﾠnumber	 ﾠof	 ﾠassembled	 ﾠtranscripts	 ﾠpredicted	 ﾠbetween	 ﾠPlasmoDBv10.0	 ﾠannotations,	 ﾠand	 ﾠ
the	 ﾠnumber	 ﾠof	 ﾠassembled	 ﾠtranscripts	 ﾠpredicted	 ﾠantisense	 ﾠto	 ﾠPlasmoDBv10.0	 ﾠannotations.	 ﾠIn	 ﾠ
total,	 ﾠ5,777	 ﾠtranscripts	 ﾠare	 ﾠannotated	 ﾠin	 ﾠPlasmoDBv10.0.	 ﾠ	 ﾠ	 ﾠ	 ﾠ
	 ﾠ Contiguity  Chimerism  Total	 ﾠ Intergenic	 ﾠ Antisense 	 ﾠ
PlasmoDBv10.0	 ﾠ 	 ﾠ 	 ﾠ 5,777	 ﾠ 	 ﾠ 	 ﾠ
Cufflinks	 ﾠ 81.5%	 ﾠ 7.9%	 ﾠ 7,065	 ﾠ 660	 ﾠ 479	 ﾠ
Cufflinks 
RABT	 ﾠ
100%	 ﾠ 6.7%	 ﾠ 9,434	 ﾠ 660	 ﾠ 474	 ﾠ
Genome-
guided Trinity	 ﾠ
57.1%	 ﾠ 3.8%	 ﾠ 43,816	 ﾠ 8,260	 ﾠ 11,070	 ﾠ
Genome-
guided Trinity 
RABT	 ﾠ
100%	 ﾠ 2.5%	 ﾠ 21,182	 ﾠ 5,839	 ﾠ 7,234	 ﾠ
*RABT	 ﾠ=	 ﾠReference	 ﾠannotation	 ﾠbased	 ﾠtranscript	 ﾠassembly	 ﾠ	 ﾠ
	 ﾠ
	 ﾠ
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To further benchmark Cufflinks assembly performance in P. falciparum, we compared 
the expression properties, GC content, and length of Cufflinks-assembled transcripts to those of 
previous annotations. Towards this end, we paired 5727 and 7736 assembled transcripts with 
PlasmoDBv10.0 annotated transcripts in the unassisted and assisted Cufflinks assemblies, 
respectively. We then calculated the correlation between paired expression profiles, finding a 
median correlation of 0.98 and 0.99 for unassisted and assisted transcripts, respectively. This led 
us to conclude that analyzing assembled transcript expression profiles was essentially 
interchangeable with analyzing annotated transcript expression profiles. We did, however, note a 
shift towards lower FPKM (fragments per kilobase of exon per million fragments mapped) 
expression level and lower GC content for assembled transcripts. This was largely because 
assembled transcripts were generally longer and included unannotated, likely un-translated 
regions (UTRs) with less read support and reduced GC content as compared to coding regions 
[Supplementary Table 3.4, Supplementary Figure 3.5]. We selected the annotation-assisted 
Cufflinks transcriptome for further analyses, unless otherwise noted, as it represented the most 
complete P. falciparum transcriptome.    
In sum, annotation-assisted Cufflinks assembly predicted 9434 transcripts, including 660 
unannotated intergenic transcripts (647 unique loci) and 474 antisense transcripts (467 unique 
loci) [Figure 3.1A, Figure 3.3A, see GSE57439]. The 467 unique antisense loci overlapped 462 
annotated genes in an approximately 1:1 ratio. This encompassed transcription of at least 73% of 
the P. falciparum genome, a 13% increase compared to annotation alone, and included the 
prediction of high-confidence antisense transcription from 8% of annotated genes. Annotation-
assisted Cufflinks assembly also predicted 2134 novel splice-junctions. On the other hand, 
Cufflinks assembly without annotation rediscovered 6918 out of 8537 annotated splice-junctions 	 ﾠ
	 ﾠ
	 ﾠ
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(81%) and, as noted above, predicted contiguous transcripts spanning 4707 out of 5777 
annotated transcripts (81.5%) [Figure 3.3A]. These high rediscovery rates suggested that we 
may have annotated the majority of P. falciparum intergenic lncRNAs and antisense RNAs using 
deeply sequenced, blood stage samples. Of course, further strand-specific sequencing studies of 
the sexual blood and mosquito stages will be necessary to identify and characterize the full range 
of non-coding transcripts in P. falciparum.     
Coding Region Identification 
We next explored whether the 1134 previously unannotated transcripts had coding 
potential, and found that at least 98.5% represented bona fide non-coding RNAs. Using 
TransDecoder [72], we predicted putative coding regions in 5213 out of the 5229 (99.7%) 
possible protein-coding transcripts, but in just seven out of the 660 intergenic transcripts (1.1%) 
and eleven out of the 474 antisense transcripts (2.3%) [Figure 3.1A]. These proportions of 
putative coding regions in our candidate lncRNA sets did not significantly differ from the 
proportions that TransDecoder predicted in random regions (97 out of 6600 random intergenic 
regions, Fisher’s exact test, p-value = .493; 57 out of 4740 random antisense regions, Fisher’s 
exact test, p-value = .053). Moreover, we found no precedent for overlapping genes in P. 
falciparum [15]. Given this body of data and the small proportion that the ambiguous transcripts 
represented in their respective data sets, we retained but noted these transcripts for further 
investigation [see GSE57439].   
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Figure	 ﾠ3.3	 ﾠ|	 ﾠCharacterization	 ﾠof	 ﾠ1134	 ﾠunannotated	 ﾠP.	 ﾠfalciparum	 ﾠlncRNAs	 ﾠreveals	 ﾠ
global	 ﾠtrends	 ﾠas	 ﾠwell	 ﾠas	 ﾠintriguing	 ﾠoutliers.	 ﾠ(A)	 ﾠWithout	 ﾠannotation	 ﾠassistance,	 ﾠat	 ﾠleast	 ﾠ
4707	 ﾠout	 ﾠof	 ﾠ5777	 ﾠ(81.5%)	 ﾠannotated	 ﾠtranscripts	 ﾠcould	 ﾠbe	 ﾠcontiguously	 ﾠassembled	 ﾠin	 ﾠour	 ﾠ
blood	 ﾠstage	 ﾠsamples.	 ﾠ696	 ﾠannotated	 ﾠtranscripts	 ﾠcould	 ﾠnot	 ﾠbe	 ﾠcontiguously	 ﾠassembled,	 ﾠand	 ﾠ
we	 ﾠexcluded	 ﾠ374	 ﾠshort	 ﾠand/or	 ﾠstructural	 ﾠRNAs	 ﾠfrom	 ﾠassembly.	 ﾠGiven	 ﾠthis	 ﾠhigh	 ﾠreassembly	 ﾠ
rate	 ﾠof	 ﾠknown	 ﾠtranscripts,	 ﾠit	 ﾠis	 ﾠpossible	 ﾠthat	 ﾠthe	 ﾠ660	 ﾠintergenic	 ﾠlncRNAs	 ﾠand	 ﾠ474	 ﾠantisense	 ﾠ
RNAs	 ﾠdescribed	 ﾠhere	 ﾠrepresent	 ﾠthe	 ﾠmajority	 ﾠof	 ﾠlncRNAs	 ﾠtranscribed	 ﾠin	 ﾠP.	 ﾠfalciparum.	 ﾠ(B)	 ﾠ
Comparative	 ﾠinspection	 ﾠof	 ﾠnon-ﾭ‐clustering	 ﾠheatmaps	 ﾠshowed	 ﾠthat	 ﾠpredicted	 ﾠlncRNAs	 ﾠwere	 ﾠ
developmentally	 ﾠregulated	 ﾠin	 ﾠa	 ﾠsimilar	 ﾠperiodic	 ﾠfashion	 ﾠto	 ﾠannotated	 ﾠmRNAs.	 ﾠHowever,	 ﾠit	 ﾠ
was	 ﾠalso	 ﾠapparent	 ﾠthat	 ﾠa	 ﾠsubset	 ﾠof	 ﾠlncRNAs	 ﾠstrongly	 ﾠpeaked	 ﾠin	 ﾠexpression	 ﾠduring	 ﾠparasite	 ﾠ
invasion,	 ﾠand	 ﾠthat	 ﾠthere	 ﾠwas	 ﾠa	 ﾠpaucity	 ﾠof	 ﾠantisense	 ﾠexpression	 ﾠduring	 ﾠparasite	 ﾠinvasion.	 ﾠThe	 ﾠ
48	 ﾠhpi	 ﾠinvasion	 ﾠtime-ﾭ‐point	 ﾠis	 ﾠindicated	 ﾠwith	 ﾠpurple	 ﾠarrows.	 ﾠTranscripts	 ﾠare	 ﾠordered	 ﾠby	 ﾠ
their	 ﾠangular	 ﾠposition	 ﾠin	 ﾠthe	 ﾠMDS	 ﾠplot	 ﾠof	 ﾠtranscript	 ﾠexpression	 ﾠprofiles,	 ﾠand	 ﾠsamples	 ﾠare	 ﾠ
ordered	 ﾠby	 ﾠtime.	 ﾠMean-ﾭ‐centered	 ﾠexpression	 ﾠis	 ﾠin	 ﾠunits	 ﾠof	 ﾠlog2(FPKM+1).	 ﾠ(C)	 ﾠThe	 ﾠ
distribution	 ﾠof	 ﾠmaximum	 ﾠexpression	 ﾠlevels	 ﾠfor	 ﾠeach	 ﾠtranscript	 ﾠclass	 ﾠsuggested	 ﾠthat	 ﾠboth	 ﾠ
intergenic	 ﾠlncRNAs	 ﾠ(red)	 ﾠand	 ﾠantisense	 ﾠRNAs	 ﾠ(blue)	 ﾠwere	 ﾠrobustly	 ﾠexpressed,	 ﾠalbeit	 ﾠthey	 ﾠ
typically	 ﾠreached	 ﾠlower	 ﾠmaximum	 ﾠexpression	 ﾠlevels	 ﾠthan	 ﾠannotated	 ﾠmRNAs	 ﾠ(black).	 ﾠ 
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Figure	 ﾠ3.3	 ﾠ(Continued)	 ﾠ|	 ﾠCharacterization	 ﾠof	 ﾠ1134	 ﾠunannotated	 ﾠP.	 ﾠfalciparum	 ﾠ
lncRNAs	 ﾠreveals	 ﾠglobal	 ﾠtrends	 ﾠas	 ﾠwell	 ﾠas	 ﾠintriguing	 ﾠoutliers.	 ﾠ(D)	 ﾠPearson	 ﾠcorrelation	 ﾠ
during	 ﾠthe	 ﾠ56-ﾭ‐hour	 ﾠtime	 ﾠcourse	 ﾠbetween	 ﾠ50,000	 ﾠrandom	 ﾠmRNA	 ﾠgene	 ﾠpairs	 ﾠ(orange)	 ﾠas	 ﾠ
compared	 ﾠto	 ﾠ5251	 ﾠmRNA-ﾭ‐neighboring	 ﾠgene	 ﾠpairs	 ﾠ(black),	 ﾠ498	 ﾠintergenic	 ﾠlncRNA-ﾭ‐
neighboring	 ﾠgene	 ﾠpairs	 ﾠ(red),	 ﾠand	 ﾠ445	 ﾠantisense-ﾭ‐sense	 ﾠgene	 ﾠpairs	 ﾠ(blue).	 ﾠTo	 ﾠbe	 ﾠconsistent,	 ﾠ
we	 ﾠdefined	 ﾠthe	 ﾠneighboring	 ﾠgene	 ﾠused	 ﾠin	 ﾠboth	 ﾠthe	 ﾠmRNA	 ﾠand	 ﾠintergenic	 ﾠlncRNA	 ﾠpairings	 ﾠas	 ﾠ
the	 ﾠmore	 ﾠcorrelated	 ﾠneighboring	 ﾠmRNA.	 ﾠ(E)	 ﾠThe	 ﾠdistribution	 ﾠof	 ﾠGC	 ﾠcontent	 ﾠfor	 ﾠeach	 ﾠ
transcript	 ﾠclass	 ﾠindicated	 ﾠthat	 ﾠintergenic	 ﾠlncRNAs	 ﾠ(red)	 ﾠand	 ﾠantisense	 ﾠRNAs	 ﾠ(blue)	 ﾠtypically	 ﾠ
had	 ﾠlower	 ﾠGC	 ﾠcontent	 ﾠthan	 ﾠannotated	 ﾠtranscripts	 ﾠ(green),	 ﾠthough	 ﾠa	 ﾠhandful	 ﾠof	 ﾠintergenic	 ﾠ
lncRNAs	 ﾠhad	 ﾠunusually	 ﾠhigh	 ﾠGC	 ﾠcontent	 ﾠ(purple	 ﾠarrow).	 ﾠ(F)	 ﾠThe	 ﾠdistribution	 ﾠof	 ﾠtranscript	 ﾠ
length	 ﾠfor	 ﾠeach	 ﾠtranscript	 ﾠclass	 ﾠshowed	 ﾠthat	 ﾠintergenic	 ﾠlncRNAs	 ﾠ(red)	 ﾠand	 ﾠantisense	 ﾠRNAs	 ﾠ
(blue)	 ﾠwere	 ﾠcomparable	 ﾠin	 ﾠlength	 ﾠto	 ﾠannotated	 ﾠtranscripts	 ﾠ(green),	 ﾠwith	 ﾠthe	 ﾠaverage	 ﾠof	 ﾠ
each	 ﾠclass	 ﾠbeing	 ﾠlonger	 ﾠthan	 ﾠ1	 ﾠkb.	 ﾠMarkedly	 ﾠlong	 ﾠintergenic	 ﾠlncRNAs	 ﾠ(>	 ﾠ4	 ﾠkb)	 ﾠare	 ﾠindicated	 ﾠ
with	 ﾠa	 ﾠpurple	 ﾠarrow.	 ﾠ(G)	 ﾠPlotting	 ﾠthe	 ﾠnormalized	 ﾠdistribution	 ﾠof	 ﾠantisense	 ﾠRNAs	 ﾠrelative	 ﾠto	 ﾠ
annotated	 ﾠgene	 ﾠbodies	 ﾠrevealed	 ﾠa	 ﾠ3’	 ﾠtail-ﾭ‐to-ﾭ‐tail	 ﾠbias.	 ﾠ	 ﾠ
 
Differential Expression and Regulation of the P. falciparum Transcriptome 
We leveraged Cuffdiff to compute the differential expression and regulation of our 
annotation-assisted transcriptome across developmental stages [71]. In brief, we compared 
samples harvested approximately eight hours apart during the 56-hour time course, and estimated 
biological variation across the blood stage using biological replicate samples. This approach is 
unprecedented in P. falciparum; previous studies have either not assessed differential expression 
or have arbitrarily compared samples without biological replication or respect for time course 
topology [24,43-45]. Employing these specifications and excluding chimeric results, we found 
3815 differentially expressed genes, 127 alternative splicing events, and 81 cases of alternative 
promoter usage in the annotation-assisted transcriptome [Figure 3.1A, see GSE57439]. This 
included 354 significant intergenic lncRNA loci (out of 647) and 69 significant antisense loci 
(out of 467). 
 	 ﾠ
	 ﾠ
	 ﾠ
88	 ﾠ
LncRNA Transcript Properties 
   After ensuring data integrity, including validating the non-coding nature of unannotated 
transcripts, we set out to characterize lncRNA transcript properties. Towards this end, we first 
compared the expression periodicity of lncRNA transcripts to that of annotated mRNA 
transcripts, as stage-specific expression is likely to correlate with function. Indeed, when we 
visualized the expression of each transcript class in a non-clustering heatmap, we found a similar 
pattern of developmental regulation for both lncRNAs and mRNAs [Figure 3.3B], although 
lncRNAs typically reached lower maximum expression levels than mRNAs [Table 3.2, Figure 
3.3C]. Notably, the lower expression regime of P. falciparum lncRNAs was in agreement with 
previous genome-wide studies of lncRNA characteristics in humans and model organisms 
[76,77]. Taken together, this global analysis revealed the remarkable similarity between lncRNA 
and mRNA expression cascades during blood stage development and suggested stage-specific 
roles for P. falciparum lncRNAs.  
Table	 ﾠ3.2	 ﾠ|	 ﾠGlobal	 ﾠproperties	 ﾠof	 ﾠP.	 ﾠfalciparum	 ﾠlncRNAs	 ﾠinclude	 ﾠreduced	 ﾠexpression,	 ﾠ
length,	 ﾠGC	 ﾠcontent,	 ﾠand	 ﾠsplicing	 ﾠas	 ﾠcompared	 ﾠto	 ﾠannotated	 ﾠtranscripts.	 ﾠWe	 ﾠcalculated	 ﾠ
the	 ﾠaverage	 ﾠmaximum	 ﾠFPKM	 ﾠand	 ﾠaverage	 ﾠaverage	 ﾠFPKM	 ﾠacross	 ﾠeach	 ﾠtranscript	 ﾠclass	 ﾠduring	 ﾠ
the	 ﾠ56-ﾭ‐hour	 ﾠtime	 ﾠcourse.	 ﾠAverage	 ﾠlength	 ﾠand	 ﾠaverage	 ﾠGC	 ﾠcontent	 ﾠreflect	 ﾠexonic	 ﾠsequence	 ﾠ
only.	 ﾠAnnotated	 ﾠtranscript	 ﾠproperties	 ﾠrefer	 ﾠto	 ﾠPlasmoDBv10.0	 ﾠtranscript	 ﾠmodels.	 ﾠ
  LncRNA  Antisense  Annotated 
Average maximum FPKM  56  25  469 
Average average FPKM  18  8  164 
Average Length  1218  1413  2197 
Average GC content  15.0%  21.8%  25.4% 
Single exon rate  93.5%  89.5%  47.8% 
Maximum exon count  3  5  34 
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Additionally, this visual approach highlighted two intriguing lncRNA expression profile 
deviations during RBC rupture and parasite invasion [purple arrows in Figure 3.3B]. Upon close 
inspection of the intergenic lncRNA expression profiles shown in Figure 3.3B, we noted that a 
subset of intergenic lncRNAs strongly peaked in expression during the 48 hpi invasion time-
point. We found that this subset included all members of the family of telomere-associated 
lncRNA-TAREs that we previously identified [42]. Second, upon close inspection of the 
antisense RNA expression profiles shown in Figure 3.3B, we noted a paucity of antisense 
transcription during parasite invasion. In fact, we calculated that out of the 35% of antisense 
RNAs (166) increasing in expression between 36-44 hpi, 72% dropped in expression during 
parasite invasion and then increased in expression afterwards. A similar percentage of annotated 
mRNA transcripts (27% or 1435) increased in expression between 36-44 hpi, but only 19% 
exhibited the invasion-specific expression drop (Fisher’s exact test, p-value < .0001).   
  We next investigated the correlation properties of P. falciparum lncRNAs and annotated 
mRNAs, as positive or negative correlation between lncRNAs and neighboring genes may 
indicate a regulatory relationship [52,78,79]. Specifically, we compared the expression 
correlation between randomly sampled mRNAs (location-independent null) to that of the 
following location-dependent gene pairs: (1) annotated mRNAs and their more correlated 
neighboring mRNA, (2) intergenic lncRNAs and their more correlated neighboring mRNA, and 
(3) sense-antisense partners. We observed significantly more positively correlated intergenic 
lncRNA-neighbor pairs and mRNA-neighbor pairs than random mRNA pairs (Wilcoxon rank 
sum p-value < 2.2e-16 in both cases) [Figure 3.3D]. On the other hand, we found that sense-
antisense partners exhibited an entirely different expression correlation trend. Namely, we 	 ﾠ
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observed significantly more negatively (or anti-) correlated sense-antisense pairs than random 
mRNA pairs (Wilcoxon rank sum p-value = 3.834e-11) [Figure 3.3D].  
Finally, we found that intergenic lncRNA-neighbor pairs were significantly more 
positively correlated than mRNA-neighbor pairs (Wilcoxon rank sum p-value < 2.2e-16) [Figure 
3.3D]. Given this feature, we pursued numerous additional analyses of intergenic lncRNA-
neighbors and mRNA-neighbors to explore whether positive correlation may be dependent on 
orientation and/or genomic distance between neighboring loci. In brief, we found that both 
lncRNAs and mRNAs had a significantly more correlated neighbor (Wilcoxon signed-rank test 
p-value < 2.2e-16 for both lncRNAs and mRNAs), that the distance between intergenic lncRNA-
neighbor pairs was not particularly indicative of higher correlation (ρ = -.25), and that lncRNAs 
and mRNAs were located at comparable distances from other annotated mRNAs (1576 bp versus 
1585 bp, respectively) [Supplementary Figure 3.6]. In terms of orientation, we found that 
expression correlation was equally distributed for tandem (￠ ￠) and divergent (￟ ￠) 
intergenic lncRNA-neighbor pairs, although convergent (￠ ￟) pairs were markedly less 
frequent and behaved similarly to mRNA-neighbor pairs (Wilcoxon rank sum p-value = 0.3607) 
[Supplementary Figure 3.6]. Taken together, our results indicated a role for genomic 
architecture in P. falciparum lncRNA and mRNA expression dynamics, as has been recently 
described by Ay et al. using three-dimensional modeling of the P. falciparum genome [36]. 
However, we did not find genomic distance between neighboring loci to be a strong indicator of 
expression correlation. Moreover, our results indicated additional complexity, as mRNAs, 
intergenic lncRNAs, and antisense RNAs had significantly different expression correlation 
properties with neighboring loci.  	 ﾠ
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  We next considered the GC content and length of lncRNA transcripts. The GC content of 
intergenic lncRNAs was generally lower than that of antisense RNAs, which was lower than that 
of annotated transcripts [Table 3.2, Figure 3.3E]. This was not surprising given the higher GC 
content of coding sequences, ribosomal RNA, and transfer RNA in the P. falciparum genome 
[15]. In terms of transcript length, both lncRNA classes were quite long, with the average length 
of intergenic lncRNAs, antisense RNAs, and annotated transcripts being 1218 bp, 1413 bp, and 
2197 bp, respectively [Table 3.2, Figure 3.3F]. The small subset of relatively GC-rich (> 29%) 
intergenic lncRNAs generally corresponded to the subset of relatively long intergenic lncRNAs 
(> 4 kb), and included all members of the telomere-associated lncRNA-TARE family, whose 
high GC content and length we previously characterized [arrows in Figure 3.3E and Figure 
3.3F] [42]. The only two unannotated transcripts with greater than 40% GC content shared 82% 
pairwise sequence identity, and they were both situated between var pseudogenes and PHISTB 
genes. TransDecoder predicted a coding region in one of these transcripts, and given their high 
GC content and sequence similarity, we reasoned that both of these transcripts likely represented 
unannotated pseudogenes.  
Finally, we considered the relative location of antisense RNAs within annotated gene 
bodies and the splicing properties of lncRNAs. This revealed that P. falciparum antisense RNAs 
largely overlapped tail-to-tail with annotated genes, a property that has been described in 
previous viral, prokaryotic, and lower eukaryotic genome-wide studies [Figure 3.3G] [80]. 
Specifically, the vast majority of P. falciparum antisense RNAs initiated transcription 
downstream of annotated gene bodies and tended to terminate transcription towards the 3’ end of 
gene bodies [Supplementary Figure 3.7]. In terms of splicing, we found that lncRNA 
transcripts were more likely to be single exon than annotated transcripts, although we also 	 ﾠ
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identified several multi-exonic lncRNAs. We calculated that 93.5% and 89.5% of predicted 
intergenic lncRNAs and antisense RNAs were single exon, respectively, versus 47.8% of 
annotated transcripts [Table 3.2].  
Notable LncRNAs 
  Based on the diverse characteristics examined above, we searched for P. falciparum 
lncRNAs with intriguing properties. For example, we found that a putative Apicoplast RNA 
methyltransferase precursor (Pf3D7_0218300) and an Early Transcribed Membrane Protein 
(ETRAMP; Pf3D7_0936100) transcribe multi-exonic antisense RNAs across their full gene 
bodies [Figure 3.4A and Figure 3.4B]. Expression of the Apicoplast RNA methyltransferase 
precursor sense-antisense pair was not particularly correlated (ρ = .20), while expression of the 
ETRAMP sense-antisense pair was moderately anti-correlated (ρ = -.50) [Figure 3.4C and 
Figure 3.4D]. Interestingly, ETRAMP antisense transcription was substantially higher than 
ETRAMP sense transcription, reaching a maximum FPKM of 550 in early stages. This was the 
highest expression level observed for predicted P. falciparum antisense RNAs at any stage. Both 
the Apicoplast RNA methyltransferase precursor and ETRAMP antisense RNAs also 
demonstrated the 48 hpi invasion expression drop phenomenon. Namely, both antisense 
transcript levels increased between 36-44 hpi, dropped during parasite invasion, and then 
increased. Their sense partners did not exhibit this pattern.  
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Figure	 ﾠ3.4	 ﾠ|	 ﾠNotable	 ﾠlncRNAs	 ﾠinclude	 ﾠmulti-ﾭ‐exonic	 ﾠand	 ﾠtelomere-ﾭ‐associated	 ﾠ
transcripts.	 ﾠ(A)/(B)	 ﾠMulti-ﾭ‐exonic	 ﾠantisense	 ﾠtranscripts	 ﾠspan	 ﾠan	 ﾠapicoplast	 ﾠRNA	 ﾠ
methyltransferase	 ﾠprecursor	 ﾠ(PF3D7_0218300)	 ﾠand	 ﾠan	 ﾠETRAMP	 ﾠ(PF3D7_0936100)	 ﾠgene,	 ﾠ
respectively.	 ﾠAnnotated	 ﾠgene	 ﾠmodels	 ﾠare	 ﾠshown	 ﾠin	 ﾠdark	 ﾠgreen	 ﾠand	 ﾠdark	 ﾠblue,	 ﾠand	 ﾠ
assembled	 ﾠtranscript	 ﾠmodels	 ﾠare	 ﾠshown	 ﾠin	 ﾠlight	 ﾠgreen	 ﾠand	 ﾠlight	 ﾠblue.	 ﾠReads	 ﾠfrom	 ﾠeach	 ﾠ56-ﾭ‐
hour	 ﾠtime	 ﾠcourse	 ﾠsample	 ﾠmapping	 ﾠto	 ﾠthe	 ﾠ(-ﾭ‐)	 ﾠstrand	 ﾠare	 ﾠshown	 ﾠbelow	 ﾠeach	 ﾠhorizontal	 ﾠaxis	 ﾠin	 ﾠ
light	 ﾠgreen,	 ﾠwhile	 ﾠreads	 ﾠmapping	 ﾠto	 ﾠthe	 ﾠ(+)	 ﾠstrand	 ﾠare	 ﾠshown	 ﾠabove	 ﾠeach	 ﾠhorizontal	 ﾠaxis	 ﾠin	 ﾠ
light	 ﾠblue.	 ﾠIntron	 ﾠreads	 ﾠare	 ﾠshown	 ﾠin	 ﾠpurple.	 ﾠUniqueness	 ﾠof	 ﾠ100mers	 ﾠis	 ﾠplotted	 ﾠin	 ﾠred	 ﾠas	 ﾠa	 ﾠ
mappability	 ﾠtrack.	 ﾠ(C)/(D)	 ﾠPearson	 ﾠcorrelation	 ﾠbetween	 ﾠthe	 ﾠPf3D7_0218300	 ﾠsense-ﾭ‐
antisense	 ﾠpair	 ﾠand	 ﾠETRAMP	 ﾠsense-ﾭ‐antisense	 ﾠpair	 ﾠduring	 ﾠthe	 ﾠ56-ﾭ‐hour	 ﾠtime	 ﾠcourse	 ﾠwas	 ﾠ0.20	 ﾠ
and	 ﾠ-ﾭ‐0.50,	 ﾠrespectively.	 ﾠNotably,	 ﾠPf3D7_0218300	 ﾠand	 ﾠETRAMP	 ﾠantisense	 ﾠtranscript	 ﾠlevels	 ﾠ
dropped	 ﾠduring	 ﾠparasite	 ﾠinvasion,	 ﾠwhile	 ﾠsense	 ﾠtranscript	 ﾠlevels	 ﾠdid	 ﾠnot.	 ﾠExpression	 ﾠis	 ﾠ
plotted	 ﾠin	 ﾠunits	 ﾠof	 ﾠlog2(FPKM+1).	 ﾠ(E)	 ﾠMulti-ﾭ‐exonic	 ﾠlncRNAs	 ﾠare	 ﾠencoded	 ﾠin	 ﾠthe	 ﾠPfGDV1	 ﾠ
region	 ﾠon	 ﾠchromosome	 ﾠnine,	 ﾠantisense	 ﾠto	 ﾠPfGDV1	 ﾠand	 ﾠbetween	 ﾠPfGDV1	 ﾠand	 ﾠGEXP22.	 ﾠRefer	 ﾠ
to	 ﾠ(A)/(B)	 ﾠfor	 ﾠa	 ﾠdescription	 ﾠof	 ﾠtracks.	 ﾠ(F)/(G)	 ﾠPearson	 ﾠcorrelation	 ﾠbetween	 ﾠthe	 ﾠPfGDV1	 ﾠ
sense-ﾭ‐antisense	 ﾠpair	 ﾠwas	 ﾠ0.96,	 ﾠwhile	 ﾠPearson	 ﾠcorrelation	 ﾠbetween	 ﾠthe	 ﾠdivergent	 ﾠintergenic	 ﾠ
lncRNA	 ﾠand	 ﾠGEXP22	 ﾠpair	 ﾠwas	 ﾠ0.46	 ﾠduring	 ﾠthe	 ﾠ56-ﾭ‐hour	 ﾠtime	 ﾠcourse.	 ﾠExpression	 ﾠis	 ﾠplotted	 ﾠin	 ﾠ
units	 ﾠof	 ﾠlog2(FPKM+1).	 ﾠ(H)	 ﾠAs	 ﾠwe	 ﾠhave	 ﾠpreviously	 ﾠdescribed,	 ﾠthe	 ﾠtelomere-ﾭ‐associated	 ﾠ
repetitive	 ﾠelement	 ﾠ(TARE)	 ﾠ2-ﾭ‐3	 ﾠregion	 ﾠtranscribes	 ﾠa	 ﾠfamily	 ﾠof	 ﾠlncRNA-ﾭ‐TAREs,	 ﾠwith	 ﾠ
transcription	 ﾠalways	 ﾠproceeding	 ﾠtowards	 ﾠthe	 ﾠtelomere	 ﾠ[42].	 ﾠFor	 ﾠexample,	 ﾠlncRNA-ﾭ‐TARE-ﾭ‐2L	 ﾠ
is	 ﾠtranscribed	 ﾠon	 ﾠthe	 ﾠleft	 ﾠarm	 ﾠof	 ﾠchromosome	 ﾠtwo.	 ﾠPf3D7_0200100	 ﾠis	 ﾠa	 ﾠsubtelomeric	 ﾠupsB-ﾭ‐
type	 ﾠPfemp1-ﾭ‐encoding	 ﾠvar	 ﾠgene.	 ﾠ	 ﾠBoundaries	 ﾠof	 ﾠthe	 ﾠtelomere,	 ﾠTAREs	 ﾠ1-ﾭ‐5,	 ﾠand	 ﾠRep20	 ﾠare	 ﾠ
shown	 ﾠin	 ﾠpurple.	 ﾠSee	 ﾠ(A)/(B)	 ﾠfor	 ﾠa	 ﾠfurther	 ﾠdescription	 ﾠof	 ﾠtracks.	 ﾠ(I)	 ﾠPlotting	 ﾠthe	 ﾠexpression	 ﾠ
level	 ﾠof	 ﾠ22	 ﾠlncRNA-ﾭ‐TARE	 ﾠfamily	 ﾠmembers	 ﾠshowed	 ﾠthat	 ﾠlncRNA-ﾭ‐TARE	 ﾠexpression	 ﾠwas	 ﾠco-ﾭ‐
regulated,	 ﾠwith	 ﾠmaximal	 ﾠfiring	 ﾠcoinciding	 ﾠwith	 ﾠparasite	 ﾠinvasion.	 ﾠExpression	 ﾠis	 ﾠplotted	 ﾠin	 ﾠ
units	 ﾠof	 ﾠlog2(FPKM+1).	 ﾠ(J)	 ﾠPearson	 ﾠcorrelation	 ﾠbetween	 ﾠlncRNA-ﾭ‐TARE-ﾭ‐2L	 ﾠand	 ﾠthe	 ﾠ
neighboring	 ﾠPfemp1-ﾭ‐encoding	 ﾠvar	 ﾠgene	 ﾠwas	 ﾠ-ﾭ‐0.09	 ﾠduring	 ﾠthe	 ﾠ56-ﾭ‐hour	 ﾠtime	 ﾠcourse.	 ﾠ
Expression	 ﾠis	 ﾠplotted	 ﾠin	 ﾠunits	 ﾠof	 ﾠlog2(FPKM+1).  	 ﾠ
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Figure	 ﾠ3.4	 ﾠ(Continued)	 ﾠ|	 ﾠNotable	 ﾠlncRNAs	 ﾠinclude	 ﾠmulti-ﾭ‐exonic	 ﾠand	 ﾠtelomere-ﾭ‐
associated	 ﾠtranscripts. 
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Remarkably, our approach also revealed that a region on chromosome nine required for 
early sexual development [33] harbors a highly expressed, developmentally regulated, multi-
exonic antisense transcript to P. falciparum Gametocyte Development Protein 1 (PfGDV1; 
Pf3D7_0935400), as well as two intergenic lncRNAs downstream of PfGDV1 [Figure 3.4E]. 
Correlation during the 56-hour blood stage time course between PfGDV1 sense and antisense 
transcript levels was the highest of any predicted P. falciparum sense-antisense pair (ρ = 0.96), 
with PfGDV1 antisense transcript levels typically exceeding PfGDV1 sense transcript levels 
[Figure 3.4F]. This was in sharp contrast to the majority of P. falciparum sense-antisense pairs, 
which displayed a trend towards anti-correlated expression. Notably, while the expression 
correlation was again high between PfGDV1 sense-antisense transcript levels in the four 
biological replicate samples (ρ = 0.85), the difference between transcript levels was greater, with 
the PfGDV1 antisense transcript reaching a maximum FPKM of 255 [Supplementary Figure 
3.8]. The nearby, multi-exonic, intergenic lncRNA exhibited only moderately correlated 
expression to GEXP22 (Pf3D7_0935500) and evidence of alternative splicing (ρ = 0.46) [Figure 
3.4G]. In summary, the PfGDV1 antisense transcript’s expression properties, multi-exonic 
structure, and position relative to other genes made it a clear outlier in the genome.  
While we have previously detected and characterized telomere-associated lncRNA-
TAREs, the properties of this yet to be annotated lncRNA family again stood out in our analyses 
[42]. Our results confirmed that lncRNA-TAREs were long, high-GC, and transcribed towards 
the telomere [Figure 3.4H, and arrows in Figure 3.3E and Figure 3.3F]. We also confirmed that 
lncRNA-TARE transcription was generally restricted to the expected TARE 2-3 region, although 
we did find that in one case the entire TARE 1-6 region was transcribed [Supplementary Figure 
3.9]. To build on our previous results, long, paired-end, uniquely mapped sequencing reads 	 ﾠ
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showed that lncRNA-TARE transcripts likely originated from 22 chromosome ends in our 
parasite populations. Moreover, the increased time resolution and scope of our samples showed 
that lncRNA-TARE transcript levels coordinately peaked during parasite invasion [Figure 3.4I]. 
Interestingly, we noted that the expression of previously described, sterile var transcripts peaked 
during parasite invasion as well, but that not all var genes produced these non-coding transcripts 
[Supplementary Figure 3.3] [81]. For example, the subtelomeric var gene (Pf3D7_0200100) 
neighboring lncRNA-TARE-2L was lowly expressed during the ring stage and did not produce 
appreciable sterile transcripts [Figure 3.4H and Figure 3.4I]. Collectively, these findings 
suggested co-regulated firing of lncRNA-TARE and sterile var transcripts during parasite 
invasion, which could indicate coordinated function.   
Discovery of CircRNAs in P. falciparum 
Given recent reports of circRNAs across eukaryotes and their hypothesized regulatory 
functions, we searched for evidence of P. falciparum circRNAs in our data set as well 
[46,82,83]. CircRNAs can be distinguished in non-polyA-selected deep sequencing libraries by 
spliced reads in which sequence ending in a splice donor maps downstream of sequence 
beginning with a splice acceptor. Following the analysis pipeline and criterion published by 
Memczak et al., we found 1381 predicted P. falciparum circRNAs, between 0.1 and 10 kb long, 
with at least two unique reads spanning their splice junction [Figure 3.1A] [83]. Of these, 273 
had five or more unique reads of support (the gold standard being 2 reads) [Supplementary 
Table 3.5]. As compared to the transcriptome-wide results reported in Table 3.2, we found that 
P. falciparum transcripts with predicted circRNAs were more highly expressed on average (2646 
average maximum FPKM; 791 average average FPKM). Indeed, the circRNA-producing gene 	 ﾠ
	 ﾠ
	 ﾠ
97	 ﾠ
set was enriched for ribosome-related components; ribosomal proteins are typically highly 
expressed [Supplementary Table 3.6].  
In contrast to human circRNAs, P. falciparum circRNAs were generally predicted to be 
short, with the majority being less than 200 bp [84]. Only 510 out of 1381 predicted circRNAs 
with at least two unique supporting reads were predicted to be 200 bp or longer. In the more 
stringent set of 273 circRNA candidates with at least five unique supporting reads, only 72 were 
predicted to be 200 bp or longer. We defined circRNA size as the genomic distance between 
predicted donor site and acceptor site, inclusive of the donor and acceptor site. Thus, this should 
be read as a maximum size, as circRNAs can span introns, which may be spliced out of the 
circRNA sequence. In summary, short circRNAs appeared to outnumber longer circRNAs in P. 
falciparum and deserve further attention.  
We predicted an intriguing top P. falciparum circRNA candidate within the apoptosis-
related protein (ARP;Pf3D7_0909300), termed ARP_circRNA [Figure 3.5A]. 56 unique reads 
spanned the predicted splice junction between ARP’s exon-4 donor site (GT) and upstream exon-
3 acceptor site (AG) [Figure 3.5B]. To validate that this non-canonical junction was not the 
result of a library preparation or sequencing artifact, we reverse-transcribed total RNA and 
amplified the predicted ARP_circRNA junction from the resulting complementary DNA (cDNA) 
using PCR and divergent primer pairs. We designed divergent ARP_circRNA primer pairs, as is 
depicted in Figure 3.5B, such that primer pairs could not amplify genomic DNA (gDNA) or 
cDNA in the absence of the predicted ARP_circRNA splice junction.  
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Figure	 ﾠ3.5	 ﾠ|	 ﾠDivergent	 ﾠprimers	 ﾠand	 ﾠSanger	 ﾠsequencing	 ﾠvalidate	 ﾠcircRNA	 ﾠsplicing	 ﾠin	 ﾠP.	 ﾠ
falciparum.	 ﾠ(A)	 ﾠThe	 ﾠapoptosis-ﾭ‐related	 ﾠprotein	 ﾠ(ARP)	 ﾠencodes	 ﾠa	 ﾠpredicted	 ﾠcircRNA,	 ﾠtermed	 ﾠ
ARP_circRNA,	 ﾠconsisting	 ﾠof	 ﾠARP	 ﾠexon-ﾭ‐3	 ﾠand	 ﾠexon-ﾭ‐4	 ﾠsequence.	 ﾠ(B)	 ﾠTo	 ﾠvalidate	 ﾠthe	 ﾠnon-ﾭ‐
canonical	 ﾠexon-ﾭ‐4	 ﾠdonor	 ﾠ(GT)/exon-ﾭ‐3	 ﾠacceptor	 ﾠ(AG)	 ﾠsplice	 ﾠjunction	 ﾠin	 ﾠARP_circRNA,	 ﾠwe	 ﾠ
designed	 ﾠa	 ﾠdivergent	 ﾠPCR	 ﾠprimer	 ﾠpair.	 ﾠThe	 ﾠprimer	 ﾠpair	 ﾠis	 ﾠconsidered	 ﾠto	 ﾠbe	 ﾠdivergent,	 ﾠrather	 ﾠ
than	 ﾠconvergent,	 ﾠbecause	 ﾠthe	 ﾠreverse	 ﾠprimer	 ﾠbinds	 ﾠupstream	 ﾠof	 ﾠthe	 ﾠforward	 ﾠprimer.	 ﾠ(C)	 ﾠ
PCR	 ﾠusing	 ﾠdivergent	 ﾠprimers	 ﾠamplified	 ﾠa	 ﾠproduct	 ﾠof	 ﾠthe	 ﾠexpected	 ﾠsize	 ﾠ(161	 ﾠbp,	 ﾠindicated	 ﾠ
with	 ﾠan	 ﾠarrow)	 ﾠwhen	 ﾠthe	 ﾠtemplate	 ﾠwas	 ﾠcDNA	 ﾠfrom	 ﾠeither	 ﾠtime	 ﾠcourse,	 ﾠbut	 ﾠnot	 ﾠwater	 ﾠor	 ﾠ
gDNA.	 ﾠThe	 ﾠlarger	 ﾠproducts	 ﾠin	 ﾠthe	 ﾠdivergent	 ﾠcDNA	 ﾠreactions	 ﾠmay	 ﾠrepresent	 ﾠnon-ﾭ‐specific	 ﾠor	 ﾠ
rolling-ﾭ‐circle	 ﾠreverse	 ﾠtranscription	 ﾠproducts	 ﾠ[46].	 ﾠOn	 ﾠthe	 ﾠother	 ﾠhand,	 ﾠPCR	 ﾠusing	 ﾠconvergent	 ﾠ
primers	 ﾠamplified	 ﾠproducts	 ﾠof	 ﾠthe	 ﾠexpected	 ﾠsize	 ﾠwhen	 ﾠthe	 ﾠtemplate	 ﾠwas	 ﾠcDNA	 ﾠfrom	 ﾠeither	 ﾠ
time	 ﾠcourse	 ﾠor	 ﾠgDNA.	 ﾠWe	 ﾠconfirmed	 ﾠthat	 ﾠthe	 ﾠsmaller	 ﾠproduct	 ﾠsize	 ﾠin	 ﾠthe	 ﾠcase	 ﾠof	 ﾠconvergent	 ﾠ
cDNA	 ﾠreactions	 ﾠcorresponded	 ﾠto	 ﾠintron	 ﾠremoval.	 ﾠ(D)	 ﾠSanger	 ﾠsequencing	 ﾠof	 ﾠdivergent	 ﾠ
amplicons	 ﾠof	 ﾠthe	 ﾠexpected	 ﾠsize	 ﾠconfirmed	 ﾠthe	 ﾠARP_circRNA	 ﾠjunction	 ﾠin	 ﾠboth	 ﾠtime	 ﾠcourses.	 ﾠ
The	 ﾠextra	 ﾠGTAG	 ﾠin	 ﾠthe	 ﾠpredicted	 ﾠsequence	 ﾠmarks	 ﾠthe	 ﾠnon-ﾭ‐canonical	 ﾠARP_circRNA	 ﾠsplice	 ﾠ
junction	 ﾠ(highlighted	 ﾠin	 ﾠred	 ﾠin	 ﾠthe	 ﾠconsensus	 ﾠsequence).	 ﾠ 
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 ﾠ Our results confirmed that ARP_circRNA represented a bona fide P. falciparum 
circRNA. The ARP_circRNA divergent primer pair produced amplicons of the expected size 
when the template was cDNA prepared from either biological replicate time course, and did not 
produce specific amplicons with gDNA or water as the template. On the other hand, the 
ARP_circRNA convergent primer pair amplified both cDNA and gDNA, with the smaller 
product size in the cDNA reactions corresponding to intron removal [Figure 3.5C]. We further 
confirmed the identity of the ARP_circRNA divergent and convergent amplicons by Sanger 
sequencing. Sequence confirmation for the ARP_circRNA divergent amplicon is shown in 
Figure 3.5D, where the GTAG splice donor-acceptor tag is included in the predicted sequence as 
a marker for the circRNA splice junction. 	 ﾠ
We used a parallel strategy to validate five out of eight additional P. falciparum 
circRNAs, for a 67% validation rate of high quality candidates [Supplementary Figure 3.10 and 
Supplementary Table 3.7]. The nine tested candidates had the most read support out of 
predicted P. falciparum circRNAs with either a donor or acceptor site in common with an 
annotated transcript, were predicted to be larger than 200 bp (genomic distance), and were not 
predicted within ribosomal genes. Interestingly, while two of the additional validated P. 
falciparum circRNAs were associated with genes of unknown function, two were predicted 
within rhoptry-related genes, and the final validated candidate was within metacaspase-like 
protein (MCA2), another gene involved in apoptosis.  
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3.3  Discussion 
In this work we make immense progress towards the functional characterization of P. 
falciparum lncRNAs. We assemble 1134 unannotated P. falciparum intergenic lncRNA and 
antisense transcript structures, predict 1381 P. falciparum circRNA candidates (6/9 experimental 
confirmation rate), compile a comprehensive catalog of transcript properties, summarize global 
trends, and prioritize a small set of P. falciparum lncRNA candidates for immediate 
investigation. This required development of a state-of-the-art, strand-specific RNA sequencing 
protocol sensitive to the extreme AT content of P. falciparum, unprecedented time-point 
resolution of sequencing samples, and biological replication. Despite a handful of important 
studies over the past few years in this space [42-45], including our own pilot study using high-
density tiling microarrays [42], the next-generation sequencing advancements, sample set, and 
computational pipeline that we employ here technologically surpass previous studies.  
Our findings have several implications for parasite biology and shed new light on 
previous P. falciparum sequencing studies, especially in regards to the function and expression 
properties of antisense transcripts. Lopez-Barragan and colleagues suggested that P. falciparum 
genes transcribed bidirectionally (sense and antisense) were more likely to be spliced, and 
hypothesized that P. falciparum antisense RNAs may be involved in the splicing of sense 
transcripts [43]. However, we found that 43.1% of genes transcribed bidirectionally were single 
exon, which was not significantly different from the genome-wide rate of 47.8% (Fisher’s exact 
test, p-value = .053). As another example, Siegel et al. predicted that 22% of annotated genes 
produce antisense RNAs (1247), and did not find global correlation or anti-correlation between 
sense-antisense pair expression [45]. We identified high-confidence antisense transcription from 	 ﾠ
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8% of annotated P. falciparum genes (462), and detected a significant global shift towards anti-
correlated sense-antisense pair expression [Supplementary Figure 3.11]. 
The enrichment of negatively correlated, tail-to-tail overlapping sense-antisense 
transcript pairs aligns with a role for many P. falciparum antisense RNAs in transcriptional 
and/or post-transcriptional regulation of their sense mRNA partners [49]. For example, P. 
falciparum antisense RNAs could function through transcriptional interference, as has been 
extensively studied in Saccharomyces cerevisiae [80,85-87]. In the transcriptional interference 
model, antisense transcription interferes with sense transcription through either polymerase 
collisions or alternative mechanisms. As an alternative or additional model, antisense-mediated 
transcriptional suppression is also possible and has been described in human studies [88-90]. In 
antisense-mediated transcriptional suppression, antisense RNAs act as epigenetic silencers, 
catalyzing local heterochromatin formation. P. falciparum antisense RNAs may also act post-
transcriptionally on sense transcripts by inhibiting their nuclear export or translation [49]. In 
support of this notion, peptide nucleic acids (PNAs) designed as specific antisense molecules 
have been recently shown to regulate both transgenic and endogenous P. falciparum genes in a 
sequence-specific, post-transcriptional manner [91]. Albeit controversial, numerous studies from 
the 1990s also reported on antisense oligonucleotide-mediated silencing of target genes in P. 
falciparum [92,93]. Taken together, the often antagonistic interplay between sense and antisense 
transcript levels in P. falciparum aligns with known regulatory mechanisms of antisense RNAs 
in humans and model organisms, and is likely to be functionally significant.  
Searching our catalog for P. falciparum lncRNAs with unique properties revealed that an 
essential protein in early gametocyte development, PfGDV1, has a highly and coordinately 
expressed, multi-exonic antisense counterpart, as well as multiple neighboring intergenic 	 ﾠ
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lncRNAs. Though the regulation and mechanism of early gametocyte development events 
remain largely unknown, Eksi et al. have shown that PfGDV1 complementation restores 
gametocytogenesis in PfGDV1-null parasites, and that episomal PfGDV1 over-expression 
increases gametocytemia in wild-type parasites [33]. This suggests that endogenous PfGDV1 
expression levels might correlate with gametocytemia as well, and that silencing the endogenous 
PfGDV1 locus could disrupt transmission. Notably, Kafsack et al. have also shown that a 
member of the ApiAP2 transcription factor family is involved in early gametocyte development 
[37]. However, loss of this factor did not affect PfGDV1 transcript levels [37], suggesting that 
the PfGDV1 locus may be subject to additional regulatory complexity. In light of these recent 
findings, and given that future strategies to block malaria transmission largely hinge on 
understanding the development of the transmissable P. falciparum sexual stages [12-14], the 
lncRNA transcripts in the PfGDV1 region warrant immediate functional follow-up. Specifically, 
we hypothesize that the antisense RNA to PfGDV1 may play a major regulatory role in early 
gametocyte commitment events, perhaps similar to S. cerevisiae antisense-mediated entry into 
meiosis [52,53].  
We previously described and hypothesized that a family of telomere-associated lncRNA-
TARE transcripts is involved in telomere maintenance and/or subtelomeric var gene regulation 
[42,94]. Supporting such nuclear roles, Siegel et al. have recently reported significant enrichment 
of telomere-associated P. falciparum lncRNAs in the nuclear, as opposed to total and 
cytoplasmic, P. falciparum RNA fractions [45]. Adding to the lncRNA-TARE family profile, we 
have now shown that lncRNA-TARE transcripts are maximally expressed during parasite 
invasion, along with the sterile, non-coding var transcripts transcribed from bidirectional var 
intron promoters [81]. Interestingly, when parasites invade RBCs pre-loaded with episomal 	 ﾠ
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Pfemp1-encoding var genes, these episomal var genes are not silenced during the first ring stage. 
Var gene silencing is, however, somehow established by the subsequent ring stage and then 
remains the default status [95]. While it has been hypothesized that passage through S-phase is 
the critical requirement for var gene silencing, we suggest that expression of non-coding 
transcripts during parasite invasion may play an important regulatory role as well [96,97]. High-
resolution studies of chromatin mark dynamics over episomal and endogenous var loci during 
parasite invasion may help to resolve these models.  
Finally, this work represents the discovery and validation of at least seven bona fide P. 
falciparum circRNAs, as well as the prediction of hundreds more. With the majority of predicted 
P. falciparum circRNAs being shorter than the average library fragment size, and, as such, likely 
selected against during library preparation, a focused sequencing effort using circRNA-specific 
protocol adjustments may reveal even more abundance of this intriguing class of non-coding 
RNAs. In support of this notion, Wang et al. recently mined the Siegel et al. RNA sequencing 
data set and validated two low-abundance P. falciparum circRNAs [45,46]. As we did not find 
evidence for either of these candidates in our study, this further hints that library preparation 
and/or bioinformatic processing may be tunable to capture additional P. falciparum circRNAs. 
Alternatively, as our sample sets differed, these circRNAs may be highly linked to the 
phenotypic state of the parasite.    
Notably, Memczak et al. and others have hypothesized that circRNAs may act as 
microRNA sponges [83,84]. In this model, the circRNAs behave as competitive inhibitors, 
sponging up microRNAs to reduce the microRNA pool available to bind messenger RNA 
targets. However, it is highly unlikely that microRNA binding is involved in P. falciparum 
circRNA function, as P. falciparum does not encode microRNAs nor microRNA processing 	 ﾠ
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machinery, and the only reported, non-canonical function for human microRNAs in P. 
falciparum does not involve microRNA binding either [41,98]. Taken together, our discovery of 
hundreds of circRNAs in an organism lacking RNA interference points to potential additional 
roles for circRNAs across eukaryotes.  
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3.4  Materials and Methods 
Parasite Culture and Sample Harvesting 
We harvested a total of fifteen samples from two independent P. falciparum blood-stage 
time courses. In each experiment, we cultured a freshly thawed P. falciparum strain 3D7 clone 
(ATTC) in human RBCs from healthy anonymous donors (Research Blood Components, Boston, 
MA) using standard methods [11]. We maintained cultures at 4% hematocrit and supplemented 
RPMI-HEPES medium with 5% human serum (O+) and 5% Albumax II (Gibco). We 
synchronized cultures using multiple 5% sorbitol solution treatments [99], and expanded cultures 
to accommodate harvesting of at least 50 mL of culture at each planned time-point (time course 
1: every ~4 hours for 56 hours; time course 2: ~4 hours before and after the ring to trophozoite 
and trophozoite to schizont morphological stage transitions). We centrifuged 50 mL aliquots of 
harvested culture at 2400 rpm in a Sorval RT6000B to obtain at least 2 mL of packed RBCs per 
time-point. For time course 1, we stored packed RBCs in 15 mL of Buffer RLT (with BME 
added) at -80°C prior to RNA extraction. For time course 2, we lysed packed RBCs using a .05% 
saponin solution, washed liberated parasites using phosphate-buffered saline (pH 7.4), pelleted 
parasites at 13.2 RPM in a micro-centrifuge, and stored parasites in 1 mL of TRIZOL reagent at -
80°C prior to RNA extraction.  
Total RNA Extraction 
For time course 1, we thawed RBC samples stored in Buffer RLT, added one volume of 
70% ethanol, and immediately loaded the mixture onto RNeasy Midi columns (Qiagen). For time 
course 2, we thawed parasite samples stored in TRIZOL reagent, performed TRIZOL-
chloroform extraction, and immediately applied the aqueous layer to RNeasy Mini columns 	 ﾠ
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(Qiagen). During both RNeasy Midi and Mini RNA extraction procedures, we performed the 
optional on-column DNase I digestion for thirty minutes to remove genomic DNA. We stored 
isolated total RNA aliquots at -80°C with 1 unit/uL RNaseOUT (Invitrogen), and validated RNA 
quality using an Agilent Bioanalyzer RNA 6000 Pico Kit.  
Strand-specific, Non-polyA-selected, Library Preparation and Sequencing 
We began library preparation with a second DNase treatment (Ambion TURBO DNase) 
using 20 units of SUPERase-In (Ambion) and 40 units of RNaseOUT (Invitrogen) to protect 
RNA from degradation. Each DNase reaction was incubated at 25°C for 30 minutes followed by 
1.8X RNAclean SPRI bead purification (Agencourt). Second, we used a Human/Mouse/Rat 
Ribo-Zero Magnetic Kit (Epicentre) to deplete 18S and 28S rRNA from DNase-treated total 
RNA. We used 3.5-5 ug of DNase-treated total RNA for all samples except T6, T14, and TT8. In 
these cases, we used .4 ug, 1 ug, and .7 ug of DNase-treated total RNA, respectively. 
Furthermore, for T6 we mixed 4 and 8 hpi total RNA 1:1, and for T14 we mixed 12 and 16 hpi 
total RNA 1:1. Third, we fragmented rRNA-depleted RNA at 85°C for 8 minutes using Mg
2+ 
Fragmentation Buffer (New England Biolabs), followed by 1.8X RNAclean SPRI bead 
purification (Agencourt). Fourth, we reverse-transcribed the fragmented RNA using SuperScript 
III (Invitrogen), 200 ng/uL of freshly prepared Actinomycin D (Sigma-Aldrich), 3 ug of 76% 
AT-biased random hexamers (Integrated DNA Technologies), and a gradually ramping-up 
thermocycler program. Specifically, we set the ramp speed of a PTC-225 DNA Engine Tetrad 
(MJ Research) to .1°C/second and used the following program: 5°C, 10°C, 15°C, 20°C, 25°C, 
30°C, 35°C for 5 minutes each, 42°C for 30 minutes, 45°C, 50°C, 55°C for 10 minutes each. We 
cleaned up first strand synthesis (FSS) reactions using both Micro Bio-Spin P-30 RNase-free 
columns (Bio-Rad) and 1.8X RNAclean SPRI bead purification (Agencourt). Fourth, we 	 ﾠ
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performed second strand synthesis (SSS) using a biased dACG-TP/dU-TP mix (Fermentas), 10 
units of E. coli DNA ligase (Invitrogen), 160 units of E. coli DNA polymerase (Invitrogen), and 
2 units of E. coli RNase H (Invitrogen), followed by 1.8X AmpureXP SPRI bead purification 
(Agencourt). Fifth, we used an Illumina series KAPA Library Preparation Kit (Kapa Biosystems) 
and barcoded Y-adapters developed by the Broad Institute to end repair, A-tail, and ligate 
adapters to each library. We added adapters in approximately 15-fold excess of library targets, 
and removed un-ligated adapters and adapter-dimers using 1.0X AmpureXP SPRI bead 
purification (Agencourt). Sixth, we digested the dUTP-marked second strand at 37°C for 30 
minutes, followed by 25°C for 15 minutes, using Uracil-Specific Excision Reagent (USER) 
enzyme (New England Biolabs). Seventh, we amplified libraries for as few cycles as necessary 
using a KAPA Real-Time PCR Library Amplification Kit (Kapa Biosystems) and PCR primers 
developed by the Broad Institute. Each library except for T6, T14, and TT8 required only four 
PCR cycles, while T14 and TT8 required eight PCR cycles, and T6 required twelve PCR cycles. 
Following a 2 minute denaturation step at 98°C, we cycled libraries using an ABI 7900 Real-
Time PCR machine and the following 2-step program: (1) denaturation at 98°C for 20 seconds, 
(2) annealing and extension at 55°C for 190 seconds.  
Finally, we quantified libraries using a KAPA Library Quantification Kit (Kapa 
Biosystems) and an Agilent Bioanalyzer High Sensitivity DNA Kit. We combined barcoded 
libraries into two pools, and sequenced each pool on an Illumina Hiseq 2000 machine (one lane 
per pool) using 101-bp, paired-end read technology. We prepared the fifteen libraries used in this 
study in parallel (except for real-time amplification). We used the FASTX-Toolkit v0.0.13 to 
assess raw read quality. See Supplementary Figure 3.1 and Supplementary Protocol 3.1 for a 
library preparation flowchart and a detailed library preparation protocol, respectively. The data 	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discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus [100] 
and are available through GEO Series accession number GSE57439 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57439). 
Read Processing, TopHat Read Alignment, and Aligned Read Benchmarking 
We trimmed the last base from reads passing Illumina filtering (PF) using Picard release 
1.94 (SamToFastq). We then aligned reads from each sample to the PlasmoDBv10.0 reference 
genome using TopHat v2.0.9 and the following parameters: -r 300 –mate-std-dev 100 –library-
type fr-firststrand –i 70 –I 5000 –read-mismatches 0 –segment-mismatches 0 –max-segment-
intron 5000 –max-coverage-intron 5000 –b2-very-sensitive –read-gap-length 0 –read-edit-dist 0 
–read-realign-edit-dist 0 –max-deletion-length 0 –max-insertion-length 0 –max-multihits 2 –no-
mixed –no-discordant [63]. These parameters specified an average fragment size of 300 bp with 
a standard deviation of 100 bp, strand-specific reads prepared using the dUTP method, and an 
expected intron size of 70-5,000 bp. Also, to allow only perfect read pair mapping in the 
expected orientation, and to report only two alignments for non-unique read pairs.  
To remove non-unique reads, we then used SAMtools v0.1.19 (view –q 10) to remove 
read pairs with a mapping quality of 10 or less, meaning at least a 10% chance that the read pair 
truly came from somewhere else in the genome. We used SAMtools v0.1.19 (flagstat) to compile 
the unique read alignment rate per sample. Subsequently, we used RNA-SeQC hosted by 
Genepattern to calculate the strand-specificity, exonic rate, intronic rate, intergenic rate, gap rate, 
and coefficient of variation of the top 1000, 2000, and 4000 expressed genes for each set of 
aligned reads [64,101]. We also used RSeQC to calculate the rRNA rate and insert size of 
aligned reads, and the GC content of rRNA-filtered, aligned reads [65]. We used the FASTX-
Toolkit v0.0.13 to assess aligned read quality. 	 ﾠ
	 ﾠ
	 ﾠ
109	 ﾠ
We generated the mappability track displayed (in red) in the Array Studio version 7.0 
Genome Browser (OmicSoft Corporation) screen shots using the following procedure: (1) We 
shredded the PlasmoDBv10.0 genome (excluding mitochondrial and apicoplast contributions) 
into every possible 100mer sequence. (2) We used the R-project Biostrings package to search for 
each 100mer sequence in the PlasmoDBv10.0 genome. (3) We scored the mappability of each 
100mer by tallying the number of exact matches possible. (4) Lastly, we viewed the minimum 
mappability score of 100mers along the genome, such that deviations above the baseline (score 
of one) indicated regions where 100-bp single-end reads could not uniquely align. We calculated 
that 96.53% of all possible 100mers in the PlasmoDBv10.0 genome are unique. We used 
MUSCLE to compute the pairwise sequence identity between CLAG3.1 and CLAG3.2 coding 
regions (96.4%) [102].  
Cufflinks Assembly   
We used Cufflinks v2.1.1 to assemble aligned reads from each sample into transfrags 
using the following parameters: –library-type fr-firststrand –max-intron-length 5000 –overlap-
radius 1 –min-isoform-fraction .25 –pre-mrna-fraction .25 –min-frags-per-transfrag 50 –trim-3-
dropoff-frac .2 –frag-bias-correct [73]. These parameters specified strand-specific reads prepared 
using the dUTP method and a maximum intron size of 5,000 bp. Also, to not merge transfrags, to 
filter minor isoforms less than 25% as abundant as the major isoform, to ignore intronic 
alignments if not as abundant as specified, to require at least fifty aligned reads per assembled 
transfrag, to trim the 3’ end of assembled transfrags at 20% of average coverage, and to run the 
built-in bias correction algorithm prior to estimating transcript abundance. We also specified a 
set of 374 short (<300 bp) and/or structural RNAs (all PlasmoDBv9.3 transcripts with class code: 
tRNA, rRNA, or snoRNA) to exclude from assembly (and abundance estimation), such that 	 ﾠ
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analyses relying on expression profiles correspond to mRNAs. We used Cuffmerge to 
parsimoniously merge assembled transfrags from each sample into a final transcriptome 
assembly, with or without incorporating PlasmoDBv10.0 annotated transcript models (RABT) 
[71].  
Genome-guided Trinity Assembly 
We merged all trimmed reads passing Illumina filtering (PF), aligned merged reads to the 
PlasmoDBv10.0 genome using GSNAP release 2013-11-27, and then used scripts from Trinity 
release 2013-11-10 to assemble a genome-guided P.falciparum transcriptome (PASA release 
2013-09-07, GMAP release 2013-11-27, Blat v34) [72]. We specified a maximum intron size of 
5,000 bp and strand-specific reads prepared using the dUTP method where appropriate. We also 
parsimoniously merged the genome-guided Trinity assembly with PlasmoDBv10.0 annotated 
transcript models (using Cuffmerge [71]) to yield a Genome-guided Trinity RABT assembly.  
Assembly Performance Assessment 
To assess Cufflinks and genome-guided Trinity assembly performance, we used 
Cuffcompare to calculate the total number of assembled transcripts, the number of intergenic 
transcripts, and the number of antisense transcripts [71]. We also transformed assembly GTF 
files into BED12 files, and used BEDTools v2.18.2 to investigate assembly contiguity and 
chimerism [103]. We defined contiguity as the rate of PlasmoDBv10.0 annotated transcripts 
covered by one assembled transcript over at least 90% of the annotated transcript exonic length 
in the correct orientation. We defined chimerism as the rate of assembled transcripts that span 
more than one PlasmoDBv10.0 annotated transcript in the correct orientation. For contiguity rate, 
we used the following BEDTools command: < bedtools intersect –split –s –f .90 –wa –wb –a 
PlasmoDBv10.0.bed12 –b Assembly.bed12 >. For chimerism we used the following BEDTools 	 ﾠ
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command: < bedtools intersect –split –c –s –a Assembly.bed12 –b PlasmoDBv10.0.bed12 >, 
followed by brief post-processing.  
We next paired 5727 and 7736 assembled transcripts from the Cufflinks and Cufflinks 
RABT transcriptomes, respectively, with PlasmoDBv10.0 annotated transcripts, and computed 
the Pearson correlation between paired expression profiles. Previously unannotated assembled 
transcripts (including antisense) were naturally excluded from pairings. We calculated a median 
correlation of .98 and .99 for Cufflinks and Cufflinks RABT paired expression profiles, 
respectively. We also compared the following properties of paired Cufflinks transcripts, paired 
Cufflinks RABT transcripts, and PlasmoDBv10.0 annotated transcripts: average maximum 
FPKM, average average FPKM, average length, average GC content, single exon rate, and 
maximum exon count. We only considered exonic sequence in transcript length and GC content 
calculations [Supplementary Table 3.4 and Supplementary Figure 3.5].   
Coding Region Prediction 
We used TransDecoder release 2013-11-17 to predict coding regions in the Cufflinks 
RABT transcriptome [72]. TransDecoder identifies regions in spliced transcript models that 
likely encode peptides greater than 100 amino acids based on (1) a match to a Pfam domain 
above the noise threshold or (2) a log-likelihood score of a Markov model for coding DNA that 
is greater than zero and greatest when calculated in the predicted open reading frame. Using this 
approach, we predicted coding regions in 5213 out of 5229 assembled protein-coding transcripts 
at least 100 amino acids long (99.7%), versus just 7 out of 660 intergenic transcripts (1.1%) and 
11 out of 474 antisense transcripts (2.3%).  	 ﾠ
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To estimate the background rate of coding potential detected by TransDecoder, we used 
BEDTools v2.18.2 (shuffle) to randomly generate 6600 size-matched intergenic intervals and 
4740 size-matched antisense intervals [72,103]. Following minor post-processing, we paired the 
shuffled regions with PlasmoDBv10.0 transcript models (to train TransDecoder) and assessed 
coding potential prediction. TransDecoder predicted coding regions in 97 out of the 6600 random 
intergenic regions (1.5%) and 57 out of the 4740 random antisense regions (1.2%). We 
concluded from this analysis that the rate of coding potential in the lncRNA transcript sets was 
not significantly different from the background rate in size-matched shuffled regions (Fisher’s 
exact test, p-value = .493 for intergenic regions; Fisher’s exact test, p-value = .053 for antisense 
regions).  
Differential Expression and Regulation 
To assess differential expression and regulation of both the PlasmoDBv10.0 and the 
Cufflinks RABT transcriptomes, we used Cuffdiff v2.1.1 and the following parameters: –library-
type fr-firststrand –time-series –min-reps-for-js-test 1. These parameters specified strand-specific 
reads prepared using the dUTP method, time course samples, and to not require replication of all 
conditions. We again specified a set of 374 short (<300 bp) and/or structural RNAs (all 
PlasmoDBv9.3 transcripts with class code: tRNA, rRNA, or snoRNA) to exclude from 
abundance estimation, such that analyses relying on expression profiles correspond to mRNAs.   
We instructed Cuffdiff to compare samples from the 56-hour time course harvested 
approximately 8 hours apart (T6 vs. T14, T14 vs. T24, T20 vs. T28, T24 vs. T32, T28 vs. T36, 
T32 vs. T40, T36 vs. T44, T40 vs. T48, T48 vs. TT8) and to estimate biological variation across 
the blood stage using the four replicated conditions [71]. Specifically, we considered the 
correlation matrix between sample profiles and paired R with T14 and T20, ET with T28, LT 	 ﾠ
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with T32, and S with T40. We then supplied these replicated conditions to Cuffdiff as samples in 
addition to specifying the desired sample comparisons described above. Finally, we used the 
Benjamini and Hochberg method and a FDR cut-off of 5% to threshold significance.  
After removing chimeric results, our analysis of the Cufflinks RABT transcriptome 
predicted 3815 differentially expressed genes, 127 alternative splicing events, and 81 cases of 
alternative promoter usage [see GSE57439]. This included 354 significant intergenic lncRNA 
loci (out of 647) and 69 significant antisense loci (out of 467). We noted an absence of strong 
correlation between maximum sense and antisense partner expression [ρ = .19, Supplementary 
Figure 3.12], which reiterated the strand-specificity of our sequencing reads and the integrity of 
the antisense signal. Analyzing the PlasmoDBv10.0 annotated transcriptome alone predicted 
4284 differentially expressed mRNA genes.  
GO Term Enrichment   
We defined 1632 ring-specific genes as differentially expressed, annotated genes with 
maximum expression between 6-20 hpi during the 56-hour time course. Similarly, we defined 
1378 trophozoite-specific genes (24-36 hpi maximum expression) and 1274 schizont-specific 
genes (40-48 hpi maximum expression). We converted PlasmoDBv10.0 gene annotations to 
SangerDB P. falciparum gene annotations, and then used GOstat and a FDR cut-off of 1% to 
search for biological process GO terms significantly over-represented in the ring-specific, 
trophozoite-specific, and schizont-specific gene sets [70]. See Supplementary Table 3.3 for 
stage-specific results.  
We intersected the 1381 predicted circRNA loci with PlasmoDBv10.0 gene annotations 
to yield a circRNA-producing gene set, and used an analogous approach to search for 	 ﾠ
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significantly over-represented GO terms. In the circRNA GO term analysis, we included 
biological process, molecular function, and cellular component results [Supplementary Table 
3.6].  
Sample Staging and Expression Profile Visualizations 
To visualize sample similarities on a transcriptome-wide scale, we first constructed a 
distance matrix of sample expression profiles as follows: (1) we only considered contributions 
from the 5077 annotated mRNAs with an FPKM rising above one during the 56-hour time 
course, (2) we transformed FPKM values as log2(FPKM+1), (3) we computed the Pearson 
correlation (ρ) matrix between sample expression profiles, and (4) we transformed this matrix as 
(1- ρ)/2. We then used MDS as implemented by the R-project cmdscale function to visualize 
sample expression profile similarities in two dimensions.   
To visualize differentially expressed, annotated mRNA expression profile dynamics 
during the 56-hour time course, we followed steps 1-2 as above using the 4284 differentially 
expressed mRNA genes, and then used the nMDS and circularmap functions distributed in the 
R-project NeatMap package [68]. The NeatMap package implements the non-metric MDS 
algorithm previously proposed by Taguchi and Oono [68,104]. We used the more traditional 
make.heatmap1 function distributed in the R-project NeatMap package to compare the 
expression profiles of lncRNAs and annotated mRNAs (FPKM >0) during the 56-hour time 
course.  
Stage Specificity Score   
  To summarize transcript stage specificity in a single quantitative metric, we calculated a 
maximum transcript specificity score that is based on the Jensen-Shannon (JS) divergence. This 	 ﾠ
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metric has been fully described by Cabili et al. and was used by this group to annotate the tissue 
specificity of human intergenic lncRNA transcripts [76]. Specifically, we calculated specificity 
scores for each transcript, inspected the top 5% most stage-specific transcripts, and compared 
transcript specificity scores by transcript class. We normalized transcript expression levels as in 
Cabili et al. and used the shannon.entropy, JSdistVec, and JSdistFromP functions implemented 
in the R-project CummeRbund package, except that we used a logarithmic base of two in the 
Shannon entropy calculation to match the Cabili et al. methods [71,76]. We also performed this 
analysis on the set of 1619 annotated mRNAs with an average FPKM of less than 20 (set 
metrics: average average FPKM 1.95; average maximum FPKM 4.3).  
Corroborating our visual observations, each telomere-associated lncRNA-TARE 
transcript was in the set of top stage-specific transcripts [see GSE57439]. However, global 
comparisons of lncRNA specificity scores and mRNA specificity scores were less conclusive; 
lncRNAs appeared to be more stage-specific than the full set of annotated mRNAs, but this 
difference was not clear when we compared lncRNAs to only lowly expressed mRNAs 
[Supplementary Figure 3.13]. Thus, while the specificity metric accurately summarized the 
increased stage specificity of certain transcripts, such as the telomere-associated lncRNA-
TAREs, further comparisons will be necessary to make any global conclusions as to the 
increased or equivalent specificity of P. falciparum lncRNAs versus mRNAs.  
Expression Correlation   
To generate a null distribution of location-independent gene pair correlation, we 
investigated the Pearson correlation during the 56-hour time course between 50,000 random 
PlasmoDBv10.0 mRNA gene pairs. We then computed the Pearson correlation between 5251 
mRNA-neighboring gene pairs, 498 intergenic lncRNA-neighboring gene pairs, and 445 sense-	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antisense gene pairs, and compared these distributions to the null distribution of location-
independent gene pair correlation. To be consistent, we defined the neighboring gene of both 
mRNAs and intergenic lncRNAs as their more correlated neighboring mRNA (unless otherwise 
specified). We excluded gene pairs from analysis when one of the genes was a short and/or 
structural RNA, or otherwise had an FPKM of zero during the 56-hour time course. Also, we 
excluded the result if the more or less correlated neighbor of an intergenic lncRNA was another 
intergenic lncRNA. 
Using this approach, we found a significant shift towards positive correlation in the case 
of both mRNA-neighboring genes and intergenic lncRNA-neighboring genes (Wilcoxon rank 
sum p-value < 2.2e-16 in both cases), and a significant shift towards negative correlation in the 
case of sense-antisense genes (Wilcoxon rank sum p-value = 3.834e-11). Our results also 
indicated that lncRNA-neighboring gene pairs were significantly more highly correlated than 
mRNA-neighboring gene pairs (Wilcoxon rank sum p-value < 2.2e-16). We pursued this result 
further. See Supplementary Figure 3.6 for details.   
LncRNA Length, GC content, and Antisense Relative Location 
  We only considered exonic sequence in lncRNA transcript length and GC content 
calculations. However, we included both intronic and exonic sequence in the antisense transcript 
location and annotated gene body length normalizations.  
CircRNA Prediction   
  We predicted 1381 P. falciparum circRNAs using the methods developed by Memczak et 
al. [83]. In brief, we aligned reads to the PlasmoDBv10.0 genome using Bowtie v2.1.0, and used 
circBase v1.0 scripts to split high-quality unaligned reads into anchors, subsequently screening 	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anchors for linear or head-to-tail (circular) splicing. To get a reasonable set of circRNA 
candidates, we used the default circBase filtering suggestions, except for specifying a minimum 
circRNA size of 100 bp and a maximum circRNA size of 10,000 bp.  
CircRNA Primer Design 
We designed convergent and divergent PCR primers for nine P. falciparum genes with 
predicted circRNAs using AlleleID v7.6 software (Premier Biosoft International). Furthermore, 
we designed divergent forward primers as the reverse complement of convergent reverse 
primers, and divergent reverse primers as the reverse complement of convergent forward 
primers. We then added a tail consisting of the T7 promoter sequence 5’-TAA TAC GAC TCA 
CTA TAG GG-3’ and 5’-TAG TAG TAG TAG-3’ to all forward primers, and a tail consisting of 
the M13F(-47) sequence 5’-CGC CAG GGT TTT CCC AGT CAC GAC-3’ and 5’-TAG TAG 
TAG TAG-3’ to all reverse primers. This allowed us to directly sequence both divergent and 
convergent PCR amplicons using universal T7 or M13F(-47) primers. Primer and expected 
amplicon sequences are listed in Supplementary Table 3.7.  
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Chapter 4 | Discussion 
4.1  Concluding remarks 
Pervasive transcription of lncRNA has been described for nearly every eukaryotic 
genome [1]. However, albeit clear examples of functional lncRNAs in humans and model 
organisms, it is widely accepted that not all lncRNAs are functionally important [2-4]. Thus, it is 
necessary to systematically identify, classify, and prioritize lncRNA candidates for functional 
investigation [3,5,6].  
To identify lncRNAs, microarray-based or RNA sequencing approaches have been 
classically used, and in this thesis we apply both technologies to P. falciparum transcriptome 
analysis. In Chapter 2, we use a high-resolution DNA tiling array to annotate 60 non-coding, 
intergenic, transcriptionally active regions (TARs), and characterize a compelling family of 
telomere-associated lncRNAs [7]. In Chapter 3, we develop and apply strand-specific, non-
polyA-selected RNA sequencing. Using this approach, we pursue the first P. falciparum 
transcriptome assembly from RNA sequencing reads, and assemble 660 intergenic lncRNA and 
474 antisense RNA transcript structures. We also investigate and predict 1381 non-canonical 
circular RNA splice junctions.  
In terms of lncRNA classification, some natural classifications exist, and may be 
generally predictive of function [5]. For example, lncRNAs can be grouped by their relationship 
to known transcripts and regulatory elements: antisense, intronic, intergenic, circular, 
pseudogenic, promoter-associated, or enhancer-associated. In Chapter 2 and Chapter 3, we 
extensively analyze P. falciparum lncRNA transcript properties, including lncRNA relationship 	 ﾠ
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to known transcripts, expression, stage-specificity, splicing, length, GC content, and 
conservation. Our analyses reveal global trends for intergenic lncRNAs versus antisense RNAs, 
as well as outliers that may represent specific subclasses. As an example of how global analysis 
can predict function, we find that lncRNAs are developmentally regulated, and that sense-
antisense transcript pairs are often inversely expressed. This suggests that much of P. falciparum 
lncRNA may play a regulatory role, especially via antagonistic mechanisms in the case of 
antisense RNAs.  
The end goal of this thesis work was to prioritize lncRNA candidates for functional 
investigation. Our top candidates include a family of twenty-two telomere-associated lncRNAs 
whose expression peaks during parasite invasion, as well as a spliced, highly correlated antisense 
counterpart to an essential gene in the early gametocyte commitment program. We also find 
additional examples of highly expressed, developmentally regulated, spliced lncRNAs, and an 
intriguing subset of antisense RNAs whose expression markedly drops during parasite invasion.  
Taken together, the work herein confirms the regulatory capacity of P. falciparum 
lncRNA. Our results provide an immediate foundation for future in depth functional analyses of 
P. falciparum lncRNAs. Our methods and analysis pipeline also enable further genome-wide 
studies of lncRNAs in sexual blood and mosquito stages or during growth perturbations.  
4.2  Future directions 
The CRISPR (clustered regularly interspaced short palindromic repeats) system functions 
as an immune system in many prokaryotic organisms [8]. In this natural system, when foreign 
DNA is introduced, a unique spacer is created and integrated into the genome. Transcribed 
CRISPR spacers, in complex with a CRISPR-associated (Cas) nuclease, then cut and inactivate 	 ﾠ
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foreign DNA [8-10]. In early 2013, Mali et al. and Cong et al. ported the CRISPR system to 
human cell culture, and demonstrated its utility in human genome editing [11,12]. Also in 2013, 
the CRISPR genome editing technique was applied to numerous model organisms: mice [13], 
zebra fish [14], yeast [15], nematodes [16], and plants [17], amongst others. Importantly, the 
CRISPR system is more specific than RNA interference-based approaches, and the effect is 
permanent [18-21]. The CRISPR system is also far less cumbersome, expensive, and time-
consuming than previous genome editing techniques, as the specificity for each target is imparted 
through the design of a custom guide RNA rather than a custom protein [10].  
Experimental investigation of P. falciparum lncRNA should be dramatically more 
feasible given the recent adaptation of the CRISPR genome editing system to P. falciparum [22]. 
Ghorbal et al. have demonstrated that CRISPR/Cas9 can be used to replace an endogenous P. 
falciparum target gene with a drug-selectable marker. More significantly, this group has used 
CRISPR/Cas9 to introduce single-nucleotide base changes into targeted loci in the P. falciparum 
genome without integrating a drug-selectable marker [22]. P. falciparum genetic engineering has 
been notoriously intractable for decades, but the flexibility and efficiency of the CRISPR system 
is revolutionary. Taken together, this timely technical advancement greatly expands the P. 
falciparum genetic engineering toolkit, such that investigating P. falciparum lncRNA function 
and mechanism using genetic dissections routinely performed in model organisms is now 
tractable. A suggested first set of experiments is: (1) to edit endogenous lncRNA promoter 
sequences such that transcription is abrogated, temporally offset, and/or constitutive, and (2) to 
assay for putative phenotypic consequences.  
Additional systematic studies of P. falciparum lncRNAs to generate further hypotheses 
are called for as well. Strand-specific deep profiling of the transition from asexual to sexual 	 ﾠ
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development, gametocyte maturation, and mosquito stages is fundamentally needed. In model 
organisms, profling lncRNAs in mutants lacking a component of the exosome has been 
particularly revealing [23-26], as has profiling the lncRNA transcriptional response to heat shock 
and various other environmental perturbations [27]. P. falciparum possesses conserved exosome 
components which could similarly be knocked out to investigate roles for unstable non-coding 
transcription [28]. Perturbation assays to investigate changes in P. falciparum lncRNA 
expression caused by fluctuating nutrient and/or oxygen levels, and febrile temperature would 
also be important to explore, as there is a clear precedent for lncRNA-mediated integration of 
various environmental signals in other organisms [27,29-33].  
To date, most P. falciparum genome-wide studies have focused on one or two aspects of 
suspected gene regulation, such as steady-state transcript levels, RNA decay rate, chromatin 
state, or protein levels [28,34-37]. Albeit a massive undertaking, pairing strand-specific deep 
sequencing with polysome-associated RNA profiling, ChIP-sequencing, chromatin capture, 
and/or peptide profiling in matched samples would provide a much more cohesive picture of P. 
falciparum gene regulation. Moreover, most P. falciparum genome-wide studies have only 
incorporated a handful of samples from one blood stage time-course. Our results, however, 
demonstrate the added benefit of incorporating biological replication, sampling parasites at 
approximately four-hour intervals, and assaying at least 56 hours of blood stage development.  
A final comment is that the analyses and interpretations presented throughout this thesis 
are based on populations of cells. However, the story may be considerably different within single 
cells. Indeed, the few genome-wide studies that have investigated single cell transcriptional 
dynamics have documented considerable heterogeneity [38]. Adaption of such single-cell 
approaches to the AT rich P. falciparum transcriptome is likely on the horizon [39]. Immediately 	 ﾠ
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feasible, albeit lower throughput, is fluorescence in situ hybridization (FISH). FISH can be used 
to quantify transcript abundance for a handful of mRNA and/or lncRNA targets in single cells 
[40]. FISH also reveals the localization compartment of lncRNAs at a snapshot in time, which 
provides an important clue to their functional role [41 ,42]. 
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Supplementary	 ﾠFigure	 ﾠ2.1	 ﾠ|	 ﾠDNA	 ﾠtiling	 ﾠarray	 ﾠgenome	 ﾠcoverage	 ﾠis	 ﾠdense	 ﾠand	 ﾠ
systematic.	 ﾠP.	 ﾠfalciparum	 ﾠstrain	 ﾠ3D7	 ﾠchromosomes	 ﾠ2,	 ﾠ4,	 ﾠ7,	 ﾠand	 ﾠ9	 ﾠare	 ﾠcompletely	 ﾠtiled.	 ﾠ
Chromosomes	 ﾠ3,	 ﾠ5,	 ﾠand	 ﾠ12	 ﾠare	 ﾠpartially	 ﾠtiled	 ﾠ(*).	 ﾠNumber	 ﾠof	 ﾠprobes	 ﾠper	 ﾠ10,000	 ﾠbp	 ﾠis	 ﾠplotted	 ﾠ
versus	 ﾠchromosomal	 ﾠposition.	 ﾠThe	 ﾠmedian	 ﾠprobe	 ﾠresolution	 ﾠis	 ﾠ12	 ﾠbp,	 ﾠcorresponding	 ﾠto	 ﾠ
approximately	 ﾠ830	 ﾠprobes	 ﾠper	 ﾠ10,000	 ﾠbp.	 ﾠ
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Supplementary	 ﾠFigure	 ﾠ2.2	 ﾠ|	 ﾠLncRNAs	 ﾠand	 ﾠprotein-ﾭ‐coding	 ﾠtranscripts	 ﾠdisplay	 ﾠsimilar	 ﾠ
expression.	 ﾠ(a)	 ﾠHierarchical	 ﾠclustering	 ﾠof	 ﾠlncRNAs	 ﾠand	 ﾠprotein-ﾭ‐coding	 ﾠtranscripts	 ﾠby	 ﾠ
euclidian	 ﾠdistance	 ﾠwithout	 ﾠmean	 ﾠcentering	 ﾠacross	 ﾠtime-ﾭ‐points.	 ﾠ(b)	 ﾠClustering	 ﾠby	 ﾠnon-ﾭ‐Metric	 ﾠ
Multidimensional	 ﾠScaling	 ﾠ(nMDS)	 ﾠwithout	 ﾠmean	 ﾠcentering	 ﾠacross	 ﾠtime-ﾭ‐points.	 ﾠ(c)	 ﾠ
Histogram	 ﾠof	 ﾠmaximum	 ﾠlog2	 ﾠexpression	 ﾠin	 ﾠany	 ﾠtime-ﾭ‐point	 ﾠfor	 ﾠlncRNAs	 ﾠ(blue)	 ﾠand	 ﾠprotein-ﾭ‐
coding	 ﾠtranscripts	 ﾠ(red).	 ﾠ
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Supplementary	 ﾠFigure	 ﾠ2.3	 ﾠ|	 ﾠDistribution	 ﾠof	 ﾠtime	 ﾠcourse	 ﾠcorrelations	 ﾠbetween	 ﾠthe	 ﾠ60	 ﾠ
putative	 ﾠlncRNAs	 ﾠand	 ﾠtheir	 ﾠneighboring	 ﾠcoding	 ﾠgenes	 ﾠ(teal)	 ﾠversus	 ﾠcorrelations	 ﾠ
between	 ﾠcoding	 ﾠgenes	 ﾠand	 ﾠtheir	 ﾠneighboring	 ﾠcoding	 ﾠgenes	 ﾠ(red).	 ﾠThe	 ﾠset	 ﾠof	 ﾠ60	 ﾠputative	 ﾠ
lncRNAs	 ﾠis	 ﾠenriched	 ﾠfor	 ﾠtranscripts	 ﾠthat	 ﾠare	 ﾠhighly	 ﾠcorrelated	 ﾠto	 ﾠnearby	 ﾠgenes,	 ﾠsuggesting	 ﾠ
that	 ﾠsome	 ﾠare	 ﾠspliced	 ﾠor	 ﾠun-ﾭ‐annotated	 ﾠuntranslated	 ﾠregions	 ﾠ(UTRs)	 ﾠto	 ﾠgenes.	 ﾠThe	 ﾠarrow	 ﾠ
marks	 ﾠthe	 ﾠcorrelation	 ﾠof	 ﾠlncRNA-ﾭ‐TARE-ﾭ‐4L	 ﾠto	 ﾠits	 ﾠneighbor.	 ﾠ
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Supplementary	 ﾠFigure	 ﾠ2.4	 ﾠ|	 ﾠLncRNA-ﾭ‐TARE	 ﾠhomology.	 ﾠClustering,	 ﾠconservation,	 ﾠand	 ﾠ
SPE2	 ﾠmotifs	 ﾠwithin	 ﾠthe	 ﾠ22	 ﾠpredicted	 ﾠlncRNA-ﾭ‐TARE	 ﾠloci.	 ﾠFigure	 ﾠproduced	 ﾠusing	 ﾠGeneious	 ﾠ
software.	 ﾠClustering	 ﾠperformed	 ﾠusing	 ﾠClustalW.	 ﾠ
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21. lncRNA-TARE-3R
22. lncRNA-TARE-8L
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Supplementary	 ﾠFigure	 ﾠ2.5	 ﾠ|	 ﾠSequenced	 ﾠlncRNA-ﾭ‐TARE	 ﾠRLM-ﾭ‐RACE	 ﾠproducts.	 ﾠProducts	 ﾠ
were	 ﾠBLASTed,	 ﾠtrimmed	 ﾠto	 ﾠexclude	 ﾠexcessive	 ﾠvector	 ﾠsequence	 ﾠand	 ﾠlow-ﾭ‐quality	 ﾠbase	 ﾠcalls,	 ﾠ
and	 ﾠaligned	 ﾠto	 ﾠthe	 ﾠchromosome	 ﾠfour	 ﾠreference	 ﾠsequence	 ﾠusing	 ﾠGeneious	 ﾠsoftware.	 ﾠ(a)	 ﾠ5’	 ﾠ
RLM-ﾭ‐RACE	 ﾠsequencing	 ﾠidentified	 ﾠa	 ﾠsingle	 ﾠputative	 ﾠtranscriptional	 ﾠstart	 ﾠsite	 ﾠfor	 ﾠlncRNA-ﾭ‐
TARE-ﾭ‐3L	 ﾠcorresponding	 ﾠto	 ﾠthe	 ﾠTARE	 ﾠ3	 ﾠsubtelomeric	 ﾠrepeat	 ﾠboundary.	 ﾠPurple	 ﾠarrows	 ﾠ
represent	 ﾠthe	 ﾠ5’	 ﾠRLM-ﾭ‐RACE	 ﾠadapter/primer	 ﾠsequence	 ﾠ(Ambion).	 ﾠ(b)	 ﾠ3’	 ﾠRACE	 ﾠdemonstrated	 ﾠ
that	 ﾠa	 ﾠlong	 ﾠtranscript	 ﾠencompassing	 ﾠthe	 ﾠTARE2	 ﾠsubtelomeric	 ﾠrepeat	 ﾠis	 ﾠtranscribed	 ﾠtowards	 ﾠ
the	 ﾠtelomeres.	 ﾠGreen	 ﾠarrows	 ﾠrepresent	 ﾠthe	 ﾠ3’	 ﾠRACE	 ﾠadapter/primer	 ﾠsequence	 ﾠ(Ambion).	 ﾠ
(c)	 ﾠ3‘	 ﾠRACE	 ﾠalso	 ﾠpredicted	 ﾠa	 ﾠshorter	 ﾠtranscript	 ﾠterminating	 ﾠjust	 ﾠupstream	 ﾠof	 ﾠTARE	 ﾠ2.	 ﾠGreen	 ﾠ
arrows	 ﾠrepresent	 ﾠthe	 ﾠ3’	 ﾠRACE	 ﾠadapter/primer	 ﾠsequence	 ﾠ(Ambion).	 ﾠPurple	 ﾠarrows	 ﾠ
represent	 ﾠthe	 ﾠlncRNA-ﾭ‐TARE	 ﾠfamily-ﾭ‐specific	 ﾠ3’	 ﾠRACE	 ﾠprimer	 ﾠsequence.	 ﾠFigure	 ﾠproduced	 ﾠ
using	 ﾠGeneious	 ﾠv4.8	 ﾠsoftware.	 ﾠ
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Supplementary	 ﾠFigure	 ﾠ2.5	 ﾠ(Continued	 ﾠ)	 ﾠ|	 ﾠSequenced	 ﾠlncRNA-ﾭ‐TARE	 ﾠRLM-ﾭ‐RACE	 ﾠ
products.	 ﾠ
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Supplementary	 ﾠFigure	 ﾠ2.5	 ﾠ(Continued)	 ﾠ|	 ﾠSequenced	 ﾠlncRNA-ﾭ‐TARE	 ﾠRLM-ﾭ‐RACE	 ﾠ
products.	 ﾠ
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Supplementary	 ﾠFigure	 ﾠ2.5	 ﾠ(Continued)	 ﾠ|	 ﾠSequenced	 ﾠlncRNA-ﾭ‐TARE	 ﾠRLM-ﾭ‐RACE	 ﾠ
products	 ﾠ
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Supplementary	 ﾠFigure	 ﾠ2.6	 ﾠ|	 ﾠLncRNA-ﾭ‐TARE	 ﾠis	 ﾠco-ﾭ‐expressed	 ﾠwith	 ﾠSPE2-ﾭ‐binding	 ﾠ
transcription	 ﾠfactor	 ﾠPfSip2.	 ﾠqRT-ﾭ‐PCR	 ﾠamplification	 ﾠof	 ﾠlncRNA-ﾭ‐TARE-ﾭ‐4L	 ﾠand	 ﾠthe	 ﾠSPE2-ﾭ‐
binding	 ﾠtranscription	 ﾠfactor	 ﾠPfSip2	 ﾠdemonstrates	 ﾠco-ﾭ‐expression	 ﾠduring	 ﾠparasite	 ﾠ
schizogony,	 ﾠwith	 ﾠmaximal	 ﾠlncRNA-ﾭ‐TARE-ﾭ‐4L	 ﾠexpression	 ﾠoccurring	 ﾠslightly	 ﾠafter	 ﾠPfSip2	 ﾠ
expression.	 ﾠLncRNA-ﾭ‐TARE-ﾭ‐4L	 ﾠand	 ﾠPfSip2	 ﾠrelative	 ﾠexpression	 ﾠis	 ﾠplotted	 ﾠin	 ﾠtime-ﾭ‐points	 ﾠT30,	 ﾠ
T36,	 ﾠT38,	 ﾠand	 ﾠT40	 ﾠ+/-ﾭ‐	 ﾠ3	 ﾠhpi	 ﾠwith	 ﾠrespect	 ﾠto	 ﾠT30.	 ﾠError	 ﾠbars	 ﾠrepresent	 ﾠthe	 ﾠpropagated	 ﾠ
standard	 ﾠerror	 ﾠof	 ﾠthe	 ﾠmean	 ﾠ(pSEM)	 ﾠfrom	 ﾠfour	 ﾠtechnical	 ﾠreplicates.	 ﾠHousekeeping	 ﾠgene	 ﾠ
PF08_0085	 ﾠwas	 ﾠused	 ﾠas	 ﾠthe	 ﾠreference	 ﾠgene.	 ﾠ
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Supplementary	 ﾠFigure	 ﾠ2.7	 ﾠ|	 ﾠQuantile	 ﾠnormalization	 ﾠcorrects	 ﾠsystematic	 ﾠbiases	 ﾠin	 ﾠraw	 ﾠ
data	 ﾠwithout	 ﾠovercorrecting.	 ﾠ(a)	 ﾠLog2	 ﾠprobe	 ﾠhybridization	 ﾠintensity	 ﾠdistributions	 ﾠfrom	 ﾠ
each	 ﾠsample	 ﾠprior	 ﾠto	 ﾠquantile	 ﾠnormalization	 ﾠand	 ﾠafter	 ﾠquantile	 ﾠnormalization	 ﾠ(black	 ﾠcurve).	 ﾠ
(b)	 ﾠBoxplots	 ﾠof	 ﾠquantile	 ﾠnormalized,	 ﾠlog2	 ﾠtransformed	 ﾠprobe	 ﾠhybridization	 ﾠintentensities	 ﾠ
from	 ﾠeach	 ﾠsample.	 ﾠ(c)	 ﾠPairwise	 ﾠcorrelation	 ﾠscatterplots	 ﾠbetween	 ﾠraw	 ﾠand	 ﾠquantile	 ﾠ
normalized	 ﾠdata	 ﾠ(-ﾭ‐Q)	 ﾠshows	 ﾠthat	 ﾠthe	 ﾠcorrelation	 ﾠis	 ﾠvery	 ﾠstrong	 ﾠbetween	 ﾠmatched	 ﾠsamples	 ﾠ
(Pearson’s	 ﾠcorrelation	 ﾠcoefficient	 ﾠ(CC)	 ﾠ=	 ﾠ1.0).	 ﾠ
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Supplementary	 ﾠFigure	 ﾠ2.8	 ﾠ|	 ﾠMinimal	 ﾠincrease	 ﾠin	 ﾠmedian	 ﾠintergenic	 ﾠprobe	 ﾠ
hybridiization	 ﾠintensity	 ﾠis	 ﾠobserved	 ﾠwith	 ﾠnumber	 ﾠof	 ﾠGC	 ﾠbases.	 ﾠBoxplots	 ﾠof	 ﾠintergenic	 ﾠ
probe	 ﾠhybridization	 ﾠintensities	 ﾠfor	 ﾠeach	 ﾠsample	 ﾠafter	 ﾠquantile	 ﾠnormalization.	 ﾠProbes	 ﾠare	 ﾠ
grouped	 ﾠaccording	 ﾠto	 ﾠthe	 ﾠnumber	 ﾠof	 ﾠGC	 ﾠbases	 ﾠin	 ﾠtheir	 ﾠsequence.	 ﾠ
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Supplementary	 ﾠTable	 ﾠ2.1	 ﾠ|	 ﾠStage-ﾭ‐specific	 ﾠgene	 ﾠontology	 ﾠanalysis.	 ﾠThe	 ﾠtop	 ﾠfour	 ﾠover-ﾭ‐
represented	 ﾠGO	 ﾠterms	 ﾠin	 ﾠeach	 ﾠtime-ﾭ‐point.	 ﾠ	 ﾠ
	 ﾠ
  Best GOs  p-value  description 
T18  GO:0020013  2.84E-08  rosetting 
  GO:0007157  2.84E-08  heterophilic cell-cell adhesion 
  GO:0020030  6.45E-08  infected host cell surface knob 
  GO:0016337  6.45E-08  cell-cell adhesion 
       
T24  GO:0044237  0.000131586  cellular metabolic process 
  GO:0044238  0.000131586  primary metabolic process 
  GO:0043170  0.003819134  macromolecule metabolic process 
  GO:0006139  0.004118201 
nucleobase, nucleoside, nucleotide and nucleic acid 
metabolic process 
       
T30  GO:0016788  0.0321  hydrolase activity, acting on ester bonds 
  GO:0004518  0.0624  nuclease activity 
  GO:0006259  0.0755  DNA metabolic process 
  GO:0006260  0.0933  DNA replication 
       
T36  GO:0008234  0.112  cysteine-type peptidase activity 
  GO:0008233  0.112  peptidase activity 
  GO:0004197  0.112  cysteine-type endopeptidase activity 
  GO:0004175  0.112  endopeptidase activity 
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Supplementary	 ﾠTable	 ﾠ2.2	 ﾠ|	 ﾠPutative	 ﾠsmall	 ﾠRNAs.	 ﾠChromosome,	 ﾠcoordinates,	 ﾠand	 ﾠlength	 ﾠ
of	 ﾠ46	 ﾠputative	 ﾠsmall	 ﾠRNAs	 ﾠeliminated	 ﾠfrom	 ﾠlncRNA	 ﾠcandidate	 ﾠlist.	 ﾠ
	 ﾠ
chromosome  start  stop  length 
Pf3D7_02  76857  76947  91 
Pf3D7_02  91072  91184  113 
Pf3D7_02  102873  102989  117 
Pf3D7_02  175192  175358  167 
Pf3D7_02  210863  210907  45 
Pf3D7_02  273406  273534  129 
Pf3D7_02  349389  349559  171 
Pf3D7_02  410233  410375  143 
Pf3D7_02  413194  413310  117 
Pf3D7_02  441867  441911  45 
Pf3D7_03  122490  122642  153 
Pf3D7_04  269938  270032  95 
Pf3D7_04  458795  458877  83 
Pf3D7_04  627801  627849  49 
Pf3D7_04  679162  679206  45 
Pf3D7_04  704637  704775  139 
Pf3D7_04  946452  946500  49 
Pf3D7_04  958351  958399  49 
Pf3D7_04  981177  981225  49 
Pf3D7_05  1139348  1139540  193 
Pf3D7_05  1140246  1140416  171 
Pf3D7_07  208840  208912  73 
Pf3D7_07  208992  209040  49 
Pf3D7_07  807151  807233  83 
Pf3D7_07  913847  914023  177 
Pf3D7_07  995858  995964  107 
Pf3D7_07  1068513  1068641  129 
Pf3D7_09  133451  133495  45 
Pf3D7_09  133589  133721  133 
Pf3D7_09  363973  364045  73 
Pf3D7_09  537936  538101  166 
Pf3D7_09  650017  650201  185 
Pf3D7_09  650371  650439  69 
Pf3D7_09  700267  700371  105 
Pf3D7_09  1042227  1042317  91 
Pf3D7_09  1148725  1148817  93 
Pf3D7_09  1254633  1254727  95 
Pf3D7_09  1263209  1263337  129 
Pf3D7_09  1331291  1331337  47 
Pf3D7_09  1422839  1422883  45 
Pf3D7_09  1427281  1427363  83 
Pf3D7_09  1436275  1436333  59 
Pf3D7_12  91081  91129  49 
Pf3D7_12  163021  163219  199 
Pf3D7_12  421028  421222  195 
Pf3D7_12  577188  577306  119 
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Supplementary	 ﾠTable	 ﾠ2.3	 ﾠ|	 ﾠPutative	 ﾠgenes	 ﾠor	 ﾠpseudogenes.	 ﾠChromosome,	 ﾠcoordinates,	 ﾠ
and	 ﾠlength	 ﾠfor	 ﾠ17	 ﾠputative	 ﾠgenes	 ﾠor	 ﾠpseudogenes	 ﾠeliminated	 ﾠfrom	 ﾠlncRNA	 ﾠcandidate	 ﾠlist.	 ﾠ
	 ﾠ
chromosome  start  end  length 
Pf3D7_02  10394  11762  1369 
Pf3D7_02  86173  86529  357 
Pf3D7_02  102270  102618  349 
Pf3D7_04  224998  225306  309 
Pf3D7_04  568293  568535  243 
Pf3D7_07  80066  80462  397 
Pf3D7_07  83609  84272  664 
Pf3D7_07  774410  775089  680 
Pf3D7_07  790877  791737  861 
Pf3D7_07  1023527  1023988  462 
Pf3D7_07  1336280  1336808  529 
Pf3D7_09  177874  178908  1035 
Pf3D7_09  537284  537678  395 
Pf3D7_09  1138997  1139900  904 
Pf3D7_09  1285576  1285999  424 
Pf3D7_12  186108  186825  718 
Pf3D7_12  195558  197020  1463 
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 ﾠ
Supplementary	 ﾠTable	 ﾠ2.4	 ﾠ|	 ﾠCharacteristics	 ﾠof	 ﾠ60	 ﾠP.	 ﾠfalciparum	 ﾠlncRNA	 ﾠcandidates.	 ﾠ
Properties of lncRNA-TARE-4L are boxed. Candidates highlighted in pink are located > 1 kb 
away from a neighboring protein-coding gene. Candidates highlighted in blue exhibit Pearson 
correlation < 0.9 with their more correlated neighboring gene.  	 ﾠ
	 ﾠ
  chr  start  stop  length 
coverage     
(# of probes)  GC% 
overlap with 
PlasmoDB v7.1 
ncRNAs 
nearest gene 
1  Pf3D7_02  90364  90872  509  31  13.75%    PFB0095c 
2  Pf3D7_02  98908  99480  573  30  9.77%    PFB0095c 
3  Pf3D7_02  108948  109314  367  22  13.90%    PFB0105c 
4  Pf3D7_02  161261  161889  629  19  11.29%    PFB0160w 
5  Pf3D7_02  407481  408619  1139  60  15.89%  PF02TR001  PFB0445c 
6  Pf3D7_02  410525  410755  231  13  22.94%    PFB0450w 
7  Pf3D7_02  521868  522114  247  11  14.98%    PFB0560w 
8  Pf3D7_02  593316  594090  775  48  15.74%    PFB0665w 
9  Pf3D7_02  637779  638182  404  23  15.59%    PFB0700c 
10  Pf3D7_02  638799  639127  329  16  13.98%    PFB0705w 
11  Pf3D7_03  128996  129694  699  52  19.17%  PF03TR002  PFC0115c 
12  Pf3D7_03  146103  146672  570  40  15.61%    PFC0130c 
13  Pf3D7_04  8254  12006  3753  50  32.11%     PFD0005w 
14  Pf3D7_04  156608  157411  804  51  20.90%    PFD0115c 
15  Pf3D7_04  221362  222522  1161  51  12.75%  RNAzID:3065  PFD0185c 
16  Pf3D7_04  465979  466243  265  20  20.75%    PFD0485w 
17  Pf3D7_04  654078  654348  271  18  15.50%    PFD0692c 
18  Pf3D7_04  707195  708303  1109  54  14.70%    PFD0775c 
19  Pf3D7_04  735375  735781  407  20  14.99%  PF04TR001  PFD0807c 
20  Pf3D7_04  830465  833119  2655  100  12.50%  PF04TR003  PFD0885c 
21  Pf3D7_04  1055726  1055949  224  9  16.96%    PFD1100c 
22  Pf3D7_04  1074520  1075252  733  37  17.74%    PFD1120c 
23  Pf3D7_04  1119682  1120248  567  29  11.64%    PFD1170c 
24  Pf3D7_05  1002403  1002926  524  13  9.54%    PFE1195w 
25  Pf3D7_05  1018995  1019384  390  18  11.03%    PFE1230c 
26  Pf3D7_05  1162996  1163395  400  13  13.25%    PFE1405c 
27  Pf3D7_05  1170633  1171342  710  36  14.08%    PFE1415w 
28  Pf3D7_05  1224183  1224589  407  29  16.46%    PFE1500c 
29  Pf3D7_07  91404  92007  604  39  15.07%  PF07TR001  MAL7P1.230 
30  Pf3D7_07  97857  98495  639  43  9.23%    MAL7P1.231 
31  Pf3D7_07  105724  106082  359  27  13.37%    MAL7P1.228 
32  Pf3D7_07  159485  159827  343  16  7.87%    PF07_0008 
33  Pf3D7_07  271123  271401  279  11  16.49%    MAL7P1.19 
34  Pf3D7_07  340595  340821  227  16  19.82%    MAL7P1.300 
35  Pf3D7_07  370441  370752  312  10  16.67%    MAL7P1.204 
36  Pf3D7_07  440174  440588  415  24  13.98%    PF07_0029 
37  Pf3D7_07  1147335  1148031  697  48  18.79%    PF07_0107 
38  Pf3D7_09  151334  151676  343  26  15.74%    PFI0165c 
39  Pf3D7_09  275014  275478  465  27  13.76%    PFI0265c 
40  Pf3D7_09  324073  325747  1675  55  9.85%  PF09TR001  PFI0325c 
41  Pf3D7_09  326059  327734  1676  62  11.99%  PF09TR001  PFI0325c 
42  Pf3D7_09  356053  356337  285  17  17.89%    PFI0360c 
43  Pf3D7_09  440457  440863  407  24  17.69%    PFI0470w 
44  Pf3D7_09  509630  509878  249  15  22.09%    PFI0545w 
45  Pf3D7_09  554392  555099  708  31  15.11%    PFI0610w 
46  Pf3D7_09  698206  699397  1192  44  12.84%    PFI0820c 
47  Pf3D7_09  741852  742164  313  22  18.53%    PFI0880c 
48  Pf3D7_09  762853  763259  407  25  24.57%  RNAzID:4653  PFI0905w 
49  Pf3D7_09  852079  852445  367  16  12.53%    PFI1020c 
50  Pf3D7_09  939059  939539  481  27  17.67%    PFI1130c 
51  Pf3D7_09  1074703  1075688  986  55  16.84%  RNAzID:4694  PFI1300c 
52  Pf3D7_09  1396100  1396574  475  20  16.21%    PFI1715w 
53  Pf3D7_09  1426449  1426655  207  13  15.46%    PFI1740c 
54  Pf3D7_09  1426665  1427132  468  20  12.39%    PFI1740c 
55  Pf3D7_09  1431827  1432370  544  29  18.57%  RNAzID:4797  PFI1745c 
56  Pf3D7_12  235695  236219  525  23  14.67%    PFL0270c 
57  Pf3D7_12  304588  305687  1100  64  13.45%    PFL0335c 
58  Pf3D7_12  413796  415379  1584  59  12.63%    PFL0445w 
59  Pf3D7_12  594179  594923  745  38  13.15%    PFL0675c 
60  Pf3D7_12  598926  599486  561  32  14.08%    PFL0675c 
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Supplementary	 ﾠTable	 ﾠ2.4	 ﾠ(Continued)	 ﾠ|	 ﾠCharacteristics	 ﾠof	 ﾠ60	 ﾠP.	 ﾠfalciparum	 ﾠlncRNA	 ﾠ
candidates.	 ﾠ	 ﾠ
	 ﾠ
 
distance to 
nearest gene 
max correlation 
with neighboring 
gene 
fold change 
distance to 
neighboring gene 
with max 
correlation 
max  
time-point 
max probe 
intensity 
1  446  0.995052594  3.67727881  446  T18  25.3 
2  70  0.981759536  3.342655313  70  T18  6.1 
3  250  0.97958822  1.841013208  250  T36  6.5 
4  19  0.938022972  1.571523106  176  T24  7.4 
5  1126  0.759336454  1.661183541  1126  T18  3.0 
6  297  -0.167377667  0.273653001  297  T24  37.0 
7  122  0.099466422  2.114153871  122  T24  17.8 
8  106  0.995196901  3.169826237  106  T36  3.2 
9  272  0.996325865  0.822834061  272  T18  5.2 
10  1273  0.993359742  0.784461262  1292  T24  9.1 
11  2081  0.964970012  2.408835642  2403  T36  2.7 
12  119  0.974126719  1.677265219  119  T18  4.1 
13  23147  -0.295570023  2.591987191  39996  T36  2.8 
14  1768  0.783888023  2.231480862  1768  T18  3.1 
15  1044  0.976884288  1.963195203  1044  T36  3.4 
16  364  0.619950843  1.003855895  364  T18  6.3 
17  24  0.999387225  3.732924308  24  T30  9.6 
18  206  -0.151776699  0.273846694  206  T36  4.5 
19  413  0.997818747  0.757552646  413  T24  6.0 
20  1144  0.952507595  0.904543821  1144  T24  3.5 
21  67  0.95271842  2.55613031  67  T36  5.3 
22  621  0.828742942  1.731965884  621  T24  12.0 
23  1567  0.962824823  2.906810269  3058  T18  5.2 
24  284  0.669843589  1.189718072  284  T24  10.2 
25  196  0.878751018  1.494455992  196  T24  10.9 
26  7  0.839679446  2.27533969  1449  T24  15.3 
27  311  0.980654158  3.103472129  3086  T36  3.8 
28  2  0.626834415  1.999431118  2  T24  9.6 
29  128  0.994484972  2.753246062  128  T18  9.3 
30  176  0.917669192  2.801368561  4888  T18  3.4 
31  142  0.872494021  2.213895188  142  T24  6.2 
32  496  0.989753519  3.471594294  496  T18  19.9 
33  3  0.999824531  2.152716093  3  T18  14.8 
34  32  0.947310662  3.352449172  32  T18  57.1 
35  40  0.993695202  2.28866887  40  T18  11.0 
36  182  0.977057716  1.835105868  373  T18  7.4 
37  911  0.725560466  2.104869294  911  T18  3.3 
38  23  0.991803058  2.012729887  23  T18  18.2 
39  227  0.953898382  2.667464921  227  T36  5.7 
40  734  0.990173149  2.215246438  734  T18  3.1 
41  2720  0.986217308  1.299729826  2720  T18  2.5 
42  321  0.938508778  2.904288987  321  T36  11.6 
43  43  -0.487368854  1.222003636  5448  T18  5.5 
44  47  0.967111263  2.042565141  47  T36  10.4 
45  982  0.950320895  1.916811529  982  T18  4.0 
46  187  0.965692296  1.110192479  187  T18  2.9 
47  320  0.915651649  3.44931118  320  T36  9.1 
48  137  0.604987619  1.924518765  137  T24  6.4 
49  70  0.945066028  2.687622707  70  T18  15.1 
50  31  0.968663876  1.402635855  31  T24  9.4 
51  217  0.991764486  1.50043645  876  T36  2.3 
52  4215  0.110732928  0.809282807  16359  T30  7.3 
53  808  0.998617666  3.474515586  808  T18  11.3 
54  331  0.979374432  4.012441607  331  T18  20.7 
55  692  0.775882784  1.962751937  692  T18  4.3 
56  51  0.304466604  0.173562662  51  T24  5.1 
57  1765  0.976556071  2.024865895  1765  T18  3.4 
58  19  -0.422811312  0.459209104  3322  T24  2.7 
59  237  0.967954798  0.805568773  237  T18  11.5 
60  289  0.972201999  1.440896368  289  T18  3.6 	 ﾠ
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Supplementary	 ﾠTable	 ﾠ2.5	 ﾠ|	 ﾠqRT-ﾭ‐PCR	 ﾠand	 ﾠRLM-ﾭ‐RACE	 ﾠprimers.	 ﾠGene-ﾭ‐specific	 ﾠlncRNA-ﾭ‐
TARE/PfSip2	 ﾠ(PFF0200c)	 ﾠqRT-ﾭ‐PCR	 ﾠprimer	 ﾠsequences	 ﾠand	 ﾠfamily-ﾭ‐specific	 ﾠlncRNA-ﾭ‐TARE	 ﾠ
RLM-ﾭ‐RACE	 ﾠprimer	 ﾠsequences.	 ﾠ
	 ﾠ
target  sequence 
lncRNA-TARE-1L_F  ATAACCGTACTACTTCCT 
lncRNA-TARE-1L_R  CATCATATTATGTTGAAGCTA 
   
lncRNA-TARE-2R_F  ACTTACGAACTAAGGAAA 
lncRNA-TARE-2R_R  AATGATGATGATTTGGG 
   
lncRNA-TARE-3L_F  TACTACTTCCTAGCAACA 
lncRNA-TARE-3L_R  CATGAAATAGAATATGGGTTAA 
   
lncRNA-TARE-3R_F  TTTGTTTGCATTATGTGTT 
lncRNA-TARE-3R_R  AACCATTTAGTCCAATCAA 
   
lncRNA-TARE-4L_F  AATTTACCCATTTTTCAAA 
lncRNA-TARE-4L_R  AAGTACTCGTGGCAAT 
   
lncRNA-TARE-4R_F  ACTTCTAACTATCAGATTCAT 
lncRNA-TARE-4R_R  AACCATATCATCATTAAGAAC 
   
lncRNA-TARE-6R_F  TTTCCTAAAAAATTTGGTCCAT 
lncRNA-TARE-6R_R  CGTGGCAATTAGGTGAA 
   
lncRNA-TARE-7L_F  GGGTAGTACCATAAGTTT 
lncRNA-TARE-7L_R  TACAACTAACCTAACTAAC 
   
lncRNA-TARE-7R_F  AACTGGAGGAATAAATTCT 
lncRNA-TARE-7R_R  GTTGTTCGGAAGTAGTAA 
   
lncRNA-TARE-8R_F  TCTAACTATCACATTCATATCT 
lncRNA-TARE-8R_R  CATCTACAACATCATCAATG 
   
lncRNA-TARE-9L_F  GTGTGTTTGTTTGGGGGTAG 
lncRNA-TARE-9L_R  AACTAAGCCAACTAACAACATCAA 
   
lncRNA-TARE-9R_F  ATGGTCACTTACAAACTAAT 
lncRNA-TARE-9R_R  GTGTGTTTTGGGGTTAA 
   
lncRNA-TARE-10L_F  TTCTAATACTACTACTTCATGT 
lncRNA-TARE-10L_R  GTGGTAAATAATGGAGGAA 
   
lncRNA-TARE-11L_F  TGTGAAGGGGTATTAC 
lncRNA-TARE-11L_R  AATTGGTGAACTATGAC 
   
lncRNA-TARE-12L_F  TTAGTTCTACCCGTTTG 
lncRNA-TARE-12L_R  CACATCAAGCAGACAT 
   
PfSip2_F  GTACCATTAAATTCACGTAAGG 
PfSip2_R  TATTATTATTCTCCATACCATCCC 
   
5'-RACE-outer  CACTAAGGTTCAAGGTTCTC 
5'-RACE-inner  GATGTTGTAGATGATGTCGTT 
3'-RACE  GAGAACCTTGAACCTTAGTG 
	 ﾠ
	 ﾠ
	 ﾠ
	 ﾠ	 ﾠ
	 ﾠ
	 ﾠ
149	 ﾠ
Supplementary	 ﾠTable	 ﾠ2.6	 ﾠ|	 ﾠRLM-ﾭ‐RACE	 ﾠsyntenic	 ﾠtranscript	 ﾠcoordinates.	 ﾠOriginal	 ﾠ
chromosome	 ﾠand	 ﾠsyntenic	 ﾠcoordinates	 ﾠon	 ﾠthe	 ﾠleft	 ﾠend	 ﾠof	 ﾠchromosome	 ﾠfour	 ﾠfor	 ﾠeach	 ﾠ
sequenced	 ﾠRACE	 ﾠproduct.	 ﾠ
	 ﾠ
3' RACE products 
original chromosome              
(any ambiguities are noted) 
syntenic coordinates on 
chromosome four 
2 right  8156 
5 left or 13  left  8156 
4 left or 6 right  8209 
9 right  8210 
4 left or 6 right  8213 
5 left or 13 left  8221 
8 left  8221 
12 left  8221 
2 right  8221 
9 right  8221 
1 left  8221 
1 left  8221 
4 left or 6 right  8221 
9 right  8221 
1 left  9821 
4 left or 6 right  9821 
5 left or 13  left  9821 
3 right  9821 
7 right  9821 
7 right  9821 
7 left  9821 
2 right  9821 
9 right  9826 
4 left or 6 right  9875 
3 right  9958 
3 right  10022 
12 left  10050 
5' RACE products 
original chromosome              
(any ambiguities are noted) 
syntenic coordinates on 
chromosome four 
3 left  11278 
3 left  11278 
3 left  11278 
3 left  11278 
3 left  11278 
3 left  11278 
3 left  11278 
3 left  11278 
3 left  11278 
3 left  11278 	 ﾠ
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Supplementary Figure 3.1 | Strand-specific, non-polyA-selected P. falciparum libraries can 
be comfortably prepared in one week. The flowchart shows major protocol steps and sample 
progression during library preparation, beginning with parasite total RNA stored in TRIZOL 
Reagent and ending with amplified double-stranded DNA libraries ready for quantification and 
Illumina sequencing. 	 ﾠ
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Supplementary Figure 3.2 | Raw reads have high quality scores. (A/B) Read 1 and Read 2 
raw quality scores, respectively. Each plot summarizes approximately 307 million reads 
agglomerated from all fifteen samples. We trimmed the last base and filtered the 4-8% of reads 
from each sample that did not pass Illumina filtering prior to read alignment. 
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Supplementary Figure 3.3 | A central upsC-type var gene is the dominant var transcript, 
and subtelomeric upsB-type var genes produce the most non-coding transcripts. 
(A/B/C/D/E/F) Expression during the 56-hour time course of upsA-type (red), upsBA-type 
(orange), upsB-type (purple), upsBC-type (green), upsC-type (black), upsD-type (light blue) and 
upsE-type (dark blue) var genes, respectively [1]. This analysis indicated that an upsC-type gene, 
Pf3D7_0412700, was the dominant var transcript in the parasite population (black arrow). We 
also noted that the transcription of non-coding transcripts varied by upstream promoter (ups) 
type. Interestingly, the majority of upsB-type var genes transcribed non-coding transcripts during 
parasite invasion (purple arrow), whereas the majority of upsA-type and upsC-type var genes did 
not. Expression is plotted in units of log2(FPKM+1). upsA-type: Pf3D7_0425800, 
Pf3D7_1150400, Pf3D7_1300300, Pf3D7_0800200, Pf3D7_1100200, Pf3D7_0400400, 
Pf3D7_0100300, Pf3D7_0937600, Pf3D7_0600400; upsBA-type: Pf3D7_0800300, 
Pf3D7_1200400, Pf3D7_0600200, Pf3D7_0632500; upsB-type: Pf3D7_1100100, 
Pf3D7_0800100, Pf3D7_0500100, Pf3D7_0100100, Pf3D7_0115700, Pf3D7_0324900, 
Pf3D7_0400100, Pf3D7_0900100, Pf3D7_0223500, Pf3D7_1041300, Pf3D7_1200100, 
Pf3D7_0200100, Pf3D7_0300100, Pf3D7_1255200, Pf3D7_0426000, Pf3D7_0937800, 
Pf3D7_1000100, Pf3D7_1219300, Pf3D7_0632800, Pf3D7_1373500, Pf3D7_0733000, 
Pf3D7_0700100, Pf3D7_1300100, Pf3D7_0833500; upsBC-type: Pf3D7_0413100, 
Pf3D7_1240400, Pf3D7_0808700, Pf3D7_0712800, Pf3D7_0712400, Pf3D7_0421100, 
Pf3D7_1240300; upsC-type: Pf3D7_0712900, Pf3D7_0808600, Pf3D7_0420700, 
Pf3D7_0712000, Pf3D7_0412900, Pf3D7_0420900, Pf3D7_0421300, Pf3D7_0412400, 
Pf3D7_0712600, Pf3D7_0711700, Pf3D7_1240600, Pf3D7_0412700, Pf3D7_0617400; upsD-
type: Pf3D7_0533100; upsE-type: Pf3D7_1200600. 
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Supplementary Figure 3.4 | Stage-specific marker gene expression profiles match 
expectations. (A/B) Expression profiles of well established ring stage markers during the 56-
hour time course. (C/D) Expression profiles of well established invasion markers during the 56-
hour time course. (E/F) Expression profiles of well-established mosquito stage markers during 
the 56-hour time course. MAHRP = membrane-associated histidine rich protein; KAHRP = 
knob-associated histidine rich protein; MSP1 = merozoite surface protein 1; AMA1 = apical 
membrane antigen 1; CSP = circumsporozoite protein; Pfs28 = 28 kDa ookinete surface protein. 
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Supplementary Figure 3.5 | Cufflinks assembled transcripts tend to include un-annotated 
regions, likely to be UTRs. Upon comparing the properties of PlasmoDBv10.0 annotated 
transcripts (black), Cufflinks RABT transcripts (pink), and Cufflinks -RABT transcripts 
(orange), we found evidence for un-annotated, potential UTRs included in the Cufflinks 
assembled transcripts. This was supported by the slightly (A) increased length and (B) reduced 
GC content of Cufflinks assembled transcripts, as P. falciparum non-coding regions typically 
have lower GC content than coding regions. Also, when we considered mRNA transcript 
expression levels during the 56-hour time course, we found (C) reduced maximum expression 
levels of Cufflinks assembled mRNA transcripts, which further indicated that Cufflinks 
transcripts included UTRs with less read coverage. 
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Supplementary Figure 3.6 | Two-dimensional genomic distance between neighboring loci is 
not a strong indicator of expression correlation. (A)/(B) The Pearson correlation during the 
56-hour time course and the distance between mRNA-neighbor pairs (black) and intergenic 
lncRNA-neighbor pairs (red), respectively. Dashed lines correspond to pairings with the less 
correlated neighbor. This analysis indicated that both mRNAs and intergenic lncRNAs had a 
significantly more correlated neighbor. However, regardless of pairing criteria, the genomic 
distances between neighboring loci were quite similar. (C/D) We next stratified the Pearson 
correlation during the 56-hour time-course and the distance between intergenic lncRNAs and 
their more correlated neighbor by pair orientation, respectively. We found 156 tandem, 317 
divergent, and 25 convergent pairs. Notably, convergent loci, albeit exhibiting less extreme 
positive correlation, were not more distant from each other. 
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Supplementary Figure 3.7 | Sense-antisense transcripts tend to overlap in their 3’ tail 
region. The distribution of antisense transcription initiation sites (black) and antisense 
transcription termination sites (red) showed that the vast majority of antisense transcripts 
initiated transcription downstream of gene bodies, and tended to terminate transcription towards 
the 3’ tail region as well. We normalized antisense transcription initiation and termination sites 
to the location and length of their respective PlasmoDBv10.0 annotated gene partner, inclusive 
of intronic sequence. 
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Supplementary Figure 3.8 | Comparison of PfGDV1 antisense transcript levels in two time 
courses. Plotting PfGDV1 expression during both time-courses showed that PfGDV1 sense-
antisense transcript levels were highly correlated. Antisense transcript levels during the shorter 
time course reached a maximum FPKM of 255. Pearson correlation during the shorter time 
course was 0.85. We estimated the shorter time course time-points from our MDS staging 
analysis as approximately: 17, 27, 32, and 41 hpi. Expression is plotted in units of 
log2(FPKM+1). 
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Supplementary Figure 3.9 | Transcription of the entire chromosome ten left subtelomere 
during invasion. Normalized read alignment tracks across the subtelomeric upsB-type PfEMP1 
encoding var gene (Pf3D7_1000100) and chromosome ten left subtelomeric TARE region. The 
annotated Pf3D7_1000100 gene model is shown in dark blue, and assembled transcript models 
are shown in light green and light blue. Reads from each 56-hour time course sample mapping to 
the (-) strand are shown below each horizontal axis in light green, while reads mapping to the (+) 
strand are shown above each horizontal axis in light blue. Intron reads are shown in purple. 
Uniqueness of 100mers is plotted in red as a mappability track. Boundaries of the telomere, 
TAREs 1-5, and Rep20 are shown in purple as well. 
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Supplementary Figure 3.10 | Experimental confirmation of five additional P. falciparum 
circRNAs. (A)/(B) Divergent and convergent PCR reactions, respectively, for the nine tested 
loci using gDNA, water (h20), and cDNA prepared from either time-course (cDNA1/2). Ladder 
and divergent amplicon sizes are indicated. We gel-excised and sequenced each boxed amplicon. 
White boxes indicate amplicons of the expected size with positive Sanger sequencing 
confirmation. The red box indicates a non-specific amplicon (according to sequencing results). 
Smaller amplicon sizes in the convergent cDNA reactions as compared to the convergent gDNA 
reactions corresponded to intron removal. The larger products in the divergent cDNA reactions 
may represent non-specific or rolling-circle reverse transcription products. (C) Sanger 
sequencing across five additional circRNA splice junctions. 
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Supplementary Figure 3.11 | Overlap with a previously described bidirectional gene set. 
Comparing our bidirectional (sense and antisense producing) gene set to the Siegel et al. 
bidirectional gene set indicated significant differences [2]. However, the Siegel et al. study only 
included four time-points, which could account for the 202 novel genes found here. The Siegel et 
al. study also did not involve assembly of transcript structures, and we required assembled 
transcript structures to be supported by at least fifty (perfectly and uniquely) mapped reads in a 
single sample. Our use of different methods and a higher threshold for expression may account 
for the 975 genes predicted by Siegel et al. only. Indeed, we calculated that the average 
maximum RPKM of “stringent” antisense regions reported by Siegel et al. was 4, while the 
average maximum FPKM of our antisense transcripts was 25. The FPKM (fragment) 
measurements reported by Cufflinks are analgous to single-end RPKM (read) measurements [3]. 
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Supplementary Figure 3.12 | Maximum antisense expression level does not strongly 
correlate with maximum sense expression level. Each point represents a bidirectionally 
transcribed (sense and antisense) gene. We compared maximum sense and antisense transcript 
levels during the 56-hour time course. Expression is plotted in units of log2(FPKM+1). 
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Supplementary Figure 3.13 | Stage-specificity of P. falciparum lncRNAs as compared to 
mRNAs. (A) The distribution of specificity scores for each transcript class indicated that 
intergenic lncRNAs (red) and antisense RNAs (blue) typically had higher specificity scores than 
annotated mRNAs (black). However, when we considered only lowly expressed mRNAs, we 
found that the 1619 annotated mRNAs with an average FPKM of less than 20 (orange) had a 
comparable distribution of specificity scores to lncRNAs. (B) As in panel A, except that the 
cumulative distribution of specificity scores is plotted. 
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Supplementary Protocol 3.1 | Strand-specific, non-polyA-selected P. falciparum library 
preparation protocol 
 
0.  DNASE TREATMENT 
 
Reagents: 
1.  Up to 42 uL total RNA 
2.  Ambion TURBO DNase (order new lot, or ensure < 6 months old) 
3.  10X TURBO DNase Buffer 
4.  Ambion SUPERase-In (20 U/uL) 
5.  Invitrogen RNaseOUT (40 U/uL) 
6.  Agencourt RNAclean SPRI beads 
7.  Freshly prepared 75% Ethanol 
8.  (optional) Agilent Bioanalyzer RNA 6000 Pico Kit 
 
Protocol: 
**Decontaminate work space, work quickly, and maintain RNase-free** 
1.  Combine the following in a PCR tube-strip: 
___ uL  total RNA 
___ uL  H20 
5 uL  10X TURBO DNase Buffer  
1 uL   SUPERase-In 
1 uL   RNaseOUT 
1 uL  TURBO DNase 
50 uL   
2.  Incubate at room temperature for 30 minutes and proceed immediately to clean up to stop 
reaction 
3.  1.8X RNAclean SPRI bead purification in 96-well plate 
a.  Equilibrate beads to room temperature for 30 minutes, vortex bead slurry thoroughly 
before adding to RNA and pipette beads slowly to avoid forming air bubbles 
b.  Transfer 50 uL reaction to 96-well plate, add 90 uL beads, and immediately pipette 
mixture 10 times upon bead addition 
c.  Seal plate and incubate at room temperature for 20 minutes 
d.  Separate beads on magnet for 5 minutes or until solution appears clear 
e.  Remove and discard supernatant 
f.  Keeping plate on magnetic rack, wash the beads in 200 uL freshly prepared 75% 
Ethanol for at least 30 seconds 
g.  Carefully remove and discard ethanol without disturbing pellet and repeat the process 
for a total of 2 washes 
h.  Allow beads to air dry for 10 minutes (ensure no ethanol traces remain) 
i.  Resuspend beads in 30 uL h20 and incubate at room temperature for 5 minutes  
j.  Separate beads on magnet for 5 minutes or until solution appears clear 
k.  Carefully transfer 26-28 uL fragmented RNA to new tube/plate 
4.  Proceed immediately to Ribosomal RNA depletion 
5.  Recommended: save 1 uL aliquot of RNA to check RNA quality using an Agilent 
Bioanalyzer RNA 6000 Pico Kit 	 ﾠ
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Supplementary Protocol 3.1 (Continued) | Strand-specific, non-polyA-selected P. 
falciparum library preparation protocol 
 
2. RIBOSOMAL RNA DEPLETION 
 
Reagents:  
1.  1-5 ug DNase-treated RNA (cleaned up, in RNase-free h20) 
a.  26 uL maximum volume (for 2.5-5 ug) or 28 uL for < 2.5 ug input 
2.  Epicentre Ribo-Zero Magnetic Kit (Human/Mouse/Rat) 
3.  Heating block for 1.5 mL tubes, set to 50⁰C 
4.  Agencourt RNAclean SPRI beads 
5.  Freshly prepared 75% Ethanol 
6.  (optional) Agilent Bioanalyzer RNA 6000 Pico Kit 
 
Protocol: 
**Decontaminate work space, work quickly, and maintain RNase-free** 
1.  Equilibrate Ribo-Zero Magnetic Core Kit components to room temperature for 30 minutes  
2.  Remove the Ribo-Zero rRNA Removal Kit from -80⁰C, thaw the tubes, and place on ice 
3.  Individual Magnetic Bead washing procedure: 
a.  Mix the Ribo-Zero Magnetic Beads by gentle vortexing 
b.  For each reaction, slowly pipette 225 uL of Ribo-Zero Magnetic Beads into a 1.5 mL 
RNase-free tube. Store unused beads at 4⁰C 
c.  Separate beads on magnet for 5 minutes or until solution appears clear 
d.  With the tube still on the stand, remove and discard the supernatant 
e.  Remove the tube from stand and add 225 uL of RNase-free h20. Mix well by 
vortexing at medium speed 
f.  Repeat steps c and d and remove the tube from the magnetic stand 
g.  Add 65 uL of Ribo-Zero Magnetic Bead Suspension Solution to each tube. Mix well 
by vortexing at medium speed 
h.  Add 1 uL of RiboGuard RNase Inhibitor to each tube of resuspended Magnetic 
Beads. Mix briefly by vortexing.  
i.  Store at room temperature until required in step 5 
4.  Treatment of total RNA with Ribo-Zero rRNA Removal Solution 
a.  In a PCR tube-strip combine the following: 
*If < 2.5 ug total RNA, adjust Ribo-Zero rRNA Removal Solution to 8 uL 
 
b.  Gently mix the reaction(s) by pipetting and incubate at 68⁰C for 10 minutes 
c.  Store the remaining Ribo-Zero rRNA Removal Solution and Reaction Buffer at -80⁰C 
d.  Remove the reaction tubes and incubate at room temperature for 5 minutes.  
_____ uL   h20 
4 uL  Ribo-Zero Reaction Buffer 
_____ uL  2.5-5 ug total RNA sample* 
10 uL  Ribo-Zero rRNA Removal Solution 
40 uL     	 ﾠ
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Supplementary Protocol 3.1 (Continued) | Strand-specific, non-polyA-selected P. 
falciparum library preparation protocol 
 
 
5.  Magnetic Bead Reaction and rRNA Removal 
a.  Using a pipette, add the treated RNA from step 4 to the 1.5 mL tube containing the 
washed Magnetic Beads and immediately mix by pipetting at least 10 times. Then, 
vortex at medium setting for 10 seconds and place at room temperature 
b.  Incubate the 1.5 mL tube at room temperature for 5 minutes 
c.  Following incubation, mix the reations by vortexing at medium speed for 5 seconds 
and then place tube in heat block set to 50⁰C for exactly 5 minutes.  
d.  Immediately transfer tube to magnetic stand and allow beads to separate for 5 minutes 
or until solution appears clear 
e.  Carefully remove each supernatant (~90 uL) containing the RNA and transfer to a 
NEW RNase-free tube 
i.   The supernatant contains the rRNA-depleted RNA  
f.  Place the supernatant (RNA solution) on ice and immediately proceed to cleanup 
6.  1.8X RNAclean SPRI bead purification 
a.  Equilibrate beads to room temperature for 30 minutes, vortex bead slurry thoroughly 
before adding to RNA and pipette beads slowly to avoid forming air bubbles 
b.  In 1.5mL tube combine 90uL RNA + 162 uL beads, immediately pipette mixture 10 
times upon bead addition 
c.  Close cap and incubate at room temperature for 20 minutes 
d.  Separate beads on magnet for 5 minutes or until solution appears clear 
e.  Remove and discard supernatant 
f.  Keeping tubes on magnetic rack, wash the beads in 500 uL freshly prepared 75% 
Ethanol for at least 30 seconds 
g.  Carefully remove and discard ethanol without disturbing pellet and repeat the process 
for a total of 2 washes 
h.  Allow beads to air dry for 10 minutes (ensure no ethanol traces remain) 
i.  Resuspend beads in 21 uL h20 and incubate at room temperature for 5 minutes 
j.  Separate beads on magnet for 5 minutes or until solution appears clear 
k.  Carefully transfer 18 uL Ribo-Zero’d RNA to new tube/plate 
7.  Proceed immediately to RNA fragmentation 
8.  Recommended: save 1 uL aliquot of Ribo-Zero’d RNA to check ribosomal RNA depletion 
using an Agilent Bioanalyzer RNA Pico 6000 kit 
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Supplementary Protocol 3.1 (Continued) | Strand-specific, non-polyA-selected P. 
falciparum library preparation protocol 
 
3. RNA FRAGMENTATION 
 
Reagents: 
1.  18 uL DNase-treated, rRNA-depleted RNA (cleaned up, in h20) 
2.  NEB Mg
2+ Fragmentation Buffer 
3.  Agencourt RNAclean SPRI beads 
4.  Freshly prepared 75% Ethanol 
5.  (optional) Agilent Bioanalyzer RNA 6000 Pico Kit 
 
Protocol:  
**Decontaminate work space, work quickly, and maintain RNase-free techniques** 
1.  Combine in PCR-tube strip:  
2.  I
n
c
u
b
ate in PTC-225 DNA Engine Tetrad (MJ Research) thermocycler at 85⁰C for 8 minutes (YES 
heated lid) and transfer immediately to ice 
a.  8 minutes yields fragments 100-1000 bp in length; 300 bp average. Increasing time 
will shift distribution towards smaller fragments.  
b.  Place in thermocycler exactly as lid reaches 85⁰C 
c.  Remove and place on ice exactly when begins to lower temperature 
d.  Proceed immediately to cleanup to STOP reaction 
3.  1.8X RNAclean SPRI bead purification 
a.  Equilibrate beads to room temperature for 30 minutes, vortex bead slurry thoroughly 
before adding to RNA and pipette beads slowly to avoid forming air bubbles 
b.  Transfer 20 uL reaction to 96-well plate, add 36 uL beads, and immediately pipette 
mixture 10 times upon bead addition 
c.  Seal plate and incubate at room temperature for 20 minutes 
d.  Separate beads on magnet for 5 minutes or until solution appears clear 
e.  Remove and discard supernatant 
f.  Keeping plate on magnetic rack, wash the beads in 200 uL freshly prepared 75% 
Ethanol for at least 30 seconds 
g.  Carefully remove and discard ethanol without disturbing pellet and repeat the process 
for a total of 2 washes 
h.  Allow beads to air dry for 10 minutes (ensure no ethanol traces remain) 
i.  Resuspend beads in 9 uL h20 and incubate at room temperature for 5 minutes  
j.  Separate beads on magnet for 5 minutes or until solution appears clear 
k.  Carefully transfer 7 uL Fragmented RNA to new tube/plate 
4.  Proceed immediately to First-Strand Synthesis (FSS) 
5.  Recommended: save 1 uL aliquot of RNA to check fragmentation using an Agilent 
Bioanalyzer RNA Pico 6000 Kit 
18 uL  DNase’d RNA 
2 uL  NEB Mg
2+ Frag Buffer 
20 uL   	 ﾠ
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Supplementary Protocol 3.1 (Continued) | Strand-specific, non-polyA-selected P. 
falciparum library preparation protocol 
 
4. First Strand Synthesis (FSS) 
 
Reagents: 
1.  7 uL Fragmented RNA (cleaned-up, in h20) 
2.  Invitrogen 5X FS buffer 
3.  3 ug/uL random primers **see Special Notes section** 
4.  10 mM dNTP mix 
5.  100 mM DTT 
6.  Invitrogen Superscript III 
7.  Invitrogen RNaseOUT (40 U/uL) 
8.  Actinomycin D solution (1 ug/uL) **see Special Notes section** 
9.  Agencourt RNAclean SPRI beads 
10. Bio-Rad Micro Bio-Spin P-30 columns, Tris buffer (RNase-free) 
11. Freshly prepared 75% Ethanol 
12. (optional) Agilent Bioanalyzer RNA 6000 Pico Kit 
 
Protocol: 
1.  Combine the following in a PCR tube-strip: 
 
7 uL  Fragmented RNA 
1 uL  3 ug/uL custom random primers  
1 uL  10mM dNTP mix 
9 uL   
 
2.  Gently vortex and spin down 
3.  Incubate at 65⁰C for 5 min in a PTC-225 DNA Engine Tetrad (MJ Research) thermocycler 
and transfer immediately to ice for 5 minutes 
4.  Add the following components to the reaction on ice: 
  
4 uL  5X FS Buffer 
1 uL  100 mM DTT 
4 uL  1 ug/uL Actinomycin D solution 
1 uL  RNaseOUT 
1 uL  Superscript III (200 U)  
11 uL   
 
5.  Incubate in PTC-225 DNA Engine Tetrad (MJ Research) thermocycler:  
a.  Set ramp speed for each transition to .1⁰C/second, YES heated lid 
i.  5⁰C – 5 minutes 
ii.  10⁰C – 5 minutes 
iii.  15⁰C – 5 minutes 
iv.  20⁰C – 5 minutes 	 ﾠ
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v.  25⁰C – 5 minutes 
vi.  30⁰C – 5 minutes 
vii.  35⁰C – 5 minutes 
viii.  42⁰C – 30 minutes ￟ optional: @ 30” + 1uL SSIII (200 U) 
ix.  45⁰C – 10 minutes 
x.  50⁰C – 10 minutes 
xi.  55⁰C – 10 minutes 
xii.  Hold at 4⁰C forever  
xiii.  DO NOT HEAT KILL ENZYME 
6.  Raise reaction volume to 50 uL by adding 30 uL h20 
7.  Clean-up with Micro Bio-Spin P-30 RNase-free column to remove dNTPs/ActD 
a.  Obtain columns from 4⁰C cold room (check that < 1yr old) 
b.  Forcefully invert column 10 times whilst flicking to remove air bubbles 
c.  Snap off fret and remove cap 
d.  Let column drain for 3 minutes or until visibly drained 
e.  Dump drained buffer and spin in supplied collection tube at 1000 x g for 2 minutes  
f.  Place column in a new RNase-free collection tube (labeled appropriately) 
g.  Load 50 uL sample to center of gel bed without disturbing it 
h.  Spin at 1000 x g for 4 minutes (orient tubes as in previous spin) 
i.  Sample is now in 10 mM Tris-HCl, pH 7.4 
8.  1.8X RNAclean SPRI bead purification to remove primers (+dNTPs/ActD) 
a.  Equilibrate beads to room temperature for 30 minutes, vortex bead slurry thoroughly 
before adding to RNA and pipette beads slowly to avoid forming air bubbles 
b.  Check that ~45 uL reaction remains in 1.5 mL tube, add ~80 uL beads, and 
immediately pipette mixture 10 times upon bead addition 
c.  Close cap and incubate at room temperature for 30 minutes 
d.  Separate beads on magnet for 5 minutes or until solution appears clear 
e.  Remove and discard supernatant 
f.  Keeping plate on magnetic rack, wash the beads in 500 uL freshly prepared 75% 
Ethanol for at least 30 seconds 
g.  Carefully remove and discard ethanol without disturbing pellet and repeat the process 
for a total of 2 washes 
h.  Allow beads to air dry for 10 minutes (ensure no ethanol traces remain) 
i.  Resuspend beads in 95 uL h20 and incubate at room temperature for 5 minutes  
j.  Separate beads on magnet for 5 minutes or until solution appears clear 
k.  Carefully transfer 88 uL RNA:cDNA hybrid to new tube/plate 
9.  Proceed immediately to Second-Strand Synthesis (SSS) 
10. Recommended: save 1 uL aliquot of RNA:cDNA hybrid to check yield/size 
distribution/primer removal using an Agilent Bioanalyzer RNA Pico 6000 Kit 
11. Recommended: save remainder of RNA:cDNA hybrid (~5 uL) for qPCR QC check  
a.  Check genomic DNA removal using (–) enzyme control 
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Supplementary Protocol 3.1 (Continued) | Strand-specific, non-polyA-selected P. 
falciparum library preparation protocol 
 
5. Second Strand Synthesis 
 
Reagents:  
1.  88 uL RNA:cDNA hybrid (cleaned up 2X, in h20)  
2.  Invitrogen 5X FS Buffer 
3.  100 mM DTT 
4.  Fermentas 2mM dACG-TP/4mM dU-TP mix 
5.  Invitrogen 5X SS Buffer 
6.  E. coli DNA ligase (10U/uL) 
7.  E. coli DNA polymerase (10U/uL) 
8.  E. coli RNase H (2U/uL) 
9.  0.5 M EDTA 
10. Agencourt AmpureXP SPRI beads 
11. Qiagen Buffer EB 
12. Freshly prepared 75% Ethanol 
13. (optional) Agilent Bioanalyzer High Sensitivity DNA Kit 
 
Protocol:  
2.  Combine the following in a PCR tube-strip:  
 
88 uL  cDNA:RNA hybrid 
4 uL  5X FS Buffer 
2 uL  100 mM DTT 
20 uL  2 mM DACG-TP/dU-TP mix 
30 uL  5X SS Buffer 
1 uL  E. coli DNA ligase (10 U) 
4 uL  E. coli DNA polymerase (40 U) 
1 uL   E. coli RNase H (2 U) 
150 uL (+62 uL Master Mix)   
 
3.  Mix gently by pipetting and incubate at 15⁰C in PTC-225 DNA Engine Tetrad (MJ 
Research) thermocycler for 2 hours  
a.  Do not vortex 
b.  NO HEATED LID Do not let sample temperature raise above 16⁰C or DNA 
polymerase can strand displace 
c.  Transfer immediately to ice 
4.  Add 10 uL 0.5M EDTA to STOP reaction and proceed immediately to cleanup 
5.  1.8X AmpureXP SPRI bead purification  
a.  Equilibrate beads to room temperature for 30 minutes, vortex bead slurry thoroughly 
before adding to RNA and pipette beads slowly to avoid forming air bubbles 
b.  Transfer ~155 uL reaction to 1.5mL tube, add ~280 uL beads, and immediately 
pipette mixture 10 times upon bead addition 
c.  Close cap and incubate at room temperature for 10 minutes 	 ﾠ
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d.  Separate beads on magnet for 5 minutes or until solution appears clear 
e.  Remove and discard supernatant 
f.  Keeping plate on magnetic rack, wash the beads in 500 uL freshly prepared 75% 
Ethanol for at least 30 seconds 
g.  Carefully remove and discard ethanol without disturbing pellet and repeat the process 
for a total of 2 washes 
h.  Allow beads to air dry for 10 minutes (ensure no ethanol traces remain) 
i.  Resuspend beads in 88 uL Qiagen EB and incubate at room temperature for 5 
minutes  
j.  Separate beads on magnet for 5 minutes or until solution appears clear 
k.  Carefully transfer 85 uL dUTP-marked dsDNA to new tube/plate 
6.  *SAFE STOPPING POINT* 
a.  Proceed immediately to KAPA End Repair OR store dUTP-marked dsDNA at -20⁰C 
for up to 1 week 
7.  Recommended: save 1 uL aliquot of dUTP-marked dsDNA to check yield/size distribution 
using an Agilent Bioanalyzer HS DNA chip 
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Supplementary Protocol 3.1 (Continued) | Strand-specific, non-polyA-selected P. 
falciparum library preparation protocol 
 
6. KAPA End Repair 
 
Reagents:  
1.  85 uL dUTP-marked dsDNA (cleaned-up, in EB) 
2.  KAPA library prep kit 
3.  Agencourt AmpureXP SPRI beads 
4.  Qiagen Buffer EB 
5.  Freshly prepared 75% Ethanol 
 
Protocol:  
1.  Combine the following in a PCR tube strip:  
85 uL  dUTP-marked dsDNA 
10 uL  10X KAPA End Repair Buffer 
5 uL  KAPA End Repair Enzyme Mix* 
100 uL   
*15U T4 DNA Polymerase, 50U T4 Polynucleotide Kinase 
 
2.  Mix gently and incubate for 30 minutes at 20⁰C in PTC-225 DNA Engine Tetrad (MJ 
Research) thermocycler 
a.  No heated lid 
b.  Transfer to ice and proceed immediately to cleanup 
3.  1.8X AmpureXP SPRI bead purification 
a.  Equilibrate beads to room temperature for 30 minutes, vortex bead slurry thoroughly 
before adding to RNA and pipette beads slowly to avoid forming air bubbles 
b.  Transfer 100uL reaction to 1.5mL tube, add 180 uL beads, immediately pipette 
mixture 10 times upon bead addition 
c.  Close cap and incubate at room temperature for 10 minutes 
d.  Separate beads on magnet for 5 minutes or until solution appears clear 
e.  Remove and discard supernatant 
f.  Keeping tubes on magnetic rack, wash the beads in 500 uL freshly prepared 75% 
Ethanol for at least 30 seconds 
g.  Carefully remove and discard ethanol without disturbing pellet and repeat the process 
for a total of 2 washes 
h.  Allow beads to air dry for 10 minutes (ensure no ethanol traces remain) 
i.  Resuspend beads in 33 uL Qiagen EB and incubate at room temperature for 5 
minutes 
j.  Separate beads on magnet for 5 minutes or until solution appears clear 
k.  Carefully transfer 31 uL End-Repaired dsDNA to new tube/plate 
4.  *SAFE STOPPING POINT* 
a.  Proceed immediately to KAPA A-Tailing OR store End-Repaired dsDNA at -20⁰C 
for up to 1 week 
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Supplementary Protocol 3.1 (Continued) | Strand-specific, non-polyA-selected P. 
falciparum library preparation protocol 
 
7. KAPA A-Tailing 
 
Reagents:  
1.  30 uL End-Repaired dsDNA (cleaned-up, in EB) 
2.  KAPA library prep kit 
3.  Agencourt AmpureXP SPRI beads 
4.  Qiagen Buffer EB 
5.  Freshly prepared 75% Ethanol 
 
Protocol:  
1.  Combine the following in a PCR tube strip:  
30 uL  End-Repaired dsDNA 
12 uL  H20 
5 uL  10X KAPA A-Tailing Buffer* 
3 uL  KAPA A-Tailing Enzyme** 
50 uL   
*contains 2 mM dATP (.2 mM final) 
**15U 3’￠5’ exo
- klenow fragment 
2.  Mix gently and incubate for 30 minutes at 30⁰C in PTC-225 DNA Engine Tetrad (MJ 
Research) thermocycler 
a.  No heated lid 
b.  Transfer to ice and proceed immediately to cleanup 
3.  1.8X AmpureXP SPRI bead purification 
b.  Equilibrate beads to room temperature for 30 minutes, vortex bead slurry thoroughly 
before adding to RNA and pipette beads slowly to avoid forming air bubbles 
c.  Add 90 uL beads, immediately pipette mixture 10 times upon bead addition 
d.  Close cap and incubate at room temperature for 10 minutes 
e.  Separate beads on magnet for 5 minutes or until solution appears clear 
f.  Remove and discard supernatant 
g.  Keeping tubes on magnetic rack, wash the beads in 500 uL freshly prepared 75% 
Ethanol for at least 30 seconds 
h.  Carefully remove and discard ethanol without disturbing pellet and repeat the process 
for a total of 2 washes 
i.  Allow beads to air dry for 10 minutes (ensure no ethanol traces remain) 
j.  Resuspend beads in 33.5 uL Qiagen EB and incubate at room temperature for 5 
minutes 
k.  Separate beads on magnet for 5 minutes or until solution appears clear 
l.  Carefully transfer 31 uL A-Tailed dsDNA to new tube/plate 
4.  *SAFE STOPPING POINT* 
m. Proceed immediately to KAPA Adapter Ligation OR store A-Tailed dsDNA at -20⁰C 
for up to 1 week 
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Supplementary Protocol 3.1 (Continued) | Strand-specific, non-polyA-selected P. 
falciparum library preparation protocol 
 
8. KAPA Adapter Ligation 
 
Reagents:  
1.  30 uL A-Tailed dsDNA (cleaned-up, in EB) 
2.  KAPA library prep kit 
3.  15 uM Barcoded Y-Adapters 
4.  Agencourt AmpureXP SPRI beads 
5.  Qiagen Buffer EB 
6.  Freshly prepared 75% Ethanol 
 
Protocol:  
**Change gloves/clean pipette every time handle different adapter** 
1.  Dilute adapters approximately 1:10 in h20 (1.5 uM final). See calculation below.  
2.  Combine the following in a PCR tube strip:  
 
30 uL  A-Tailed dsDNA 
10 uL  5X KAPA Ligation Buffer* 
5 uL   1.5 uM Barcoded Y-Adapter 
#_____________ 
5 uL  KAPA Ligation Enzyme Mix** 
50 uL   
*Contains 30% PEG 6000 (6% final). Raising PEG concentration lowers SPRI bead size 
selection (i.e. smaller fragments elute off beads than normal) 
**30,000U T4 DNA Ligase 
***Calculate molar ratio of dsDNA target:Adapter to ensure in the 1:15 regime. Remember that 
each dsDNA fragment represents 2 targets for adapter ligation but that ER/A-tailing is not 100% 
efficient…. If assume 50% efficiency these scaling factors cancel each other out. Example 
calculation:  
(30 ng A-Tailed dsDNA, 300 bp)*(1 mole/300bp*650g) = 1.54 * 10
-4 nmoles 
(5uL * 1.5 uM Adapters)*(L/10
6 uL) = 2.5 * 10
-3 nmoles  
~1:15 
 
3.  Mix gently and incubate for 15 minutes at 20⁰C in PTC-225 DNA Engine Tetrad (MJ 
Research) thermocycler 
n.  No heated lid 
o.  Transfer immediately to ice 
4.  Proceed immediately to SPRI Bead Adapter removal 
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Supplementary Protocol 3.1 (Continued) | Strand-specific, non-polyA-selected P. 
falciparum library preparation protocol 
 
9. SPRI Bead Adapter Removal 
 
Reagents: 
1.  50 uL Adapter-Ligated dsDNA 
2.  Agencourt AmpureXP SPRI beads 
3.  Qiagen Buffer EB 
4.  Freshly prepared 75% Ethanol 
5.  (optional) Agilent Bioanalyzer High Sensitivity DNA Kit 
 
Protocol: 
1.  1.0X AmpureXP SPRI bead purification 
a.  Equilibrate beads to room temperature for 30 minutes, vortex bead slurry thoroughly 
before adding to RNA and pipette beads slowly to avoid forming air bubbles 
b.  Add 50 uL beads, immediately pipette mixture 10 times upon bead addition 
c.  Close cap and incubate at room temperature for 15 minutes 
d.  Separate beads on magnet for 5 minutes or until solution appears clear 
e.  Remove and discard supernatant 
f.  Keeping tubes on magnetic rack, wash the beads in 500 uL freshly prepared 75% 
Ethanol for at least 30 seconds 
g.  Carefully remove and discard ethanol without disturbing pellet and repeat the process 
for a total of 2 washes 
h.  Allow beads to air dry for 15 minutes (ensure no ethanol traces remain) 
i.  Resuspend beads in 22 uL Qiagen EB and incubate at room temperature for 5 
minutes 
j.  Separate beads on magnet for 5 minutes or until solution appears clear 
k.  Carefully transfer 20 uL Adapter-Ligated dsDNA to new tube/plate 
2.  *SAFE STOPPING POINT* 
a.  Proceed immediately to USER digestion OR store Adapter-Ligated dsDNA at -20⁰C 
for up to 1 week 
3.  Recommended: save 1 uL aliquot of Adapter-Ligated dsDNA to check yield/size 
distribution/adapter dimer contamination using an Agilent Bioanalyzer HS DNA chip.  
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Supplementary Protocol 3.1 (Continued) | Strand-specific, non-polyA-selected P. 
falciparum library preparation protocol 
 
10. USER digestion (DO NOT FORGET TO DIGEST dUTP-marked strand) 
 
Reagents:  
1.  47 uL Adapter-ligated dsDNA (cleaned up 1X or 2X) 
2.  NEB USER (Uracil-Specific Excision Reagent) enzyme (1U/uL) 
3.  (optional) Agilent Bioanalyzer RNA Pico Kit 
4.  (optional) Agilent Bioanalyzer High Sensitivity DNA Kit 
 
Protocol:  
1.  Add 1 uL USER enzyme to each reaction 
2.  Incubate at 37⁰C for 30 minutes, followed by 25⁰C for 15 minutes 
a.  USER is not heat inactivated 
b.  Yes heated lid 
3.  *SAFE STOPPING POINT* 
a.  Proceed immediately to KAPA Real-Time PCR Amplification OR store USER-
digested ssDNA at -20⁰C 
4.  Recommended: save 1 uL aliquot of USER-digested ssDNA to check yield/size 
distribution/adapter dimer contamination using an Agilent Bioanalyzer RNA Pico 6000 Kit 
5.  Recommended: save 1 uL aliquot of USER-digested ssDNA to check second strand digestion 
using an Agilent Bioanalyzer HS DNA chip 
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Supplementary Protocol 3.1 (Continued) | Strand-specific, non-polyA-selected P. 
falciparum library preparation protocol 
 
11. KAPA Real-Time PCR Amplification 
 
Reagents:  
1.  9 uL USER-digested ssDNA (~1/5 reaction used as input) 
2.  KAPA real-time library amplification kit 
3.  12.5 uM each Forward and Reverse Indexing PCR Primer Mix 
4.  Agencourt AmpureXP SPRI beads 
5.  Qiagen Buffer EB 
6.  Freshly prepared 75% Ethanol 
7.  Agilent Bioanalyzer High Sensitivity DNA Kit 
 
Protocol:  
1.  Add 65uL of fluorescence references 1-4 to a 96-well plate 
2.  Combine the following for each library in 96-well plate: 
 
9 uL  ssDNA sample (USER-digested) 
2 uL  F&R Indexing PCR Primer Mix* 
11 uL  2X KAPA HiFi SYBR/Rox qPCR Mix 
22 uL   
*1 uM each (final) 
 
3.  Seal, vortex and spin down plate 
4.  Transfer 3 X 20 uL of each reference to a 384-well plate using multi-channel pipette 
5.  Add 20 uL of each library to 384-well plate 
6.  Seal and spin down plate 
a.  Ensure no debris or air bubbles 
7.  Thermocycle on ABI 7900 Real-Time PCR Machine with following program 
a.  98⁰C – 2 minutes 
b.  20 cycles:  
i.  98⁰C – 20 seconds 
ii.  55⁰C* – 180 seconds 
   *Optimal annealing at 55⁰C for BROAD indexing PCR primers 
iii.  55⁰C – 10 seconds DATA ACQUISITION 
8.  SIT IN ROOM AND WATCH THE PCR MACHINE THE ENTIRE TIME TO STOP 
REACTION WHEN LIBRARY BETWEEN REFERENCE 1 and 3  
a.  Must stop during data acquisition phase before machine ramps to 98⁰C 
b.  The less PCR cycles the better. Do not over-cycle.  
c.  If expect vastly different yields, amplify libraries individually or perform a diagnostic 
amplification and repeat with normalized sample input.  
9.  1.0X AmpureXP SPRI bead purification 
a.  Equilibrate beads to room temperature for 30 minutes, vortex bead slurry thoroughly 
before adding to RNA and pipette beads slowly to avoid forming air bubbles 	 ﾠ
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b.  Transfer 20uL reaction to 96-well plate, add 20uL beads, immediately pipette mixture 
10 times upon bead addition 
c.  Seal plate and incubate at room temperature for 10 minutes 
d.  Separate beads on magnet for 5 minutes or until solution appears clear 
e.  Remove and discard supernatant 
f.  Keeping plate on magnetic rack, wash the beads in 200 uL freshly prepared 75% 
Ethanol for at least 30 seconds 
g.  Carefully remove and discard ethanol without disturbing pellet and repeat the process 
for a total of 2 washes 
h.  Allow beads to air dry for 10 minutes (ensure no ethanol traces remain) 
i.  Resuspend beads in 25 uL Qiagen EB and incubate at room temperature for 5 
minutes 
j.  Separate beads on magnet for 5 minutes or until solution appears clear 
k.  Carefully transfer 22.5 uL PCR-amplified dsDNA to new tube/plate 
6.  *SAFE STOPPING POINT* 
a.  Proceed immediately to KAPA Library Quantification OR store PCR-amplified 
dsDNA at -20⁰C 
7.  Recommended: save 1 uL aliquot of PCR-amplified final library to check yield/size 
distribution/adapter dimer contamination using an Agilent Bioanalyzer HS DNA chip. If 
necessary, repeat 1.0X AmpureXP SPRI bead purification to further remove adapter dimers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
**Special Notes** 
 
*Ideally, custom order 76% AT-biased random hexamers to reflect the approximate AT 
balance of the P. falciparum transcriptome.  
 
*Prepare the Actinomycin D solution freshly in water, keep it protected from light, and 
handle it with caution, as ActD is highly toxic. Verify the concentration of ActD solution 
using Beer’s law immediately prior to use. Chilling the ActD solution may increase solubility 
(!).  	 ﾠ
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Supplementary Table 3.1 | Sequencing metrics.  
Sample 
ID 
Lane  Lane 
type 
Read 
length 
Total reads  Pass filter 
(PF) reads 
PF 
reads % 
Strand 
balance % 
R  1  Paired  101  36,309,330  34,716,924  95.61  50 
ET  1  Paired  101  33,627,496  32,208,510  95.78  50 
LT  1  Paired  101  34,634,574  33,184,560  95.81  49.98 
S  1  Paired  101  36,181,466  34,686,070  95.87  49.96 
T6  1  Paired  101  35,928,966  34,401,300  95.75  50.02 
T14  1  Paired  101  40,993,176  39,174,956  95.56  50.01 
T20  1  Paired  101  41,758,410  39,868,948  95.48  50.01 
T24  2  Paired  101  41,510,498  38,772,456  93.4  50.02 
T28  2  Paired  101  49,140,432  45,863,464  93.33  50 
T32  2  Paired  101  43,502,870  40,844,278  93.89  49.98 
T36  2  Paired  101  48,691,486  45,536,284  93.52  49.99 
T40  2  Paired  101  44,405,570  41,662,908  93.82  49.98 
T44  2  Paired  101  44,358,344  41,491,020  93.54  49.98 
T48  2  Paired  101  40,561,706  37,815,894  93.23  49.99 
TT8  2  Paired  101  41,977,026  38,868,142  92.59  50 
 
Strand 
balance % 
Read pair 
duplicates 
Duplicate 
% 
Estimated 
library size 
Median 
insert 
size 
Mean 
insert 
size 
Adapter 
% 
50  5,995,382  35.12  18,865,157  205  233  0.0031 
50  4,803,198  30.49  21,127,976  213  243  0.003 
49.98  5,645,437  35.03  17,904,375  210  239  0.0073 
49.96  6,863,514  40.54  15,201,954  207  235  0.0109 
50.02  9,398,673  57.61  8,052,612  201  224  0.1125 
50.01  5,644,712  32.35  21,713,241  196  222  0.0877 
50.01  5,263,531  28.23  28,001,255  206  232  0.0088 
50.02  5,788,680  30.34  25,968,555  208  233  0.0032 
50  5,536,468  24.65  40,272,749  206  234  0.0006 
49.98  5,672,423  28.61  29,489,373  206  235  0.0014 
49.99  5,634,662  25.13  39,166,904  207  234  0.0004 
49.98  5,999,535  29.15  29,527,040  205  233  0.0004 
49.98  6,405,193  31.19  26,937,480  210  238  0.0007 
49.99  8,133,834  42.85  15,676,773  214  241  0.0013 
50  5,321,991  34.06  18,135,700  199  225  0.0101 
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Supplementary Table 3.2 | Aligned read metrics.  
Sample 
ID 
Uniquely 
aligned reads 
Aligned 
reads % 
Reads 
aligned to 
sense % 
rRNA 
% 
Mean 
insert size 
rRNA-
filtered 
mean GC 
% 
R  23,076,722  63.56  99.32  13.44  205  27.59 
ET  22,241,738  66.14  99.50  10.94  212  27.42 
LT  22,537,304  65.07  99.07  10.14  209  28.10 
S  23,455,234  64.83  99.14  12.82  208  27.60 
T6  22,038,452  61.34  99.28  6.55  203  25.38 
T14  24,359,556  59.42  99.19  4.88  203  25.74 
T20  25,137,560  60.20  99.26  9.37  206  24.95 
T24  25,185,524  60.67  99.48  12.72  209  24.91 
T28  30,428,074  61.92  99.40  6.33  208  24.85 
T32  26,377,500  60.63  99.28  9.83  206  24.66 
T36  30,713,000  63.08  99.42  7.56  209  24.57 
T40  27,681,836  62.34  99.42  10.11  208  24.90 
T44  27,825,036  62.73  99.44  5.62  207  25.02 
T48  24,889,826  61.36  99.81  18.32  210  26.15 
TT8  20,498,156  48.83  98.92  3.26  201  25.31 
 
Exonic 
% 
Intronic 
% 
Intergenic 
% 
Top 2000 
genes CV 
Top 2000 
genes gap % 
Top 1000 
genes CV 
Top 4000 
genes CV 
87.30  6.90  5.80  0.26  0.1  0.24  0.33 
89.60  6.70  3.60  0.32  0.1  0.28  0.39 
86.60  8.90  4.50  0.32  0.1  0.29  0.41 
89.50  6.70  3.70  0.33  0.1  0.31  0.39 
87.50  6.00  6.50  0.29  0.4  0.26  0.33 
83.50  8.60  7.80  0.27  0.1  0.25  0.33 
82.40  8.60  9.00  0.24  0.1  0.23  0.32 
86.60  6.90  6.60  0.25  0.1  0.24  0.31 
84.70  7.40  7.90  0.23  0  0.23  0.26 
83.50  9.10  7.40  0.25  0.1  0.24  0.28 
86.60  7.10  6.30  0.25  0.1  0.24  0.27 
87.00  6.90  6.20  0.25  0.1  0.24  0.28 
86.20  6.90  6.90  0.27  0.2  0.26  0.3 
90.90  5.20  3.90  0.31  0.5  0.29  0.36 
82.50  8.10  9.40  0.27  0.1  0.26  0.33 
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Supplementary Table 3.3 | GO term enrichment results.  
Ring-specific GO term 
Ring-specific  
GO term  
p-value 
cell-cell adhesion  4.95E-18 
rosetting  1.93E-17 
heterophilic cell adhesion  1.93E-17 
adhesion to other organism during symbiotic interaction  3.16E-16 
cytoadherence to microvasculature, mediated by parasite protein  3.16E-16 
adhesion to host  3.16E-16 
cell adhesion  4.42E-16 
biological adhesion  6.31E-15 
pathogenesis   4.88E-14 
interaction with host  5.28E-14 
gene expression   2.17E-11 
translation  3.14E-05 
RNA processing  0.000144 
macromolecule biosynthetic process  0.000146 
RNA metabolic process  0.00017 
ribosome biogenesis and assembly  0.000498 
 
Trophozoite-specific GO term 
Trophozoite-
specific  
GO term        
   p-value 
DNA replication  0.00105 
amino acid and derivative metabolic process  0.00105 
nitrogen compound metabolic process  0.00105 
carboxylic acid metabolic process  0.00105 
organic acid metabolic process  0.00105 
amine metabolic process  0.00105 
amino acid metabolic process  0.00124 
biosynthetic process  0.00164 
protein folding  0.00342 
aldehyde metabolic process  0.00462 
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Supplementary Table 3.3 (Continued) | GO term enrichment results.  
Schizont-specific GO term 
Schizont-
specific  
GO term                  
p-value 
proteolysis  0.000000348 
DNA metabolic process  0.0000119 
DNA replication initiation  0.0000121 
protein catabolic process  0.0000234 
ubiquitin-dependent protein catabolic process  0.0000234 
post-translational protein modification  0.0000538 
biopolymer catabolic process  0.0000538 
modification-dependent protein catabolic process  0.0000593 
modification-dependent macromolecule catabolic process  0.0000593 
chromosome organization and biogenesis  0.000191 
chromatin assembly or disassembly  0.000202 
cellular protein catabolic process  0.000372 
proteolysis involved in cellular protein catabolic process  0.000372 
DNA packaging  0.000372 
tricarboxylic acid cycle  0.000668 
cellular respiration  0.000668 
aerobic respiration  0.000668 
coenzyme catabolic process  0.000668 
energy derivation by oxidation of organic compounds  0.000668 
acetyl-CoA catabolic process  0.000668 
cofactor catabolic process  0.000668 
establishment and/or maintenance of chromatin structure  0.000911 
cytoskeleton organization and biogenesis  0.00152 
chromatin assembly  0.00157 
acetyl-CoA metabolic process  0.00157 
localization  0.00183 
nucleosome organization  0.00183 
protein modification process  0.00183 
biopolymer modification  0.00218 
transport  0.00218 
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Supplementary Table 3.4 | Cufflinks assembled transcript property metrics.  
 
Cufflinks 
transcripts 
(excluding un-
annotated) 
Cufflinks 
RABT 
transcripts 
(excluding un-
annotated) 
PlasmoDBv10.0 
annotated 
transcripts 
Average Maximum FPKM  165  238  469 
Average average FPKM  57  83  164 
Average length  3223  2618  2197 
Average GC content  20.8%  24.0%  25.4% 
Single exon rate  46.6%  45.0%  47.8% 
Maximum exon count  32  34  34 
	 ﾠ
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Supplementary Table 3.5 | Putative P. falciparum circRNAs with at least five unique 
supporting reads.  
 
Chromosome  Start  Stop  Supporting 
reads 
Strand  Unique 
Supporting 
reads 
Length 
(genomic 
distance) 
Associated 
annotation             
(if applicable) 
Pf3D7_09_v3  913503  913614  216  +  123  111  PF3D7_092250
0  Pf3D7_11_v3  222005  222116  78  -  65  111  PF3D7_110500
0  Pf3D7_09_v3  421099  421330  71  -  56  231  PF3D7_090930
0  Pf3D7_14_v3  323890  324002  53  +  51  112  PF3D7_140860
0  Pf3D7_14_v3  1103004  1103104  72  +  51  100  PF3D7_142820
0  Pf3D7_11_v3  222005  222107  62  -  51  102  PF3D7_110500
0  Pf3D7_03_v3  315293  315518  63  -  51  225  PF3D7_030720
0  Pf3D7_08_v3  687808  687919  53  +  48  111  PF3D7_081420
0  Pf3D7_09_v3  270975  271110  58  -  46  135  PF3D7_090540
0  Pf3D7_10_v3  812336  812553  59  +  44  217  PF3D7_102000
0  Pf3D7_06_v3  1033279  1033401  45  -  41  122  PF3D7_062540
0  Pf3D7_14_v3  3036471  3037909  41  -  35  1438  PF3D7_147420
0  Pf3D7_06_v3  895390  895570  35  -  34  180  PF3D7_062190
0  Pf3D7_05_v3  1071423  1071531  34  +  31  108  PF3D7_052580
0  Pf3D7_02_v3  104059  104221  33  -  31  162  PF3D7_020200
0  Pf3D7_14_v3  2711332  2711437  33  +  30  105  PF3D7_146630
0  Pf3D7_06_v3  748384  748495  36  -  30  111  PF3D7_061780
0  Pf3D7_02_v3  306192  306309  35  -  29  117  PF3D7_020760
0  Pf3D7_06_v3  795729  795936  27  -  26  207  PF3D7_061900
0  Pf3D7_12_v3  162386  162496  30  -  26  110  PF3D7_120290
0  Pf3D7_13_v3  2187585  2187690  27  +  23  105  PF3D7_135510
0  Pf3D7_10_v3  1326738  1326897  26  -  23  159  PF3D7_103310
0  Pf3D7_14_v3  2455290  2455394  25  +  23  104  PF3D7_146010
0  Pf3D7_07_v3  717525  717677  36  +  22  152  PF3D7_071630
0  Pf3D7_10_v3  1425378  1425486  25  +  22  108  PF3D7_103590
0  Pf3D7_01_v3  342994  343120  21  +  20  126  PF3D7_010830
0  Pf3D7_05_v3  64833  64959  20  -  20  126  PF3D7_050120
0  Pf3D7_14_v3  1548535  1549065  23  +  20  530  PF3D7_143840
0  Pf3D7_10_v3  1421568  1421679  21  +  19  111  PF3D7_103580
0  Pf3D7_10_v3  1098805  1100490  21  -  19  1685  PF3D7_102600
0  Pf3D7_10_v3  1425330  1425486  21  +  19  156  PF3D7_103590
0  Pf3D7_02_v3  207222  207364  18  -  18  142  PF3D7_020470
0  Pf3D7_10_v3  341449  341557  21  +  18  108  PF3D7_100810
0  Pf3D7_04_v3  386297  386411  19  +  18  114  PF3D7_040780
0  Pf3D7_09_v3  1458815  1460208  21  +  18  1393  PF3D7_093680
0  Pf3D7_11_v3  235878  235982  18  -  18  104  PF3D7_110540
0  Pf3D7_14_v3  2825818  2825923  19  +  17  105  PF3D7_146870
0  Pf3D7_12_v3  148983  149369  20  -  16  386  PF3D7_050590
0  Pf3D7_02_v3  306204  306309  21  -  16  105  PF3D7_020760
0  Pf3D7_04_v3  666592  667254  19  +  16  662  PF3D7_041490
0  Pf3D7_14_v3  1016314  1016599  16  -  16  285  PF3D7_142600
0  Pf3D7_14_v3  799419  799576  18  -  16  157  PF3D7_141920
0  Pf3D7_10_v3  165230  165338  18  -  15  108  PF3D7_100360
0  Pf3D7_14_v3  323887  324002  15  +  15  115  PF3D7_140860
0  Pf3D7_11_v3  226728  226961  15  +  14  233  PF3D7_142790
0  Pf3D7_14_v3  1247670  1247938  14  +  14  268  PF3D7_143170
0  Pf3D7_14_v3  782077  782203  14  -  14  126  PF3D7_141880
0  Pf3D7_05_v3  713249  713364  16  -  14  115  PF3D7_051690
0  Pf3D7_09_v3  270825  271121  13  +  13  296  PF3D7_090540
0  Pf3D7_11_v3  815567  816356  23  -  13  789  PF3D7_112160
0  Pf3D7_13_v3  2052422  2052601  13  +  13  179  PF3D7_135140
0  Pf3D7_09_v3  1459118  1459313  15  +  13  195  PF3D7_093680
0  Pf3D7_13_v3  911758  911902  13  -  13  144  PF3D7_132190
0  Pf3D7_08_v3  687808  687934  13  +  12  126  PF3D7_081420
0   	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Supplementary Table 3.5 (Continued) | Putative P. falciparum circRNAs with at least five 
unique supporting reads.  
 
Pf3D7_14_v3  2091862  2091985  14  +  12  123  PF3D7_145110
0  Pf3D7_05_v3  1057813  1057951  16  +  12  138  PF3D7_052540
0  Pf3D7_11_v3  950736  950896  14  +  12  160  NA 
Pf3D7_06_v3  524430  525770  14  -  12  1340  PF3D7_061260
0  Pf3D7_07_v3  137323  137443  15  +  12  120  PF3D7_070350
0  Pf3D7_05_v3  317982  318099  12  -  12  117  PF3D7_050770
0  Pf3D7_04_v3  1059219  1059324  12  +  12  105  PF3D7_042350
0  Pf3D7_09_v3  1203756  1203881  11  +  11  125  PF3D7_093030
0  Pf3D7_09_v3  1204125  1204314  14  -  11  189  PF3D7_093030
0  Pf3D7_07_v3  277949  278054  13  -  11  105  PF3D7_070550
0  Pf3D7_08_v3  811462  812303  11  -  11  841  PF3D7_081770
0  Pf3D7_02_v3  766505  766638  13  -  11  133  PF3D7_021880
0  Pf3D7_08_v3  687961  688066  13  +  11  105  PF3D7_081420
0  Pf3D7_03_v3  706209  706371  11  -  10  162  PF3D7_031730
0  Pf3D7_09_v3  322819  322928  10  -  10  109  PF3D7_090660
0  Pf3D7_08_v3  433685  433822  10  +  10  137  PF3D7_080860
0  Pf3D7_04_v3  93202  93355  11  -  10  153  PF3D7_040160
0  Pf3D7_14_v3  1247677  1247778  12  +  10  101  PF3D7_143170
0  Pf3D7_09_v3  157500  157618  10  -  10  118  PF3D7_090340
0  Pf3D7_11_v3  1430964  1437008  10  -  10  6044  PF3D7_113650
0  Pf3D7_11_v3  353243  353363  10  +  10  120  PF3D7_110800
0  Pf3D7_10_v3  1141172  1141286  10  -  10  114  PF3D7_102730
0  Pf3D7_10_v3  107668  107776  13  -  10  108  PF3D7_100210
0  Pf3D7_13_v3  2062151  2062268  10  +  10  117  PF3D7_135170
0  Pf3D7_11_v3  1495268  1495406  13  +  10  138  PF3D7_113800
0  Pf3D7_07_v3  1330733  1330964  10  +  10  231  PF3D7_073090
0  Pf3D7_10_v3  81226  81543  11  -  10  317  PF3D7_100150
0  Pf3D7_05_v3  64815  64959  10  -  10  144  PF3D7_050120
0  Pf3D7_10_v3  1457144  1457246  11  -  10  102  PF3D7_103690
0  Pf3D7_13_v3  632574  633169  10  +  10  595  PF3D7_131490
0  Pf3D7_11_v3  1433155  1437008  10  -  10  3853  PF3D7_113650
0  Pf3D7_04_v3  762504  762606  11  +  10  102  PF3D7_041740
0  Pf3D7_09_v3  374890  375007  12  -  10  117  PF3D7_090810
0  Pf3D7_11_v3  1400498  1400631  10  -  10  133  PF3D7_113590
0  Pf3D7_14_v3  1995270  1995378  11  -  10  108  PF3D7_144850
0  Pf3D7_10_v3  1231525  1231627  12  -  10  102  PF3D7_103020
0  Pf3D7_04_v3  104555  104669  10  +  9  114  PF3D7_040180
0  Pf3D7_05_v3  64851  64959  10  -  9  108  PF3D7_050120
0  Pf3D7_08_v3  657346  657454  9  +  9  108  PF3D7_081330
0  Pf3D7_11_v3  543076  543599  12  -  9  523  PF3D7_111420
0  Pf3D7_06_v3  1172135  1173037  9  -  9  902  PF3D7_062830
0  Pf3D7_01_v3  414916  415025  9  -  9  109  PF3D7_011070
0  Pf3D7_14_v3  1844801  1844930  9  -  9  129  PF3D7_144480
0  Pf3D7_06_v3  748516  748651  9  -  9  135  PF3D7_061780
0  Pf3D7_09_v3  1427434  1427592  13  +  9  158  NA 
Pf3D7_04_v3  104555  104729  9  +  9  174  PF3D7_040180
0  Pf3D7_06_v3  1123636  1123741  19  -  9  105  PF3D7_062810
0  Pf3D7_09_v3  1176736  1176913  9  +  9  177  PF3D7_092940
0  Pf3D7_08_v3  687808  687961  11  +  9  153  PF3D7_081420
0  Pf3D7_05_v3  715867  715979  9  -  9  112  PF3D7_051700
0  Pf3D7_08_v3  1207128  1207236  10  -  9  108  PF3D7_082790
0  Pf3D7_08_v3  845195  847517  11  -  9  2322  PF3D7_081860
0  Pf3D7_13_v3  878362  878519  8  -  8  157  PF3D7_132130
0  Pf3D7_11_v3  1961815  1961941  8  +  8  126  PF3D7_120260
0  Pf3D7_06_v3  1171201  1171973  9  -  8  772  PF3D7_062830
0  Pf3D7_07_v3  339644  339767  8  +  8  123  PF3D7_070730
0  Pf3D7_13_v3  151216  151342  8  -  8  126  PF3D7_130280
0  Pf3D7_07_v3  274413  274527  8  -  8  114  PF3D7_070550 
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Supplementary Table 3.5 (Continued) | Putative P. falciparum circRNAs with at least five 
unique supporting reads.  
 
Pf3D7_08_v3  687919  688054  8  +  8  135  PF3D7_081420
0  Pf3D7_02_v3  800822  800930  8  +  8  108  PF3D7_022000
0  Pf3D7_06_v3  768777  768956  8  +  8  179  PF3D7_061830
0  Pf3D7_11_v3  139852  139989  9  -  8  137  NA 
Pf3D7_11_v3  773065  773223  8  +  8  158  PF3D7_112050
0  Pf3D7_04_v3  93066  93180  8  -  8  114  PF3D7_040160
0  Pf3D7_05_v3  1123122  1123254  8  +  8  132  NA 
Pf3D7_14_v3  1320487  1320610  8  -  8  123  PF3D7_143340
0  Pf3D7_07_v3  382721  382906  9  +  8  185  PF3D7_070840
0  Pf3D7_12_v3  670843  670960  10  +  8  117  PF3D7_121690
0  Pf3D7_05_v3  1308357  1308478  8  +  8  121  PF3D7_053230
0  Pf3D7_05_v3  295120  295332  8  -  8  212  PF3D7_050710
0  Pf3D7_04_v3  632535  632670  7  -  7  135  PF3D7_041400
0  Pf3D7_08_v3  567941  568184  7  +  7  243  PF3D7_081130
0  Pf3D7_04_v3  871555  871666  7  +  7  111  PF3D7_041960
0  Pf3D7_05_v3  1082144  1082246  7  -  7  102  PF3D7_052620
0  Pf3D7_08_v3  1304355  1304457  7  +  7  102  PF3D7_083060
0  Pf3D7_08_v3  687808  688033  7  +  7  225  PF3D7_081420
0  Pf3D7_09_v3  473244  473363  8  +  7  119  PF3D7_091020
0  Pf3D7_05_v3  84561  84669  9  -  7  108  PF3D7_050160
0  Pf3D7_12_v3  928261  928434  8  +  7  173  PF3D7_122310
0  Pf3D7_05_v3  758663  758790  7  +  7  127  PF3D7_051820
0  Pf3D7_14_v3  289161  289269  8  +  7  108  PF3D7_140790
0  Pf3D7_08_v3  1252862  1253625  7  +  7  763  PF3D7_082910
0  Pf3D7_09_v3  241930  242134  7  +  7  204  PF3D7_090510
0  Pf3D7_10_v3  727098  727245  9  -  7  147  PF3D7_101820
0  Pf3D7_08_v3  687808  687949  7  +  7  141  PF3D7_081420
0  Pf3D7_12_v3  831841  831952  7  -  7  111  PF3D7_122090
0  Pf3D7_10_v3  114807  114915  7  +  7  108  PF3D7_100220
0  Pf3D7_02_v3  278039  278144  8  -  7  105  PF3D7_020700
0  Pf3D7_06_v3  1172135  1173721  8  -  7  1586  PF3D7_062830
0  Pf3D7_09_v3  653583  653694  7  -  7  111  PF3D7_091540
0  Pf3D7_12_v3  73695  73815  9  -  7  120  PF3D7_120090
0  Pf3D7_11_v3  1249394  1249565  7  -  7  171  PF3D7_113220
0  Pf3D7_02_v3  252756  253484  7  +  7  728  PF3D7_020630
0  Pf3D7_13_v3  1137874  1137980  7  -  7  106  PF3D7_132700
0  Pf3D7_13_v3  2477303  2477438  8  -  7  135  PF3D7_136180
0  Pf3D7_06_v3  454379  454555  7  +  7  176  PF3D7_061080
0  Pf3D7_10_v3  1400988  1401168  7  +  7  180  PF3D7_103530
0  Pf3D7_03_v3  524921  525211  7  -  7  290  PF3D7_031240
0  Pf3D7_13_v3  2616125  2618062  8  -  7  1937  PF3D7_136540
0  Pf3D7_07_v3  759540  760248  11  -  7  708  PF3D7_071760
0  Pf3D7_13_v3  2435964  2436078  7  +  7  114  PF3D7_136080
0  Pf3D7_13_v3  2120087  2120189  7  -  7  102  PF3D7_135300
0  Pf3D7_04_v3  104555  104699  7  +  7  144  PF3D7_040180
0  Pf3D7_10_v3  1168067  1168187  9  +  7  120  PF3D7_102830
0  Pf3D7_02_v3  349130  349232  7  -  7  102  PF3D7_020840
0  Pf3D7_13_v3  1653743  1653968  8  -  7  225  PF3D7_134200
0  Pf3D7_11_v3  932157  932433  7  -  7  276  PF3D7_112350
0  Pf3D7_05_v3  254464  255559  7  -  7  1095  PF3D7_050590
0  Pf3D7_13_v3  953152  954054  7  +  7  902  PF3D7_132250
0  Pf3D7_04_v3  93202  93324  6  -  6  122  PF3D7_040160
0  Pf3D7_05_v3  1226931  1227131  6  +  6  200  PF3D7_053010
0  Pf3D7_07_v3  613558  613676  6  -  6  118  PF3D7_063250
0  Pf3D7_09_v3  1135907  1136188  6  +  6  281  PF3D7_092800
0  Pf3D7_08_v3  149146  149350  6  +  6  204  PF3D7_080200
0  Pf3D7_06_v3  1172135  1173355  6  -  6  1220  PF3D7_062830
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Supplementary Table 3.5 (Continued) | Putative P. falciparum circRNAs with at least five 
unique supporting reads.  
 
Pf3D7_13_v3  1419327  1419564  7  -  6  237  PF3D7_133510
0  Pf3D7_12_v3  989084  989215  6  +  6  131  PF3D7_122430
0  Pf3D7_02_v3  105049  105172  6  -  6  123  PF3D7_020200
0  Pf3D7_10_v3  449519  449744  6  +  6  225  PF3D7_101170
0  Pf3D7_07_v3  858926  859031  6  -  6  105  PF3D7_071960
0  Pf3D7_09_v3  1206088  1206203  6  +  6  115  PF3D7_093030
0  Pf3D7_14_v3  1092998  1093117  6  +  6  119  PF3D7_142790
0  Pf3D7_04_v3  192469  192595  7  -  6  126  PF3D7_040340
0  Pf3D7_10_v3  475424  475589  6  -  6  165  PF3D7_101240
0  Pf3D7_10_v3  122253  122993  7  +  6  740  PF3D7_100240
0  Pf3D7_10_v3  920722  920827  6  +  6  105  PF3D7_102200
0  Pf3D7_12_v3  298589  298700  8  -  6  111  PF3D7_120660
0  Pf3D7_13_v3  632574  633492  6  +  6  918  PF3D7_131490
0  Pf3D7_14_v3  2604524  2605189  7  -  6  665  PF3D7_146440
0  Pf3D7_11_v3  1966634  1966760  6  -  6  126  PF3D7_114900
0  Pf3D7_07_v3  632766  632915  6  -  6  149  PF3D7_071390
0  Pf3D7_05_v3  876055  876159  6  +  6  104  PF3D7_052140
0  Pf3D7_06_v3  257563  259970  7  +  6  2407  PF3D7_060610
0  Pf3D7_14_v3  2392771  2392879  6  +  6  108  PF3D7_145830
0  Pf3D7_05_v3  325677  325785  7  +  6  108  PF3D7_050780
0  Pf3D7_03_v3  315573  315983  7  -  6  410  PF3D7_030720
0  Pf3D7_13_v3  418777  419424  7  +  6  647  PF3D7_130910
0  Pf3D7_04_v3  565305  565445  6  -  6  140  PF3D7_041270
0  Pf3D7_10_v3  199455  199585  6  -  6  130  PF3D7_100430
0  Pf3D7_09_v3  740226  740347  6  -  6  121  PF3D7_091790
0  Pf3D7_04_v3  501141  501249  6  -  6  108  PF3D7_041100
0  Pf3D7_05_v3  1037806  1037910  6  +  6  104  PF3D7_052500
0  Pf3D7_08_v3  687838  687985  6  +  6  147  PF3D7_081420
0  Pf3D7_12_v3  570208  570366  7  +  6  158  PF3D7_121290
0  Pf3D7_14_v3  1911799  1911937  6  +  6  138  PF3D7_144650
0  Pf3D7_12_v3  726958  727093  7  -  6  135  PF3D7_121850
0  Pf3D7_13_v3  43904  44073  7  -  6  169  PF3D7_130030
0  Pf3D7_11_v3  637022  637178  7  -  6  156  PF3D7_111680
0  Pf3D7_09_v3  154185  154335  6  +  6  150  PF3D7_090340
0  Pf3D7_13_v3  2242116  2242263  6  -  6  147  PF3D7_135660
0  Pf3D7_09_v3  1051312  1051423  6  -  6  111  PF3D7_092610
0  Pf3D7_10_v3  998424  998527  6  -  6  103  PF3D7_102390
0  Pf3D7_07_v3  1350397  1350656  6  +  6  259  PF3D7_073130
0  Pf3D7_14_v3  2207943  2208075  6  +  6  132  PF3D7_145370
0  Pf3D7_14_v3  1717491  1717623  7  +  6  132  PF3D7_144240
0  Pf3D7_05_v3  491925  492041  6  +  6  116  PF3D7_051150
0  Pf3D7_07_v3  1350787  1351048  8  +  6  261  PF3D7_073130
0  Pf3D7_14_v3  862709  862841  5  +  5  132  PF3D7_142070
0  Pf3D7_13_v3  2338754  2338859  6  +  5  105  PF3D7_135900
0  Pf3D7_14_v3  1446583  1447361  5  -  5  778  PF3D7_143570
0  Pf3D7_11_v3  977274  977775  6  -  5  501  PF3D7_112480
0  Pf3D7_02_v3  306675  306795  5  -  5  120  PF3D7_020760
0  Pf3D7_07_v3  424191  424293  5  -  5  102  PF3D7_070940
0  Pf3D7_08_v3  1032219  1032634  6  +  5  415  PF3D7_082330
0  Pf3D7_14_v3  1022302  1022410  6  -  5  108  PF3D7_142620
0  Pf3D7_10_v3  601196  601352  5  -  5  156  PF3D7_101490
0  Pf3D7_10_v3  68337  68445  5  -  5  108  PF3D7_100110
0  Pf3D7_14_v3  2526584  2526700  5  -  5  116  PF3D7_146230
0  Pf3D7_14_v3  554485  555638  5  -  5  1153  PF3D7_141400
0  Pf3D7_08_v3  670671  670780  5  +  5  109  PF3D7_081360
0  Pf3D7_07_v3  545153  553405  5  -  5  8252  PF3D7_071230
0,PF3D7_0712
400 
Pf3D7_14_v3  516906  517045  5  -  5  139  PF3D7_141280
0  Pf3D7_11_v3  1955320  1955443  5  +  5  123  PF3D7_114900
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Supplementary Table 3.5 (Continued) | Putative P. falciparum circRNAs with at least five 
unique supporting reads.  
 
Pf3D7_03_v3  430372  430551  5  +  5  179  PF3D7_031020
0  Pf3D7_10_v3  892214  892325  5  -  5  111  PF3D7_102170
0  Pf3D7_13_v3  2473986  2474136  7  +  5  150  PF3D7_136180
0  Pf3D7_11_v3  465836  465980  5  +  5  144  PF3D7_111210
0  Pf3D7_14_v3  2934564  2934698  5  -  5  134  PF3D7_147190
0  Pf3D7_13_v3  366865  367075  5  -  5  210  PF3D7_130820
0  Pf3D7_13_v3  151216  151714  5  -  5  498  PF3D7_130280
0  Pf3D7_03_v3  724969  725857  5  +  5  888  PF3D7_031760
0  Pf3D7_10_v3  1153629  1153730  5  -  5  101  PF3D7_102780
0  Pf3D7_10_v3  1181901  1182006  6  +  5  105  PF3D7_102870
0  Pf3D7_14_v3  1975985  1976111  7  -  5  126  PF3D7_144830
0  Pf3D7_14_v3  862703  862841  5  +  5  138  PF3D7_142070
0  Pf3D7_07_v3  755846  755954  6  +  5  108  PF3D7_071750
0  Pf3D7_07_v3  1321921  1322044  5  +  5  123  PF3D7_073080
0  Pf3D7_13_v3  112759  112877  5  -  5  118  PF3D7_130200
0  Pf3D7_11_v3  390605  390925  5  -  5  320  PF3D7_110940
0  Pf3D7_07_v3  276492  276609  5  -  5  117  PF3D7_070550
0  Pf3D7_07_v3  1326576  1326678  5  +  5  102  PF3D7_073090
0  Pf3D7_14_v3  978198  979167  5  +  5  969  PF3D7_142440
0  Pf3D7_11_v3  226121  226532  6  +  5  411  PF3D7_110510
0  Pf3D7_12_v3  117070  117230  5  -  5  160  PF3D7_120220
0  Pf3D7_14_v3  289383  289558  5  -  5  175  PF3D7_140790
0  Pf3D7_11_v3  1400498  1400624  5  -  5  126  PF3D7_113590
0  Pf3D7_11_v3  914678  914807  6  +  5  129  PF3D7_112310
0  Pf3D7_13_v3  2676871  2676991  5  +  5  120  PF3D7_136690
0  Pf3D7_10_v3  436699  437481  5  +  5  782  PF3D7_101120
0  Pf3D7_05_v3  492925  493049  5  -  5  124  PF3D7_051150
0  Pf3D7_13_v3  2375163  2375284  5  +  5  121  PF3D7_135960
0  Pf3D7_10_v3  423230  424021  5  +  5  791  PF3D7_101070
0  Pf3D7_05_v3  313405  313576  7  -  5  171  PF3D7_050760
0  Pf3D7_06_v3  600323  600470  5  -  5  147  PF3D7_061430
0  Pf3D7_08_v3  687919  688033  5  +  5  114  PF3D7_081420
0  Pf3D7_12_v3  162583  162709  5  -  5  126  PF3D7_120290
0  Pf3D7_07_v3  396236  396338  5  +  5  102  PF3D7_070880
0  Pf3D7_08_v3  1161061  1161578  5  -  5  517  PF3D7_082670
0  Pf3D7_12_v3  63054  63235  5  -  5  181  PF3D7_120070
0  Pf3D7_08_v3  572635  572752  5  -  5  117  PF3D7_081130
0  Pf3D7_10_v3  162759  162930  5  -  5  171  NA 
Pf3D7_14_v3  142828  143029  5  -  5  201  PF3D7_140390
0  Pf3D7_10_v3  457256  457421  6  -  5  165  PF3D7_101180
0  Pf3D7_06_v3  111456  111609  5  -  5  153  PF3D7_060260
0  Pf3D7_09_v3  1318502  1319012  5  -  5  510  PF3D7_093320
0  Pf3D7_14_v3  127516  129502  5  +  5  1986  PF3D7_140340
0  Pf3D7_12_v3  977371  977902  5  -  5  531  PF3D7_122410
0  Pf3D7_14_v3  2207961  2208075  5  +  5  114  PF3D7_145370
0  Pf3D7_10_v3  1424310  1424445  7  -  5  135  PF3D7_103590
0   
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Supplementary Table 3.6| CircRNA GO term enrichment results 
circRNA-specific GO term  circRNA-specific  
GO term  p-value 
cytosolic ribosome (sensu Eukaryota)  2.26E-06 
cytosol  2.26E-06 
cytosolic large ribosomal subunit (sensu Eukaryota)  5.11E-06 
cytosolic part  5.15E-06 
large ribosomal subunit  2.47E-05 
ribosomal subunit  5.95E-05 
ribosome  1.96E-04 
structural constituent of ribosome  1.96E-04 
macromolecule metabolic process  2.32E-04 
macromolecule biosynthetic process  4.52E-04 
protein metabolic process  1.27E-03 
non-membrane bound organelle  1.32E-03 
intracellular non-membrane bound organelle  0.00132 
cellular protein metabolic process  0.00215 
cellular macromolecule metabolic process  0.00228 
ribonucleoprotein complex  0.0023 
translation  0.00387 
primary metabolic process  0.00413 
gene expression  0.00552 
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Supplementary Table 3.7 | Divergent circRNA PCR primer pairs targeting nine tested loci. 
Yellow indicates successful experimental confirmation of predicted circRNA junction. 
 
Target  cDNA1  cDNA2  Product 
(bp)  Divergent circRNA PCR primer sequences 
Pf3D7_0909300_F 
  T20  Ring  161 
TAA TAC GAC TCA CTA TAG 
GGtagtagtagtagAAGAAGAACAGGCTAGAAAG 
Pf3D7_0909300_R 
          
CGC CAG GGT TTT CCC AGT CAC 
GACtagtagtagtagTTCAGGTGTCAATAAGGACT 
Pf3D7_1474200_F  T32 
Late 
Trophozoite  505 
TAA TAC GAC TCA CTA TAG 
GGtagtagtagtagGTTATCCAACTACAGAGGAGA 
Pf3D7_1474200_R 
          
CGC CAG GGT TTT CCC AGT CAC 
GACtagtagtagtagATATGAACCACTTGAGTATA
TTCC 
Pf3D7_1438400_F 
  T44  Schizont  324 
TAA TAC GAC TCA CTA TAG 
GGtagtagtagtagGAAACATCAACTGCTAATATA
TCTT 
Pf3D7_1438400_R 
          
CGC CAG GGT TTT CCC AGT CAC 
GACtagtagtagtagCAAACAAACAAACACCATA
AATAAA 
Pf3D7_1026000_F  T20  Ring  591 
TAA TAC GAC TCA CTA TAG 
GGtagtagtagtagAAGTTCAAGATGGAAGTGC 
Pf3D7_1026000_R 
       
CGC CAG GGT TTT CCC AGT CAC 
GACtagtagtagtagATTCAAAATTATTATTTCAC
AGAGGA 
Pf3D7_0936800_F 
  TT8  Ring  571 
TAA TAC GAC TCA CTA TAG 
GGtagtagtagtagAAAGGGTAATAATCAAGCGA
A 
Pf3D7_0936800_R 
          
CGC CAG GGT TTT CCC AGT CAC 
GACtagtagtagtagATTGTTATGTTCTTCTGGACT
T 
Pf3D7_1202600_F 
  TT8 
Late 
Trophozoite  261 
TAA TAC GAC TCA CTA TAG 
GGtagtagtagtagTGAAATGCCAAAGAAGAAAG
A 
Pf3D7_1202600_R 
       
CGC CAG GGT TTT CCC AGT CAC 
GACtagtagtagtagATCATCCTCTTGCTCCTTATA
T 
Pf3D7_0414900_F  T6  Ring  246 
TAA TAC GAC TCA CTA TAG 
GGtagtagtagtagTTGAATCTGGTGCTTTGC 
Pf3D7_0414900_R          
CGC CAG GGT TTT CCC AGT CAC 
GACtagtagtagtagATTGAGTTGCGGATAATGC 
Pf3D7_0817700_F  TT8  Schizont  215 
TAA TAC GAC TCA CTA TAG 
GGtagtagtagtagTGAACAACTTGAAATGGATTT
ATT 
Pf3D7_0817700_R 
          
CGC CAG GGT TTT CCC AGT CAC 
GACtagtagtagtagAAGGAACTTATATCTTGACT
ATCTAG 
Pf3D7_1314900_F  T20 
Early 
Trophozoite  220 
TAA TAC GAC TCA CTA TAG 
GGtagtagtagtagATGGAATTTGCTGGTAGAAA 
Pf3D7_1314900_R 
       
CGC CAG GGT TTT CCC AGT CAC 
GACtagtagtagtagTCTCTTACAACATCTTCAAC
AA 	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